Functional Characterisation of Human MUS81 Complexes by Pepe, A
  1 
 
 
FUNCTIONAL CHARACTERISATION 
OF HUMAN MUS81 COMPLEXES 
 
 
Alessandra Pepe 
 
 
London Research Institute, Cancer Research UK 
and 
University College London 
 
PhD Supervisor: Dr Stephen C West 
 
 
A thesis submitted for the degree of 
Doctor of Philosophy 
University College London 
September 2013 
 
  
  2 
DECLARATION 
 
I Alessandra Pepe confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources, I confirm that this has been 
indicated in the thesis. 
  3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
‘We live on an island surrounded by a sea of ignorance.  
As our island of knowledge grows, so does the shore of our ignorance.’ 
 
John Archibald Wheeler 
 
 
 
 
 
 
 
 
  4 
ABSTRACT 
 
Human cells employ a variety of mechanisms to repair DNA damage and maintain 
genomic integrity. Structure-specific endonucleases play crucial roles in the repair 
of DNA lesions by removing secondary DNA structures that can lead to 
chromosome mis-segregation, aneuploidy and cancer. MUS81 is the catalytic 
subunit of two human structure-specific endonucleases, MUS81-EME1 and 
MUS81-EME2. MUS81 nuclease has been shown to function in the resolution of 
homologous recombination (HR) intermediates, in the repair of stalled replication 
forks (RFs) and in the maintenance of telomere length in alternative lengthening of 
telomeres (ALT)-positive cells. However, it is unknown whether the two MUS81 
complexes differ in their biological functions. 
 
To address this question, we carried out in vivo and in vitro studies to determine 
the roles of MUS81-EME1 and MUS81-EME2 in human cells. We found that EME2 
interacts with MUS81 preferentially during the S-phase of the cell cycle, when 
MUS81 is important for the repair of stalled RFs. Cells treated with HU and 
depleted of MUS81 or EME2, but not of EME1, showed high levels of chromosomal 
aberrations, suggesting that the MUS81-EME2 complex is important for the 
maintenance of genomic stability following HU exposure. Also, depletion of EME2 
or MUS81, but not of EME1, resulted in telomere loss, decreased rate of telomere 
sister chromatid exchanges (T-SCEs) and increased telomere fragility in ALT-
positive cells. Consistent with the in vivo functional differences, we found that 
purified MUS81 complexes have different DNA substrate specificities in vitro, with 
the activity of MUS81-EME2 being 10-fold greater than that of MUS81-EME1. 
 
Together, these results indicate that MUS81-EME1 and MUS81-EME2 have 
different biochemical properties and distinct, non-overlapping functions, with 
MUS81-EME2 being important in the repair of stalled RFs and in telomere 
maintenance of ALT cells, whereas MUS81-EME1 plays an important role in the 
resolution of HJs in the context of HR-mediated DNA repair. 
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CHAPTER 1 
Introduction 
 
1.1 DNA damage  
The faithful conservation of our genetic information is critical for the maintenance of 
genomic stability and for the prevention of cancer development. DNA needs to be 
constantly protected from different kinds of DNA damage induced by endogenous 
cellular processes and by exogenous (or environmental) factors. One of the major 
causes of spontaneous DNA damage is the incorporation of incorrect bases during 
DNA replication. DNA polymerases incorporate nucleotides that are 
non-complementary to the template DNA strand with a frequency of one 
mis-incorporation in 107 nucleotides synthesised (McCulloch and Kunkel, 2008). 
Therefore, considering the size of the human genome (approximately 3 x 109 base 
pairs), they generate hundreds of base mismatches during each round of DNA 
replication (Echols and Goodman, 1991). Other causes of DNA mismatches 
include spontaneous deamination of bases (i.e. cytosine to uracil, adenine to 
hypoxanthine and guanine to xanthine) (Lindahl, 1993) and incorporation of 
damaged nucleotides, such as oxidated 8-oxo-dGTP (Pavlov et al., 1994). 
Furthermore, the by-products of cellular metabolism such as reactive oxygen 
species (ROS) also contribute to endogenous DNA damage (Pavlov et al., 1994). 
For example, ROS (peroxide, hydrogen peroxide and hydroxyl radicals) can react 
with DNA and fragment the component base and sugar moieties, thus generating 
single strand breaks (Imlay and Linn, 1988). 
 
Exogenous DNA damage can come from either physical or chemical sources. 
Physical DNA damaging factors include ionising radiation (IR) and ultraviolet 
(UV)-light. The main sources of IR are naturally occurring radionuclides (e.g. 
cosmic radiation) and X-rays used for medical diagnosis. Exposure to IR results in 
base oxidation and in the formation of single- and double-stranded DNA breaks 
(Goodhead, 1989; Hutchinson, 1985; Teoule, 1987). UV light is an electromagnetic 
radiation found in sunlight. Extensive exposure to UV light can lead to covalent 
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linkages between two adjacent pyrimidines and to the formation of cyclobutane 
pyrimidine dimers (Setlow, 1966) and (6-4) photoproducts (Mitchell and Nairn, 
1989). Examples of chemical DNA damaging agents include alkylating agents (e.g. 
methyl methanesulfonate or MMS), which insert alkyl groups on DNA bases 
(Singer, 1975), and interstrand crosslinking agents (e.g. cisplatin, mitomycin C), 
which can covalently link the two DNA strands (interstrand crosslinks; ICLs) and 
prevent their correct separation during cell division (Iyer and Szybalski, 1963; 
Roberts and Pascoe, 1972). Both types of chemicals have been widely used as 
chemotherapic drugs because they interfere with DNA replication, transcription and 
cell division. Other DNA damaging drugs include topoisomerase inhibitors such as 
camptothecin (CPT), which inhibits DNA topoisomerase I (Froelich-Ammon and 
Osheroff, 1995), and hydroxyurea (HU), which inhibits ribonucleotide reductase 
and thereby depletes the pool of dNTPs required for DNA replication (Bianchi et al., 
1986). 
 
1.1.1 Cellular effects of DNA lesions  
DNA lesions lead to many adverse cellular effects and, if left unrepaired, result in 
irreversible mutations and can drive tumourigenesis. Many endogenous and 
exogenous factors described in the previous section generate lesions that block 
DNA replication and transcription and affect chromosome segregation during 
mitosis. For example, unrepaired DNA double strand breaks (DSBs) can result in 
the uneven distribution of genetic material between the two daughter cells, causing 
chromosomal deletions, translocations and aneuploidy, all of which represent 
hallmark features of cancer cells (Hoeijmakers, 2001). In order to allow the repair of 
the lesion, cells trigger a transient cell cycle arrest called “checkpoint”, during the 
G1/S, G2 or M phase of the cell cycle (Painter and Young, 1980). However, when 
the damage load is too great and cannot be repaired, cells undergo apoptosis and 
thereby prevent the accumulation of permanent mutations (Rich et al., 2000). 
 
Eukaryotic cells have developed a range of different mechanisms in order to cope 
with the variety of DNA damages and maintain genomic integrity. For example, 
mis-incorporated DNA bases are recognised and replaced with correct bases by 
the DNA mismatch repair pathway (Kunkel, 1995), whereas small, non-helix-
distorting lesions are repaired by the base excision repair (BER) pathway through 
CHAPTER 1 - Introduction 
 20 
excision of the damaged bases (Lindahl and Wood, 1999). Helix-distorting 
damages, such as UV-induced lesions and intrastrand crosslinks, which are formed 
by the covalent linkage of two bases on the same DNA strand, are repaired by the 
nucleotide excision repair (NER) pathway through the removal of an approximately 
30 nucleotides-long DNA fragment (Section 1.2.1). DSBs can be repaired by either 
non-homologous end joining (NHEJ), through the re-ligation of the broken ends, or 
by the homologous recombination (HR) machinery. Cells employ NHEJ or HR 
depending on the cell cycle phase during which DSBs are generated: HR is the 
primary repair pathway during S- and G2-phase, when the newly synthesised sister 
chromatid can be used as template for repair, whereas NHEJ takes place 
throughout the cell cycle but it is particularly important during G1-phase, when HR 
does not occur (Rothkamm et al., 2003). NER, NHEJ and HR will be discussed in 
greater detail in the future sections. 
 
1.2 DNA repair mechanisms 
1.2.1 Nucleotide excision repair  
NER is the most versatile of the repair mechanisms because it recognises DNA 
lesions by the local structural distortions they induce in the DNA helix (Gunz et al., 
1996). NER is particularly important for the repair of UV-induced lesions such as 
cyclobutane pyrimidine dimers and (6-4) photoproducts but it can also deal with 
damage created by crosslinking agents (e.g. cisplatin) or by chemicals that 
covalently bind DNA bases and form bulky DNA adducts (e.g. benzo[a]pyrenes 
contained in cigarettes smoke). This multistep repair mechanism involves (i) the 
recognition of DNA damage, (ii) the denaturation of DNA surrounding the lesion, 
(iii) cleavage of the damaged strand, and (iv) gap filling and DNA ligation reactions 
(Figure 1.1). First, XPC-HR23B-centrin2, a complex with high affinity for damaged 
DNA, identifies the lesion (Araki et al., 2001; Sugasawa et al., 1998). Second, the 
transcription factor TFIIH is recruited to the site of damage and its helicase 
subunits, XPB and XPD, open the two DNA strands around the lesion, creating a 
single-stranded bubble (Coin et al., 2007; Winkler et al., 2000). The next step 
involves the incision and removal of the damaged DNA. The XPG endonuclease 
incises the DNA bubble on the 3’-side of the lesion (O'Donovan et al., 1994), while 
the XPF-ERCC1 complex performs the incision on the 5’-side (Mu et al., 1996). 
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Figure 1.1 Schematic representation of nucleotide excision repair 
The initial step of nucleotide excision repair is recognition and binding of the DNA 
lesion (red circle) by the multi-subunit protein complex XPC-hHR23B-CEN2. The 
TFIIH complex is subsequently recruited to the lesion and the XPB and XPD 
helicase subunits unwind the DNA helix, thus forming a single-stranded bubble that 
is stabilised by RPA. The XPG and XPF-ERCC1 flap endonucleases cleave the 
bubble at the junctions between single-stranded and double-stranded DNA on the 
5’- and 3’-sides of the lesion (indicated by red arrows), respectively. This results in 
the excision of the DNA lesion and approximately 25 to 30 nucleotides of adjacent 
DNA. The final steps of NER involve restoration of the intact DNA duplex. More 
specifically, this requires the combined activities of DNA polymerases δ and ε, 
which catalyse gap-filling, and the XRCC1-DNA ligase III complex that joins 
adjacent DNA ends. The red-coloured DNA in the bottom panel indicates newly 
synthesised DNA. 
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Once a DNA fragment of approximately 25-30 nucleotides has been excised 
(Moggs et al., 1996), DNA polymerases δ and ε fill the single-stranded gap 
(Popanda and Thielmann, 1992) and the XRCC1-DNA ligase III complex ligates the 
remaining nicks (Moser et al., 2007). Inherited defects in the NER pathway are 
associated with the onset of human disorders that include Xeroderma 
pigmentosum (XP), Cockayne syndrome (CS) and tricothiodystrophy (TTD). As 
NER is an essential pathway for the repair of UV-induced DNA lesions, it is not 
surprising that these syndromes are all characterised by photohypersensitivity of 
the skin (Diderich et al., 2011). 
 
1.2.2 Double strand break repair 
DNA DSBs are the most toxic and mutagenic forms of DNA lesions. DSBs occur 
when both strands of the DNA duplex are broken and two physically separated 
DNA ends are created. These ends have the ability to recombine with other sites in 
the genome leading to gross chromosomal rearrangements (up to 100 million base 
pairs) and often to cell death (Richardson and Jasin, 2000). Despite their high 
mutagenic potential, cells program the formation of DSBs in the context of specific 
cellular processes like V(D)J recombination and meiosis. The V(D)J recombination 
pathway takes place in B and T-lymphocytes and promotes the production of 
diverse antigen receptors (Alt et al., 2013). These DNA DSBs are induced at 
specific loci by the lymphocyte-specific RAG endonuclease (Oettinger et al., 1990) 
and repaired by proteins of the non-homologous end-joining (NHEJ) pathway 
(Boboila et al., 2012) (Section 1.2.2). In meiosis, the programmed production of 
DSBs and their repair by HR (Section 1.2.2) is essential for proper chromosome 
segregation and for the generation of genetic diversity. Prior to the onset of meiosis 
I, the topoisomerase-like transesterase Spo11 creates DSBs via the formation of 
an intermediate in which Spo11 forms a covalent linkage with the 5’-phosphate of 
the DNA backbone (Keeney et al., 1997). Induction of DSB formation is essential 
for the initiation of meiotic recombination and the formation of inter-homologue joint 
molecules in which the interacting DNA strands are physically linked (Schwacha 
and Kleckner, 1995). Structure-specific endonucleases resolve these joint 
molecules (i.e. cleave these structures into two linear duplex DNA molecules) and 
promote the exchange of genetic material required to generate a different allele 
combination to that of the parental germline. Formation and resolution of these 
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structures is required for the bi-polar segregation of homologous chromosomes in 
anaphase I (Petronczki et al., 2003). 
 
For many years, endonucleolytic cleavage and environmental DNA damaging 
agents were considered the only sources of DSBs. DSBs that are generated during 
V(D)J recombination and meiosis have two free DNA ends and are termed 
two-ended DSBs. However, in mitotic cells, the formation of two-ended DSBs is a 
rare event. The majority of the DSBs have one free DNA end (i.e. one-ended 
DSBs) and are generated either directly or indirectly during DNA replication (Saleh-
Gohari et al., 2005), when a replication fork (RF) encounters an unrepaired single-
strand break or a lesion (e.g. ICLs) (Hanada et al., 2006; Strumberg et al., 2000). 
Eukaryotic cells have developed two major pathways to repair two-ended and one-
ended DSBs and hence maintain genomic integrity: NHEJ and HR. 
 
Non-homologous end joining 
NHEJ is a mechanism of DSB repair whereby the two broken DNA ends are 
re-joined in a sequence-independent manner (Lieber, 2010) and can be divided 
into three stages: (i) binding and tethering of the DSB ends, (ii) DNA end 
processing and (iii) DNA ligation. As illustrated in Figure 1.2A, NHEJ is initiated by 
the binding of the Ku70/80 (Ku) heterodimer and DNA-PKCS, a serine/threonine 
protein kinase that belongs to the phosphatidylinositol 3-kinase-like protein kinase 
family, to the broken DNA ends (Mimori and Hardin, 1986), where Ku forms a ring-
like structure that promotes the alignment of the two DNA extremities (Ma et al., 
2004). The second step involves the enzymatic processing of the DSB ends. 
NHEJ-mediated repair of blunt DNA DSBs is very precise, i.e. it occurs without loss 
of any nucleotide (van Heemst et al., 2004). However, the configuration of DNA 
ends at DSBs varies according to the source of the lesion and affects the fidelity of 
the ligation process. Many DNA ends contain damaged backbone sugars or DNA 
bases, 5’-hydroxyl or 3’-phosphate groups as well as 5’- or 3’-single-stranded 
extensions. As a result, cells employ a variety of DSB ends-processing enzymes 
and DNA polymerases to ensure that DNA ends are restored prior to re-ligation. 
For example, Artemis, a member of the metallo-beta–lactamase superfamily of 
enzymes, interacts with DNA-PKCS and cleaves DNA hairpins (intermediates of 
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Figure 1.2 Schematic representation of two-ended DSB repair pathways 
A. During NHEJ, DSB DNA ends are first tethered by Ku-DNA-PKCS. DNA end-processing factors such as Artemis, XRCC4-PNK, 
DNApolµ and λ and WRN bind and process DNA ends, thereby facilitating XLF-XRCC4-DNA ligase IV-dependent re-ligation.  
B. In HR-mediated repair, the damaged DNA is re-synthesised using a homologous DNA sequence as the template. DSB DNA 
end-resection results in the formation of single-stranded 3’-overhangs, which serve as substrates for the DNA-binding protein RAD51. 
The RAD51-coated DNA filament initiates the search for homology and catalyses strand invasion, which forms a D-loop structure. The 
free 3’-end of the D-loop provides a primer for the synthesis of nascent DNA. In the SDSA pathway, DNA helicases like BLM, RTEL and 
FANCM unwind the D-loop and displace the invading strand, which results in the formation of non-crossover products. In contrast, the 
DSBR pathway of HR involves the formation of a dHJ that can be processed by BTR-mediated dissolution, which exclusively generates 
non-crossover products, or by SLX-MUS/GEN1-mediated resolution, which can result in either crossover or non-crossover products, 
depending on the orientation of HJ cleavage. 
C. The SSA pathway is engaged when the DSB occurs in a region of repetitive DNA sequences (indicated by green boxes). Resected 
DSB DNA ends are bound by RAD52, which promotes the annealing of the repetitive elements. The non-homologous DNA that is located 
between the repeats forms flap structures that are cleaved by the structure-specific 3’-flap endonuclease XPF-ERCC1, resulting in the 
loss of genetic information. 
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V(D)J recombination) and 3’-single-stranded overhangs (Ma et al., 2002; Ma et al., 
2005). X-ray cross-complementing gene 4 (XRCC4) interacts with polynucleotide 
kinase (PNK) to remove 3’-phosphate groups and 5’-hydroxyl groups (Chappell et 
al., 2002), whereas DNA polymerases µ and λ, two members of the Pol X family of 
DNA polymerases, fill gaps formed by partially complementary DNA ends 
(McElhinny et al., 2005). Finally, WRN (Werner) helicase, a member of the RecQ 
family of helicases mutated in Werner syndrome, possesses an exonucleolytic 
activity that is stimulated by the interaction with the Ku complex and that is required 
for efficient DNA end joining (Perry et al., 2006). The last step of NHEJ consists in 
the ligation of the juxtaposed DNA ends, which is performed by the XLF-XRCC4–
DNA ligase IV complex, a very flexible ligase with the ability to ligate gaps of 
several nucleotides as well as incompatible DNA ends in vitro (Grawunder et al., 
1997; Gu et al., 2007). 
 
NHEJ versus HR 
Sequence alterations deriving from the processing of incompatible DNA ends make 
NHEJ an error-prone DSB repair pathway. Also, the presence of more than one 
DSB could induce inappropriate NHEJ-mediated ligation of non-contiguous 
sequences, resulting in chromosomal deletions, insertions, translocations and 
hence genomic instability. In contrast, homologous recombination (HR) is an 
accurate, error-free mechanism of DSB repair (San Filippo et al., 2008), whereby 
the damaged DNA sequence is re-synthesised using a homologous DNA molecule 
as a template for repair. The requirement for a homologous sequence makes HR 
the preferred DSB repair pathway during the S- and G2-phases of the cell cycle, 
where recombination can occur with the available intact sister chromatid 
(Rothkamm et al., 2003). Conversely, NHEJ operates throughout the cell cycle and 
is especially important during G1. Indeed, NHEJ-deficient DT40 cells are more 
sensitive to IR during G1 and early S, whereas HR-deficient cells are primarily 
sensitive during S and G2 (Takata et al., 1998). In addition, the repair of one-ended 
DSBs that arise during DNA replication can only be performed by HR, as the 
mechanism of NHEJ-mediated DSB repair requires the presence of two DNA ends. 
As a result, HR-deficient cells are sensitive to many anti-cancer drugs that block 
DNA replication whereas NHEJ-deficient cells are mostly sensitive to those that 
induce DSBs (Helleday, 2010). 
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Homologous recombination  
DSB end resection 
The initial stages of HR involve 5’-3’ nucleolytic resection of the damaged DNA 
ends and the formation of 3’-single-stranded DNA (ssDNA) overhangs (Figure 
1.2B). The mechanism of end resection is conserved from yeast to humans and 
current models suggest that resection is a two-step process (Mimitou and 
Symington, 2008; Zhu et al., 2008). The first step, called resection initiation, is 
essential when the DNA ends have covalent modifications or bulky DNA adducts 
that need to be processed in order to allow extensive resection (Gravel et al., 2008; 
Hartsuiker et al., 2009; Nicolette et al., 2010). Resection initiation requires the MRN 
complex, which is formed by the MRE11 nuclease, RAD50, a member of the SMC 
(structural maintenance of chromosomes) superfamily, and NBS1. MRN is 
recruited to the DSB, where two MRE11 and two RAD50 molecules associate to 
form a heterotetramer, which stabilises and tethers DNA ends to facilitate the repair 
of the break (Buis et al., 2008; Williams and Tainer, 2005). DNA-bound MRN 
interacts with CtIP (C-terminal-binding protein-interacting protein), which is 
recruited upon phosphorylation of the NBS1 component (Buis et al., 2012; Dodson 
et al., 2010; Sartori et al., 2007), and the MRN-CtIP complex initiates 5’-3’ resection 
of the DNA ends (Nicolette et al., 2010; Sartori et al., 2007). The second step, 
called resection extension, can be performed either by (i) the combined actions of 
the BLM helicase and the DNA2 nuclease, whereby DNA2 resects the DNA 
unwound by BLM, or by (ii) the activity of the 5’-3’ exonuclease EXO1 (Figure 1.3) 
(Nimonkar et al., 2011; Zakharyevich et al., 2010; Zhu et al., 2008). These two 
mechanisms, however, are not completely independent, as BLM has been shown 
to interact directly with EXO1 and to stimulate its dsDNA resection activity in vitro 
(Nimonkar et al., 2008).  
 
Cell-cycle regulation of NHEJ and HR occurs mainly through the control of DSB 
end resection. In particular, CtIP appears to have an essential regulatory role in this 
process: the protein levels of CtIP are kept low during G1-phase of the cell cycle 
(via proteosomal degradation), but increase as cells progress through S and G2 
(Buis et al., 2012). Furthermore, during S/G2, cyclin-dependent kinase (CDK)-
dependent phosphorylation of CtIP at Ser327 promotes its interaction with the MRN 
complex and its phosphorylation at Thr847 triggers DSB end resection (Chen et al., 
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2008a; Huertas and Jackson, 2009). DNA end resection is also regulated by the 
interplay between the tumour suppressor 53BP1 and BRCA1. 53BP1 binds 
chromatin at the DSB site and prevents the initiation of DNA resection, thus 
promoting NHEJ (Bunting et al., 2010; Nakamura et al., 2006). However, the HR 
inhibitory activity of 53BP1 must be suppressed during S/G2-phase of the cell cycle, 
when HR takes place. This is achieved by the binding of BRCA1 to the DSB, which 
counteracts the activity of 53BP1 and promotes HR (Moynahan et al., 1999). The 
mechanism by which 53BP1 and BRCA1 ensure an equilibrium between HR and 
NHEJ is unclear, although it is likely that the interaction between BRCA1 and DNA 
alters the chromatin state at the site of the DSB, thereby preventing the 
accumulation of 53BP1 (Chapman et al., 2012).  
 
RAD51-mediated strand exchange 
The core reactions of HR, strand exchange and homologous pairing, are mediated 
by the RecA/RAD51 family of recombinases. RAD51, the human ortholog of the 
Escherichia coli RecA protein, is a 38 kDa protein that polymerises on ssDNA to 
form an evolutionarily conserved right-handed helical structure formed by 6.4-6.5 
RAD51 monomers per helical turn, which cover approximately 18 nucleotides of 
ssDNA (Figure 1.3) (Benson et al., 1994; Conway et al., 2004; Ogawa et al., 1993; 
Yu et al., 2001). The formation of the RAD51 nucleofilament is required to initiate 
the strand exchange reaction and occurs in two steps referred to as (i) nucleation 
and (ii) filament extension. Filament nucleation involves the initial association of 4 
to 5 RAD51 monomers with ssDNA (van der Heijden et al., 2007). Multiple 
nucleation events occur along a ssDNA molecule in a stochastic manner and, 
although nucleation does not require ATP hydrolysis, the binding of ATP to the 
RAD51 monomer-monomer interface favours nucleation by stabilising protein-
protein interactions (Chi et al., 2006). Filament extension involves the binding of 
additional RAD51 monomers to the nucleated patches of ssDNA. Given that 
nucleation is a stochastic event, the RAD51 filaments that result from the extension 
reaction are not continuous but contain gaps of ssDNA that are not bound by 
recombinase molecules (Modesti et al., 2007; van der Heijden et al., 2007). Hence, 
each nucleoprotein filament is formed by filament patches that are approximately 
35 RAD51 monomers long, which confer high structural flexibility, thus favouring 
the strand exchange (van der Heijden et al., 2007). 
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Unlike E. coli RecA, which shows high affinity for ssDNA (West et al., 1980), 
human RAD51 binds both ssDNA and double-stranded DNA (dsDNA) with equal 
affinities (Thorslund et al., 2010; Yu et al., 2001) and needs to be targeted to 
ssDNA in order to promote strand invasion. In addition, the formation of the 
RAD51:DNA nucleoprotein filament (or presynaptic filament) is hampered by the 
binding of RPA to ssDNA following end resection. Although RPA can remove 
secondary structures in ssDNA and facilitate the loading of RAD51, its binding 
affinity for ssDNA is stronger than that of RAD51 and therefore, it represents a 
physical impediment to the nucleoprotein filament formation (Sugiyama et al., 
1997). As a result, mammalian cells employ several recombination mediator 
proteins to counteract the inhibitory activity of RPA and target RAD51 to ssDNA. 
These include (i) the tumour suppressor BRCA2 and its interacting protein PALB2, 
(ii) RAD52, (iii) RAD54 and (iv) the RAD51 paralogs.  
 
BRCA2 is the product of the human breast cancer susceptibility gene and is a 
tumour suppressor protein (Wooster et al., 1995). Mutations in the BRCA2 gene 
predispose individuals to breast, ovarian and other cancer types. Its biallelic 
inactivation results in the onset of Fanconi anaemia (FA) (Howlett et al., 2002; Roy 
et al., 2012), an autosomal recessive disorder characterised by bone marrow 
failure, susceptibility to cancer and hypersensitivity to ICL agents (D'Andrea, 2010). 
Indeed, when BRCA2-/- cells were exposed to DNA cross linkers, they exhibited 
chromosomal breakages and tri-radial chromosomes, which are hallmark features 
of FA (Patel et al., 1998). BRCA2 (also called FANCD1) is a 3418 amino acids 
protein that interacts with RAD51 and promotes its localisation to DNA damage 
sites, as cell lines deficient in BRCA2 fail to form RAD51 foci in response to DNA 
damage (Yuan et al., 1999). The BRCA2 protein contains eight conserved BRC 
motifs and a DNA binding domain composed of three 
oligonucleotide/oligosaccharide-binding (OB) folds, a helix-turn-helix (HtH) motif 
and an alpha-helical domain (Bork et al., 1996). BRCA2 binds ssDNA and interacts 
with RAD51 primarly via the BRC repeats (Chen et al., 1998; Wong et al., 1997), 
but interaction via an unrelated C-terminal motif can occur in response to DNA 
damage or in a cell cycle-dependent manner (Ayoub et al., 2009; Esashi et al., 
2005). In vitro analysis of the interaction between full length purified BRCA2 and 
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RAD51 revealed that BRCA2 is able to target RAD51 to ssDNA, thus stimulating 
RAD51-mediated strand invasion (Jensen et al., 2010; Thorslund et al., 2010). 
 
The function of BRCA2 is largely dependent on its interaction with PALB2 (partner 
and localiser of BRCA2) (Sy et al., 2009). Like BRCA2, mutations in PALB2 
predispose individuals to breast and ovarian cancer and its biallelic inactivation 
promotes the onset of FA (Rahman et al., 2007; Reid et al., 2007). Hence, PALB2 
is also known as FANCN. The BRCA2-PALB2 interaction occurs between the 
C-terminal domain of PALB2 and the N-terminus of BRCA2 (Oliver et al., 2009) and 
it is essential for the loading of RAD51 onto RPA-bound ssDNA and for the 
stabilisation and localisation of BRCA2 to the sites of DNA damage (Xia et al., 
2006). Additionally, PALB2 interacts directly with both BRCA1 and BRCA2, 
providing a physical link between the two tumour suppressor proteins (Zhang et al., 
2009).  
 
In human cells, BRCA2 is the major mediator of RAD51 nucleoprotein filament 
formation. However, recent studies have revealed that human RAD52 mediates a 
BRCA2-independent pathway of RAD51 filament formation (Feng et al., 2011; Lok 
et al., 2013). Indeed, depletion of RAD52 in BRCA2- or PALB2-deficient cells 
causes severe proliferation defects and chromosomal fragility, indicating a 
synthetic lethal relationship between RAD52, BRCA2 and PALB2. Furthermore, in 
the absence of BRCA2 or PALB2, RAD52 promotes HR and RAD51 foci formation 
in response to DNA damage (Feng et al., 2011; Lok et al., 2013). Consistent with 
the in vivo data, RAD52 has been shown to interact with RAD51 to promote 
homologous pairing and strand exchange in vitro (Benson et al., 1998; McIlwraith 
et al., 2000).  
 
RAD54 belongs to the Swi2/Snf2 family of chromatin remodelling factors, which 
contain a motor domain that promotes its ATP-dependent translocation on dsDNA 
(Ristic et al., 2001). The functions of RAD54 in HR include: (i) stabilisation of the 
RAD51 nucleoprotein filament, (ii) stimulation of DNA strand exchange and (iii) 
branch migration of recombination intermediates. Mammalian RAD54 interacts
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Figure 1.3 DSB end resection and RAD51 nucleofilament formation 
DSB DNA end resection can be performed either by (i) BLM and DNA2 through a 
mechanism in which DNA2 resects the DNA unwound by BLM or by (ii) the 
exonucleolytic activity of EXO1. Subsequently, RAD51 is loaded on resected DNA 
ends by the recombination mediator protein BRCA2. Electron microscopy image of 
the human RAD51 nucleoprotein filament (taken from (West, 2003)) 
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directly with RAD51 (Golub et al., 1997) and its depletion has been shown to impair 
RAD51 foci formation in response to DNA damage (Tan et al., 1999), 
demonstrating the biological significance of the interaction. It functions as a 
recombination mediator by stabilising the RAD51 nucleoprotein filament in an ATP-
independent manner (Agarwal et al., 2011). Indeed, the interaction between 
RAD54 and the RAD51 nucleoprotein filament has been shown to protect the 
filament against dissociation at elevated salt concentrations and to increase the 
RAD51-dependent protection of dsDNA from restriction endonucleases (Mazin et 
al., 2003). In addition, RAD54 is able to stimulate RAD51-mediated DNA strand 
exchange in vitro in an ATP-dependent manner, although the mechanism of 
stimulation remains to be determined (Sigurdsson et al., 2002). Importantly, RAD54 
may also contribute to the late stages of HR, as it has been shown that human 
purified RAD54 is able to branch migrate Holliday junctions (HJs) and dissociate 
displacement loops (D-loops) in vitro (Bugreev et al., 2007; Bugreev et al., 2006). 
Finally, it is important to mention that Mus81, the catalytic subunit of the S. 
cerevisiae structure-specific endonuclease Mus81-Mms4, was first identified in a 
two-hybrid screen using S. cerevisiae Rad54 protein as bait (Interthal and Heyer, 
2000; Mazina and Mazin, 2008). Human RAD54 also interacts with the human 
ortholog of Mus81-Mms4, MUS81-EME1, and stimulates its endonucleolytic activity 
in vitro (Mazina and Mazin, 2008). However, the biological significance of this 
interaction in human cells has not been investigated. 
 
Human cells contain five RAD51 paralogs, namely RAD51B, RAD51C, RAD51D, 
XRCC2 and XRCC3, all of which function in HR repair. Chicken DT40 cells 
depleted of any of the RAD51 paralogs exhibit sensitivity to DNA cross linkers and 
IR, as well as defects in HR repair, as indicated by an increased frequency of 
chromosomal aberrations, a reduced frequency of HR-mediated gene targeting and 
DSB repair, and reduced sister chromatid exchanges (Fuller and Painter, 1988; 
Jones et al., 1987; Pierce et al., 1999; Takata et al., 2000; Takata et al., 2001). 
Human cells depleted of RAD51C, RAD51B or XRCC3 exhibited increased 
frequencies of mitotic aberrations and centrosomal defects, with XRCC3 being 
particularly important for chromosome segregation during anaphase (Rodrigue et 
al., 2013). Furthermore, RAD51D has been shown to localise to the telomeres of 
meiotic and telomerase-positive somatic cells, where its activity is required to 
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prevent telomere shortening and chromosomal end-to-end fusions (Tarsounas et 
al., 2004). 
 
RAD51 paralogs form two functionally distinct complexes in human cells: RAD51B-
RAD51C-RAD51D-XRCC2 (BCDX2) and RAD51C-XRCC3 (CX3) (Masson et al., 
2001). Due to difficulties in the purification of the BCDX2 complex, the activities of 
the BC and DX2 sub-complexes were analysed separately. BC was found to exhibit 
a RAD51 mediator activity (Sigurdsson et al., 2001) and its depletion resulted in (i) 
increased gene conversion tract lengths, (ii) increased rate of discontinuous tracts 
and (iii) more frequent local rearrangements associated with HR (Brenneman et al., 
2002). Interestingly, recent studies demonstrated that the BCDX2 and CX3 
complexes act at different stages of the HR pathway, with BCDX2 acting upstream 
and CX3 acting downstream of RAD51 recruitment to DNA damage foci (Chun et 
al., 2013). Indeed RAD51D-depleted cells, but not XRCC3-depleted cells, showed 
defects in DNA damage-dependent RAD51 foci formation. 
 
The RAD51:DNA nucleoprotein filament recognises homologous duplex DNA and 
catalyses DNA strand exchange (Baumann et al., 1996). Specifically, the invading 
ssDNA base pairs with its complementary sequence in the duplex DNA, thus 
generating heteroduplex DNA. The strand exchange reaction results in the 
formation of an intermediate structure called a displacement loop (D-loop) (Figure 
1.2B), whereby the invading 3’-end primes the synthesis of new DNA using the 
duplex DNA as a template. In vitro studies have shown that D-loop extension 
reaction can be catalysed by both DNA polymerase η (Pol η) (McIlwraith et al., 
2005) or DNA polymerase δ (Pol δ) (Li et al., 2009). DNA synthesis by Pol δ is 
stimulated by PCNA and is more efficient than that catalysed by Pol η, suggesting 
that Pol δ might be the major DNA polymerase performing D-loop extension in vivo 
(Li et al., 2009).  
 
The fate of the D-loop intermediate defines the HR sub-pathway that the cell is 
going to employ to repair the DSB (Figure 1.2). D-loops formation can lead to the 
formation of a four-stranded DNA intermediate called the Holliday junction (HJ). 
HJs are named after Robin Holliday, who was the first to hypothesize their 
existence in 1964 (Holliday, 1964). These structures physically connect two 
homologous DNA sequences and must be processed to maintain genomic stability 
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and ensure cell viability (Lilley and White, 2001). HJs are mobile structures that can 
move along the DNA by a process called branch migration (Tsaneva et al., 1992). 
In the context of a D-loop, the HJ can branch migrate towards the 3’-end and 
disengage the invading strand from the duplex DNA (Johnson and Jasin, 2000). 
Unwinding of the D-loop structure can also be promoted by a group of helicases 
called antirecombinases, so named for their ability to revert the HR reaction. 
Examples of these helicases include the BLM protein (Karow et al., 2000; van 
Brabant et al., 2000), human regulator of telomere length RTEL1 (Barber et al., 
2008) and FANCM (Fanconi anaemia group M) (Gari et al., 2008a). Whenever the 
newly synthesised DNA strand is released, owing to branch migration or to the 
activity of antirecombinases, it re-anneals with the single-stranded overhang of the 
second DSB end. This model of HR-mediated DSB repair is called synthesis-
dependent strand annealing (SDSA) (Figure 1.2B) (Johnson and Jasin, 2000).  
 
In contrast, when the extended invading strand engages the processed second end 
of the DSB, a double HJ (dHJ) structure is formed (Bzymek et al., 2010). This 
model of DSB repair is referred to as canonical DSB repair (DSBR) and can result 
in both crossover and non-crossover products (Szostak et al., 1983) (Figure 1.2B). 
Crossovers are generated when processing of the dHJ results in the reciprocal 
exchange of DNA between the two DNA molecules. Non-crossovers occur in the 
absence of genetic exchange. In meiotic cells, crossover formation is required to 
create genetic diversity (Petronczki et al., 2003). In mitotic cells, crossovers must 
be avoided as they can result in loss of heterozygosity (LOH), whereby activation of 
oncogenes and inactivation of tumour suppressor genes could promote 
tumourigenesis (Cavenee et al., 1983). The production of crossovers or non-
crossovers depends on whether cells process dHJs by a dissolution or resolution 
pathway.  
 
Holliday junction dissolution 
The multi-protein BLM-TOPOIIIα-RMI1-RMI2 (BTR) complex catalyses dHJ 
dissolution, thus ensuring that only non-crossover products are generated (Singh et 
al., 2008; Wu and Hickson, 2003). BLM is one of the five members of the RecQ 
family of 3’-5’ helicases, which also includes WRN, RECQ1, RECQ4 and RECQ5 
(Bohr, 2008; Ellis et al., 1995). Mutations in three RecQ helicases, namely BLM, 
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WRN and RECQ4, have been associated with rare recessive genetic disorders 
characterised by premature aging and predisposition to cancer (Monnat, 2010). 
Specifically, mutations in WRN cause Werner’s syndrome (Yu et al., 1996) while 
defects in the activity of RECQ4 cause Rothmund-Thomson syndrome (RTS) 
(Siitonen et al., 2009). Bloom’s syndrome (BS) is an autosomal recessive disorder 
associated with mutations in the BLM protein and is characterised by dwarfism, 
infertility, hypersensitivity to sunlight and high predisposition to cancer (Bachrati 
and Hickson, 2003; German, 1993). At the molecular level, cells from BS patients 
exhibit hypersensitivity to DNA damaging agents, chromosomal aberrations and 
genomic instability (Chan et al., 2007; Cheok et al., 2005). Moreover, the hallmark 
feature of BS cells is an elevated frequency of sister chromatid exchanges (SCEs) 
(approximately 10-fold higher than normal cells) (Chaganti et al., 1974), which 
occur when there is a reciprocal exchange of genetic material (i.e. crossovers) 
between the two sister chromatids. Recent studies indicate that defects in BTR-
mediated dHJ dissolution lead to the processing of persistent HJs by resolution 
pathways that promote crossover formation, thereby resulting in an increased 
frequency of SCEs (Wechsler et al., 2011).  
 
The process of dHJ dissolution is initiated by the convergent branch migration of 
two HJs, which requires interactions between BLM and DNA topoisomerase IIIα 
(TOPOIIIα) (Figure 1.2) (Plank et al., 2006). In this reaction, BLM migrates the two 
HJs towards each other while TOPOIIIα removes the positive supercoils created in 
between (Plank et al., 2006). This process results in the formation of a 
hemicatenane that needs to be dissolved in order to separate the two DNA strands. 
The decatenation reaction is catalysed by TOPOIIIα and promoted by the other two 
components of the BTR complex, namely RMI1 and RMI2 (Cejka et al., 2010). 
These two OB-fold containing proteins directly interact with TOPOIIIα, stabilize the 
BTR complex and stimulate dHJ dissolution (Raynard et al., 2006; Singh et al., 
2008). 
 
Holliday junction resolution 
The resolution of dHJs involves the endonucleolytic cleavage of the covalently 
linked DNA strands and results in the formation of crossover or non-crossover 
products, depending on the orientation of cleavage. The first evidence for the 
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existence of a nuclease that promotes HJ resolution was obtained from studies 
performed with bacteriophage T4. Mutations in gene 49 of bacteriophage T4 
caused the accumulation of replicating DNA exhibiting very high sedimentation 
rates (Frankel et al., 1971) because of the presence of highly branched DNA 
molecules (Kemper and Brown, 1976). When extracts from bacteria infected with 
gene 49+ and gene 49- phages were mixed, this aberrant DNA was cleaved into a 
slower sedimenting DNA form, similar to that produced during wild-type phage 
infection (Frankel et al., 1971). The endonuclease encoded by gene 49 was then 
purified and is referred to as T4 endonuclease VII (Nishimoto et al., 1979). T4 
endonuclease VII is able to cleave a variety of DNA structures and HJ resolution 
results in the production of nicked linear duplexes that can be readily re-ligated by 
DNA ligase (Mizuuchi et al., 1982). In addition to T4 endonuclease VII, the product 
of gene 3 of bacteriophage T7, T7 endonuclease I, was also discovered to be 
involved in the resolution of branched recombination intermediates (Tsujimoto and 
Ogawa, 1978) and, as observed with T4 endo VII, T7 endo I was found to cleave 
HJ structures to generate ligatable nicked duplex DNA (Dickie et al., 1987). 
 
Later, the formation and resolution of HJs was extensively studied in bacteria. In E. 
coli, the bacterial homolog of RAD51, RecA, catalyses DNA strand exchange and 
the formation of HJs (West et al., 1983). The RuvABC proteins constitute the 
bacterial ‘resolvasome’ that processes HJs (West, 1997), by orchestrating HJ 
branch migration (catalysed by RuvAB) and resolution (catalysed by RuvC). RuvA 
is a tetrameric protein that binds HJs with high affinity and in a sequence-
independent manner (Iwasaki et al., 1992; Parsons et al., 1992; Rafferty et al., 
1996). By binding to DNA, RuvA recruits RuvB and promotes branch migration by 
causing structural changes to the HJ (Parsons et al., 1995; Parsons and West, 
1993). The HJ-bound RuvAB complex is a tripartite structure in which the RuvA 
tetramer is flanked by the two oppositely-oriented RuvB hexamers (Parsons et al., 
1995). The branch migration reaction is catalysed by the ATPase activity of RuvB, 
which rotates opposing arms of the HJ in such a way that the DNA passes out 
through each ring (Iwasaki et al., 1992; Parsons et al., 1995; Tsaneva et al., 1992). 
RuvC is a 19 kDa protein that binds HJs with a 103- to 104-fold higher affinity than 
dsDNA (Bennett et al., 1993). It binds DNA as a dimer and cleaves HJs by inserting 
symmetrically related nicks in strands of like polarity, thus generating a pair of 
nicked duplexes that can be religated (Dunderdale et al., 1991; Iwasaki et al., 
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1991). RuvC resolves HJs in a sequence-specific manner, preferentially cleaving at 
the consensus sequence 5’-A/TTT↓C>G/A-3’ and with optimal resolution occurring 
when a 5’-TT↓-3’ incision site is located at, or one nucleotide away from, the point 
of strand exchange (Bennett et al., 1993; Bennett and West, 1996; Shah et al., 
1994a, b). Hence, by catalysing HJ branch migration and resolution, the activities 
of RuvAB and RuvC provide a very efficient mechanism whereby RuvAB-mediated 
branch migration provides RuvC with a system to scan DNA for cleavable 
sequences.  
 
RuvC is referred to as ‘canonical’ HJ resolvase because it resolves HJs in a 
symmetric manner (Figure 1.4). Canonical HJ resolvases have been identified in 
budding yeast (Yen1), Caenorhabditis elegans (GEN-1), Drosophila melanogaster 
(Gen1) and human cells (GEN1), providing evidence that that the RuvC model of 
HJ resolution is conserved in eukaryotes (Bailly et al., 2010; Ip et al., 2008; 
Ishikawa et al., 2004). Saccharomyces cerevisiae Yen1 and human GEN1 belong 
to the Rad2/XPG family of structure-specific endonucleases, which also includes 
the NER protein XPG, EXO1 (Sections 1.2.1 and 1.2.2) and the 5’-flap 
endonuclease FEN1 (Harrington and Lieber, 1994). Members of this family harbour 
an N-terminal and an internal XPG nuclease motif and a helix-hairpin-helix (HhH) 
domain (Hosfield et al., 1998). Like all the other XPG family nucleases, Yen1 and 
GEN1 are 5’-flap structure-specific endonucleases but, unlike the other family 
members, they preferentially cleave HJs (Rass et al., 2010). More specifically, 
Yen1 and GEN1 catalyse the cleavage of HJs by introducing two symmetrical 
incisions located 1 nucleotide on the 3’-side of the branch point to produce nicked 
duplex products that can be re-ligated efficiently (Ip et al., 2008).  
 
GEN1’s ability to cleave HJs was supported by the observation that ectopic 
expression of an N-terminal fragment of human GEN1, GEN11-527, promotes the 
processing of recombination intermediates that accumulate in MMS-treated S. 
cerevisiae cells mutated in sgs1 or top3, the yeast orthologs of BLM and TOPOIIIα, 
respectively (Mankouri et al., 2011). Also, given that a gene encoding for Yen1 is 
absent in S. pombe and HJ resolution is solely performed by the 3’-flap 
endonuclease Mus81-Eme1, the observation that ectopically expressed GEN11-527 
can promote HJ resolution in S. pombe mus81Δ cells represented further evidence 
for its role as a HJ resolvase (Lorenz et al., 2010). However, genetic studies 
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performed in S. cerevisiae showed that yen1Δ mutant cells are resistant to DNA 
damaging agents (e.g. MMS, HU, phleomycin, cisplatin), fail to show chromosome 
segregation defects and exhibit wild-type levels of cell growth and crossover 
formation, indicating that Yen1 may act redundantly with other nucleases (Blanco 
et al., 2010; Ho et al., 2010; Tay and Wu, 2010). Moreover, the observation that 
yen1Δ mus81Δ double mutants accumulate unresolved joint molecules and exhibit 
a synthetic phenotype, suggested that Yen1 and Mus81-Mms4 work in redundant 
pathways of HJ resolution in vivo (Blanco et al., 2010; Ho et al., 2010; Tay and Wu, 
2010).  
 
Importantly, a similar mechanism exists in human cells, where HJs can be 
processed by either GEN1 or a multi-protein complex that contains the 
MUS81-EME1 (the human ortholog of Mus81-Mms4) and SLX1-SLX4 structure-
specific endonucleases (catalytic subunits are indicated first) (Andersen et al., 
2009; Fekairi et al., 2009; Munoz et al., 2009; Svendsen et al., 2009). To uncover 
the roles of these proteins in HJ resolution, genetic studies were performed in BS 
cells by determining the contribution of GEN1, MUS81, SLX1 and SLX4 to SCE 
formation. Specifically, when GEN1 was depleted in BS cells, no significant change 
was observed in the frequency of SCEs and in chromosomes conformation 
(Wechsler et al., 2011). However, BS cells co-depleted of MUS81 and GEN1, or 
SLX1/SLX4 and GEN1, exhibited an SCE frequency that was lower than that 
observed with the individual depletions. Furthermore, BS cells depleted of MUS81 
and GEN1 or GEN1 and SLX4 displayed aberrant chromosome conformations and 
condensation defects that were not observed with single protein depletions, 
providing further evidence that GEN1 and the SLX1-SLX4-MUS81-EME1 
(SLX-MUS) complex work in two distinct pathways of HJ resolution (Wechsler et al., 
2011; Wyatt et al., 2013). In contrast to RuvC and GEN1, the SLX-MUS complex 
cleaves HJs by asymmetric nicking, thereby generating mostly non-ligatable 
products (Figure 1.4) (Wyatt et al., 2013). 
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Figure 1.4 Schematic representation of HJ resolution by symmetric or 
asymmetric cleavage 
RuvC and GEN1 are canonical HJ resolvases as they cleave HJs by inserting 
symmetric nicks on strands of like polarity, thus generating ligatable products. The 
SLX-MUS complex is an example of non-canonical HJ resolvase as it cleaves HJs 
by asymmetric nicking, thus generating mostly non-ligatable products. 
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Single strand annealing  
More than 10% of the human genome is composed of repetitive sequences, which 
include, for example, greater than 106 interspersed Alu repeats (Batzer and 
Deininger, 2002). When a two-ended DSB occurs in a repetitive genomic region, 
cells activate a DSB repair mechanism called single strand annealing (SSA). This 
is a RAD51-independent mechanism that involves co-operation between the 
ssDNA-binding protein RPA and the RAD52 protein. SSA is initiated with the 
resection of the broken DNA ends to generate 3’-single-stranded overhangs 
(Figure 1.2). While RPA binds and stabilises the ssDNA tails, RAD52 binds to the 
ssDNA ends and promotes an annealing reaction that restores the integrity of the 
duplex DNA (Van Dyck et al., 2001; Wold, 1997). Annealing of the repetitive 
elements adjacent to the DSB causes the non-homologous sequences between the 
repeats to form flap structures, which are subsequently removed by the XPF-
ERCC1 endonuclease (Adair et al., 2000; Sargent et al., 1997) (Section 1.2.1) 
(Figure 1.2C). As a result, SSA-mediated DSB repair results in the deletion of DNA 
sequences located between the two repeats, making this an inherently error-prone 
mechanism of DNA repair. 
 
1.2.3 Role of HR in replication fork repair and ICL repair 
The complete and faithful replication of DNA is essential to prevent accumulation of 
genetic mutations and to ensure the successful transmission of the genetic material 
to daughter cells. DNA secondary structures, topological stress in the DNA 
template, protein-DNA complexes (e.g. transcription factors bound to DNA), or 
chemical agents (e.g. hydroxyurea and ICL agents), constitute physical obstacles 
to the DNA replication machinery and can result in the stalling and/or collapse of 
RFs (Petermann and Helleday, 2010). Stalled RFs retain the ability to resume DNA 
replication when the impediment is removed, whereas collapsed forks result in one-
ended DSBs and in the dissociation of the replication machinery.  
 
The restart of stalled and collapsed RFs has been well characterised in bacteria 
and requires a close cooperation between the DNA replication and HR machineries 
(Heller and Marians, 2006). The re-assembly of the replisome on the fork is 
CHAPTER 1 - Introduction 
 41 
essential for cell survival because bacteria only have one replication origin and, 
unlike eukaryotes, cannot rely on the licencing of other origins to complete 
replication (Petermann et al., 2010). Replisome re-assembly is achieved by the 
recruitment of the replisome loading factors PriA or PriC (Jones and Nakai, 1999). 
PriA is a DNA helicase that recognises and binds branched DNA structures such 
as D-loops (Heller and Marians, 2006). Formation of a D-loop requires the initiation 
of HR, which can occur in a DSB-dependent or independent manner. First, stalled 
RFs are regressed to generate a HJ structure. Second, the free DNA end of the HJ 
is processed by the RecBCD nuclease to create ssDNA overhangs that promote 
RecA binding and template strand invasion, ultimately forming a D-loop structure 
(Kuzminov and Stahl, 1999). Alternatively, RuvABC can cleave the HJ to generate 
a one-ended DSB that is used by RecA to invade the template DNA and establish a 
D-loop (Seigneur et al., 1998). Finally, PriA binds the D-loop structure and 
promotes the loading of the replicative DnaB helicase and replication restart (Heller 
and Marians, 2006). 
 
Proteins involved in replication fork restart in E. coli are not conserved in 
eukaryotes. However, HR is the primary DNA repair pathway during S-phase of 
mammalian cells, suggesting that recombination-mediated repair of stalled RFs is 
likely to be conserved in higher eukaryotes. This is supported by observations that 
replication-stalling agents, such as hydroxyurea (HU) and camptothecin (CPT), 
induce RAD51 foci formation and HR in mammalian cells (Arnaudeau et al., 2001; 
Saintigny et al., 2001). Indeed, human cells employ two mechanisms of HR-
mediated repair of stalled RFs and choose one or the other depending on whether 
forks stall temporarily (i.e. are able to resume replication) or stall permanently and 
become inactivated (i.e. the replication machinery has dissociated) (Petermann et 
al., 2010). 
 
If forks are stalled temporarily, HR can repair the fork and restore DNA replication. 
DNA helicases, namely BLM, WRN and FANCM, promote RF regression in vitro, 
whereby the newly synthesised DNA strands re-anneal and generate a HJ or 
‘chicken foot’ structure (Figure 1.5A) (Gari et al., 2008b; Machwe et al., 2007; Ralf 
et al., 2006). The two free DNA ends of the ‘chicken foot’ are thought to recombine 
through strand invasion with the homologous DNA template ahead of the fork and 
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generate a D-loop. Resolution of the D-loop structure restores DNA replication. In 
this context, the BLM helicase has been shown to promote efficient fork restart 
after cells are exposed briefly to HU (2 to 6 hr) (Davies et al., 2007). However, it is 
unclear whether BLM stabilizes the stalled fork by inducing its regression or by 
branch migration of the HJ (Karow et al., 2000; Ralf et al., 2006). Conversely, WRN 
is not essential for RF restart but it might have a role in the efficient progression of 
restarted forks as, after short HU treatments, RFs progress slowly in WRN-
depleted cells (Sidorova et al., 2008).  
 
FANCM protein belongs to the XPF family of structure-specific DNA binding 
proteins (Ciccia et al., 2008). It harbours an inactive excision repair cross-
complementation group 4 (ERCC4)-type nuclease domain and a DEAH helicase 
domain, which is required for its ability to catalyse DNA translocation (Gari et al., 
2008b; Meetei et al., 2005). FANCM is able to regress RFs in vitro and promotes a 
key role in the recognition and repair of DNA ICLs in the context of the FA pathway 
(Gari et al., 2008a). As mentioned in Section 1.1, ICLs are highly toxic DNA lesions 
because they covalently link two strands of DNA and thus, constitute a barrier to 
RF progression. During S-phase, FANCM recognises ICL-blocked forks, promotes 
their regression into ‘chicken foot’ structures and recruits the FA core complex 
(Gari et al., 2008a; Niedernhofer, 2007). This complex is composed of seven FA 
proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) and 
displays a FANCL-dependent ubiquitin ligase activity (Meetei et al., 2004). It 
monoubiquitinates two additional DNA binding factors, FANCI and FANCD2 
(Garcia-Higuera et al., 2001; Smogorzewska et al., 2007), which are retained on 
chromatin and co-localise with DNA repair proteins such as RAD51, BRCA1 and 
γH2AX (Bogliolo et al., 2007; Garcia-Higuera et al., 2001; Taniguchi et al., 2002). 
The reversed fork is then stabilised by HR. The free DNA ends of the ‘chicken foot’ 
structure undergo RAD51-mediated strand invasion of the homologous DNA ahead 
of the fork and generate a D-loop (Figure 1.5B). However, re-establishment of the 
replication fork requires ‘unhooking’ of the ICL, which involves (i) unwinding of the 
DNA helix, (ii) incision of the DNA backbone on the 3’- and 5’-side of the lesion and 
(iii) displacement of the ICL. Recently, several studies led to the identification of a 
new DNA repair nuclease referred to as Fanconi-associated nuclease 1 (FAN1),  
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Figure 1.5 Schematic representation of the HR-mediated repair of stalled and collapsed RFs 
A. HR promotes the restart and repair of stalled or collapsed RFs. When forks stall temporarily (top panel), fork reversal and formation of 
the ‘chicken foot’ structure promotes the invasion of the duplex DNA ahead of the fork and the formation of a dHJ. Processing of the 
intermediate structure allows the restart of DNA replication. Conversely, when forks stall permanently (bottom panel), MUS81-dependent 
cleavage of the fork results in its collapse, which generates a one-ended DSB that can be repaired by HR. Also, the progression of RFs 
from newly fired origins towards the break can lead to second-end capture and to the formation of a dHJ that can be processed by 
dissolution or resolution. B. When RFs stall at ICLs, FANCM is recruited to the lesion and subsequently catalyses fork reversal to form a 
‘chicken foot’ structure that is stabilised by HR. The excision or ‘unhooking’ of the ICL is thought to require the activities of the SLX1-
SLX4 and XPF-ERCC1 structure-specific endonucleases. The processing of recombination intermediates and synthesis of new DNA at 
the site of the lesion will ultimately promote RF restart. Adapted from (Petermann and Helleday, 2010). 
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which confers cellular resistance to ICL agents (Kratz et al., 2010; Liu et al., 2010; 
MacKay et al., 2010; Smogorzewska et al., 2010). FAN1 is a structure-specific 
endonuclease with a 5’-exonuclease activity that localises to the sites of DNA 
damage by interacting with FANCI and monoubiquitinated FANCD2. Given that 
experiments conducted in a cell-free system showed that FANCD2 
monoubiquitination is required for ICL unhooking (Knipscheer et al., 2009), a role 
for FAN1 in this step of ICL repair was hypothesized. However, although FAN1-
deficient cells exhibit hypersensitivity to ICL agents, their cellular phenotypes differ 
from those of FA cells, thus FAN1 does not appear to be a susceptibility gene for 
FA (Trujillo et al., 2012; Zhou et al., 2012). Instead, mutations in FAN1 have been 
related to the onset of karyomegalic interstitial nephritis (KIN) (Zhou et al., 2012), a 
rare progressive disorder characterised by kidney failure and dysfunction of other 
tissues, including brain and liver (Palmer et al., 2007). Hence, how FAN1 
contributes to ICL repair is still unknown. Nevertheless, given that (i) cells defective 
for the XPF-ERCC1 endonuclease exhibit hypersensitivity to ICL agents (Wood, 
2010), (ii) SLX4 is a FA gene (Stoepker et al., 2011) and (iii) the interaction 
between SLX1-SLX4 and XPF-ERCC1 is essential for ICL repair (Kim et al., 2013), 
it is likely that the ICL unhooking step requires the cooperation of XPF-ERCC1 and 
SLX1-SLX4 (Figure 1.5B). The properties and functions of SLX1-SLX4 will be 
discussed in Section 1.3. 
 
When RFs stall for many hours (e.g. 24 hr) they are inactivated and cells utilise a 
second repair mechanism that involves endonucleolytic cleavage and collapse of 
the RF (Figure 1.5A). This process is dependent on the activity of the MUS81 
structure-specific endonuclease and results in the generation of a one-ended DSB 
(Hanada et al., 2007). Whether MUS81 contributes to RF restart or not is still 
controversial. Mus81-/- mouse embryonic stem (ES) cells exposed to HU show 
defects in RF restart (Hanada et al., 2007). However, it is likely that replication 
recovery in human cells is not dependent on MUS81 and it occurs by the activation 
of new replication origins (Petermann et al., 2010), suggesting that in human cells, 
the MUS81 endonuclease may be required for the repair of stalled RFs, but not RF 
restart. 
 
Collapsed RFs that have been cleaved by MUS81 are further processed by HR 
(Arnaudeau et al., 2001). DNA end-resection of the one-ended DSB is followed by 
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RAD51 nucleoprotein filament formation, which promotes strand invasion and 
generation of a D-loop (Section 1.2.2). RFs progressing from a newly fired origin 
towards the DSB can lead to second end capture and formation of a dHJ that can 
be processed as discussed in Section 1.2.2 (Figure 1.5A) (Petermann et al., 2010).   
 
RFs also collapse when they encounter a single strand break, which is converted 
into a one-ended DSB by DNA replication ‘run-off’ (Strumberg et al., 2000). Indeed, 
mammalian cells with defective single strand break repair (i.e. XRCC1-/-) show an 
increased frequency of DSBs, SCEs and RAD51 foci formation specifically during 
the S-phase of the cell cycle (Saleh-Gohari et al., 2005; Schreiber et al., 1995; 
Thompson et al., 1982).  
 
1.3 The role of MUS81 in DNA repair 
MUS81 is a member of the XPF/MUS81 family of structure-specific endonucleases 
(Figure 1.6). Enzymes belonging to this family form heterodimeric complexes 
composed of a catalytic and a non-catalytic subunit and include XPF-ERCC1 
(Section 1.2.1), FANCM-FAAP24 (Section 1.2.3) (Coulthard et al., 2013), MUS81-
EME1 and MUS81-EME2 (catalytic subunits are indicated first) (Ciccia et al., 2008). 
As illustrated in Figure 1.6, each subunit contains an ERCC4 endonuclease domain 
and a (HhH)2 domain (Nishino et al., 2003; Shao and Grishin, 2000). In the catalytic 
subunits, the ERCC4 domain contains a GDXnERKX3D motif that harbours 
conserved Asp and Glu residues that co-ordinate the divalent metal ion required for 
catalysis. In contrast, the amino acid sequence of this motif has diverged in the 
non-catalytic subunits, thus rendering these proteins nucleolytically inactive (Enzlin 
and Scharer, 2002). The (HhH)2 domain is composed of two copies of the HhH 
motif and is required for sequence-independent DNA binding and enzyme stability 
(Newman et al., 2005; Shao and Grishin, 2000). In contrast to the other members of 
the XPF/MUS81 family, the (HhH)2 domain of MUS81 is separated, with one HhH 
located at the N-terminus and the other one found at the C-terminus. In mammalian 
cells, MUS81 forms a complex with EME1 or EME2 (Ciccia et al., 2003; Ciccia et 
al., 2007; Ögrünc and Sancar, 2003). The interaction between MUS81 and EME1 
is conserved from yeast to humans and has been the subject of many biochemical 
and genetic studies. However, no yeast ortholog of EME2 has been identified, 
potentially indicating a role for MUS81-EME2 that is specific to higher eukaryotes. 
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1.3.1 Role of MUS81-EME1 in HJ resolution 
S. pombe Mus81-Eme1 and S. cerevisiae Mus81-Mms4 
Genetics 
S. pombe Mus81 was first identified through its interaction with the replication 
checkpoint kinase Cds1 (Boddy et al., 2000) and it forms a functional heterodimer 
with a non-catalytic subunit called Eme1 (Boddy et al., 2001). Genetic studies in 
meiotic cells revealed that Mus81-Eme1 has a crucial function in the resolution of 
recombination intermediates. Meiotic mus81Δ and eme1Δ cells show severe 
chromosome segregation defects during meiosis I, which result in the generation of 
inviable spores (<1% survival) (Boddy et al., 2000; Interthal and Heyer, 2000; 
Osman et al., 2003). In agreement with a role in HJ resolution, this phenotype can 
be rescued by the ectopic expression of the bacterial HJ resolvase RusA, or by 
depletion of the SPO11 yeast ortholog rec12, which, as described in Section 1.2.2, 
is required for the formation of programmed meiotic DSBs and for the initiation of 
HR (Boddy et al., 2001; Osman et al., 2003). Also, mus81Δ cells exhibited a lower 
frequency of crossovers (8 to 25 fold) compared to that of wild-type cells, indicating 
that meiotic crossover formation in S. pombe is mainly dependent on the activity of 
Mus81-Eme1 (Boddy et al., 2001; Osman et al., 2003).  
 
In mitotic cells, Mus81-Eme1 is required for the resolution of HJs arising during the 
repair of stalled RFs. Indeed, mus81Δ and eme1Δ cells exhibit hypersensitivity to 
RF stalling agents, such as CPT, HU, UV light and MMS (Boddy et al., 2001; Doe 
et al., 2002). Also, depletion of Mus81 or Eme1 is synthetically lethal with the loss 
of Rqh1, the S. pombe ortholog of human BLM (Boddy et al., 2000; Doe et al., 
2002). Both the viability of mus81Δ rqh1Δ double mutants and the resistance of 
mus81Δ or eme1Δ cells to RF stalling agents are restored by the ectopic 
expression of RusA, indicating that the requirement for Mus81-Eme1 in RF repair is 
related to its ability to resolve HR intermediate structures (Boddy et al., 2001; Doe 
et al., 2002).  
 
In S. cerevisiae, Mus81 was first identified through its interaction with the 
recombination protein Rad54 (Interthal and Heyer, 2000) and in a synthetic lethal  
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Figure 1.6 The XPF/MUS81 family of endonucleases 
Schematic representation of the primary structure of XPF/MUS81 family members. 
As shown on the left, each protein forms a heterodimeric complex containing one 
catalytic subunit (i.e. MUS81, XPF, FANCM) and one non-catalytic subunit (i.e. 
EME1, EME2, ERCC1, FAAP24). The ERCC4 nuclease domains (red), Helix-
hairpin-Helix (HhH) DNA binding domains (black) and the DEAH helicase domains 
(blue) are indicated. The inactive ERCC4 and DEAH domains are coloured in 
white.  
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screen for genes that are essential in the absence of Sgs1, the ortholog of human 
BLM (Mullen et al., 2001). In contrast to fission yeast, S. cerevisiae meiotic cells 
lacking Mus81 exhibited a small reduction in crossover formation and reduced 
viability (approximately 50% of the spores were viable), suggesting that Mus81-
Mms4 (the ortholog of Mus81-Eme1) contributes modestly to HJ resolution and 
crossover formation (de los Santos et al., 2003). Indeed, Mlh1-Mlh3, Exo1 and 
Sgs1 are responsible for the majority of crossovers arising during meiotic 
recombination in this organism (Zakharyevich et al., 2010; Zakharyevich et al., 
2012). Moreover, a functional redundancy exists between Mus81-Mms4 and Yen1, 
such that mus81Δ yen1Δ cells exhibit less than 1% viability (Matos et al., 2011). 
Therefore, the lack of an ortholog of Yen1 in S. pombe explains the difference in 
viability between fission and budding yeast mus81Δ cells. The functional 
redundancy between Mus81-Mms4 and Yen1 has also been identified in the 
context of DNA repair (Blanco et al., 2010; Ho et al., 2010; Munoz-Galvan et al., 
2012). Indeed, depletion of Yen1 in a mus81Δ background increases cellular 
sensitivity to DNA damaging agents (e.g. MMS, HU, CPT, cisplatin) and causes 
cells to accumulate toxic recombination intermediates.  
 
Biochemistry 
Despite genetic evidence indicating that S. pombe Mus81-Eme1 and S. cerevisiae 
Mus81-Mms4 process HJs in vivo, biochemical analyses carried out with the 
purified heterodimers did not support this hypothesis, thus generating a controversy 
on whether the Mus81 endonuclease was a HJ resolvase (Haber and Heyer, 2001). 
Indeed, recombinant S. pombe Mus81-Eme1 purified from E. coli cleaves HJs with 
very low efficiency compared to 3’-flaps and RFs (Doe et al., 2002; Whitby et al., 
2003). In general, Mus81-Eme1 preferentially cleaves three-way branched 
structures by inserting nicks 3 to 6 nucleotides on the 5’-side of the branch point, 
with the nicked HJ being its preferred substrate (Gaillard et al., 2003; Osman et al., 
2003; Whitby et al., 2003). Similarly, recombinant Mus81-Mms4 purified from E. 
coli was found to be a poor HJ resolvase (Ehmsen and Heyer, 2008, 2009; Fricke 
et al., 2005; Kaliraman et al., 2001; Whitby et al., 2003). Conversely, three-way 
branched structures, including 3’-flaps and RFs, were readily converted into nicked 
duplex products by Mus81-Mms4 through a mechanism that is similar to that 
described for S. pombe Mus81-Eme1 (Bastin-Shanower et al., 2003; Whitby et al., 
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2003). Mus81-Mms4 processes a 3’-flap substrate by recognising the 5’-end of the 
DNA strand located downstream of the flap and by cleaving the duplex DNA 3 to 7 
nucleotides on the 5’-side of the branch point (Bastin-Shanower et al., 2003). Also, 
3’-flaps with a gap of more than 4 nt were not cleaved efficiently by Mus81-Mms4, 
indicating that the presence of a 5’-end positioned less than 4 nt away from the 
branch point represents the minimal requirement for Mus81-Mms4 cleavage 
(Bastin-Shanower et al., 2003).  
 
Regulation 
Partially purified Mus81-Eme1 from S. pombe was found to efficiently cleave HJs in 
vitro (Boddy et al., 2001; Gaillard et al., 2003). Specifically, cleavage by 
Mus81-Eme1 occurred by asymmetric nicking, thus generating mostly non-ligatable 
products (Boddy et al., 2001; Gaillard et al., 2003). Such observations led to the 
hypothesis that the activity of the Mus81 endonuclease on HJs in vivo could be 
modulated by post-translational modifications. In agreement with this, recent 
studies in S. cerevisiae revealed that the activities of the HJ resolvases 
Mus81-Mms4 and Yen1 are tightly regulated. During S-phase, the cleavage of HJs 
by Mus81-Mms4 and Yen1 is low and increases as cells progress in the cell cycle, 
with Mus81-Mms4 being activated at G2/M and Yen1 being activated in anaphase 
(Matos et al., 2011). The increase in HJ resolution correlated with the hyper-
phosphorylation of Mms4 by the cell cycle kinases Cdc28 (i.e. the budding yeast 
ortholog of human CDK1) and Cdc5 (i.e. the ortholog of human PLK1) and with the 
de-phosphorylation of Yen1 (Gallo-Fernandez et al., 2012; Matos et al., 2011; 
Matos et al., 2013). Indeed, phosphorylation-defective mms4 mutants exhibit 
reduced nuclease activity and increase the sensitivity of sgs1Δ cells to DNA 
damaging agents (Gallo-Fernandez et al., 2012; Matos et al., 2013). On the same 
note, premature activation of Mus81-Mms4 achieved by expression of 
phosphomimic Mms4 variants or by misregulated expression of Cdc5 resulted in an 
increased frequency in crossover formation and chromosomal translocations 
(Matos et al., 2013; Szakal and Branzei, 2013). Through this cell cycle-dependent 
mechanism of phosphorylation/de-phosphorylation-mediated activation of HJ 
resolvases, cells control the interplay between HJ dissolution and resolution, thus 
restricting the activity of crossover-promoting enzymes to the G2/M phase of the 
cell cycle.  
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Importantly, although the activity of Mus81-Mms4 is required for complete 
chromosome replication and cell viability after treatment with RF stalling agents, 
the presence of DNA damage during S-phase does not induce its activation 
(Saugar et al., 2013). Instead, the action of Mus81-Mms4 is kept restricted to G2/M, 
thus preventing the deleterious cleavage of RFs during DNA replication (Saugar et 
al., 2013). In contrast to budding yeast, S. pombe Mus81-Eme1 is activated in a 
phosphorylation-dependent manner in response to DNA damage (Dehe et al., 
2013). In particular, the sequential phosphorylation of Eme1 by the cell cycle 
kinase Cdc2 (i.e. the fission yeast ortholog of human CDK1) and by Rad1 (i.e. the 
fission yeast ortholog of human ATR) in response to CPT or bleomycin treatment 
provides a fast mechanism for Mus81-Eme1 activation in order to resolve HJs that 
have escaped dissolution prior to the onset of mitosis. The importance of Eme1 
phosphorylation is further confirmed by the observation that rqh1Δ (Rqh1 being the 
fission yeast ortholog of human BLM) cells expressing a phosphorylation-resistant 
Eme1 variant exhibit gross chromosomal rearrangements in the absence of 
exogenous DNA damage (Dehe et al., 2013). 
 
Mammalian MUS81-EME1 
The evidence for a role of mammalian MUS81 in DNA repair comes from studies 
conducted in mice, where its depletion has been associated with loss of genomic 
integrity and cancer development (McPherson et al., 2004). Metaphase spreads of 
activated T-cells from Mus81-/- and Mus81+/- mice were scored for chromosomal 
aberrations and showed an elevated rate of chromosomal breaks, fusions and 
aneuploidy. Moreover, both Mus81-/- and Mus81+/- mice were predisposed to the 
development of a wide range of lymphomas and other cancer types, including 
breast and ovarian carcinomas. Interestingly, both heterozygous and homozygous 
mice exhibited the same phenotypes, suggesting that the biallelic expression of 
Mus81 is essential for the fulfilment of its function in maintaining genome stability 
(McPherson et al., 2004). Haploinsufficiency of MUS81 was also observed in 
human cells, where both MUS81-/- and MUS81+/- cells displayed increased rates of 
chromosomal aberrations. In some of these cells, depletion of MUS81 promoted 
endoreduplication, a phenotype characterised by the association of re-duplicated 
chromosomes into diplochromosomes (Hiyama et al., 2006). Although 
diplochromosomes have been already observed in cells lacking other HR genes 
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such as XRCC3, the cause of this phenotype is still unknown (Yoshihara et al., 
2004). Importantly, the MUS81 gene is down-regulated in hepatocellular and colon 
carcinoma, providing further evidence for a role of MUS81 in the maintenance of 
genomic stability in human cells (Wu et al., 2008; Wu et al., 2011). Finally, transient 
depletion of MUS81 in human cells resulted in reduced mitotic recombination (Blais 
et al., 2004) and sensitivity to DNA damaging agents such as CPT, cisplatin and 
MMS (Hiyama et al., 2006). Moreover, MUS81 has been shown to localise to 
regions of UV-damage, as indicated by its co-localisation with cyclobutane 
pyrimidine dimers (Gao et al., 2003).  
 
Biochemistry 
As found for S. pombe Mus81-Eme1 and S. cerevisiae Mus81-Mms4, recombinant 
human MUS81-EME1 purified from E. coli was found to cleave HJs with very low 
efficiency (Ciccia et al., 2003). Conversely, 3’-flaps, RFs and nicked HJs were 
readily converted into nicked duplex products (Ciccia et al., 2003; Taylor and 
McGowan, 2008). Only the purified complex constituted by truncated versions of 
MUS81 and EME1 was able to cleave HJs efficiently, albeit it should be noted that 
20- to 100-fold excess of protein over DNA was used in these experiments (Taylor 
and McGowan, 2008). In contrast, however, immuno-precipitated or partially-
purified MUS81 from human cells showed efficient cleavage of HJs in vitro (Chen 
et al., 2001; Gaillard et al., 2003). Hence, the possibility that the activity of MUS81-
EME1 on HJs could be regulated by (i) unknown interacting partners, and/or (ii) 
post-translational modifications has been a focus of recent investigation. 
 
The SLX-MUS complex 
In agreement with the first hypothesis, MUS81-EME1 was found to interact with two 
other endonucleases: the NER enzyme XPF-ERCC1 (Section 1.2.1) and SLX1-
SLX4 (Andersen et al., 2009; Fekairi et al., 2009; Munoz et al., 2009; Svendsen et 
al., 2009). Slx4 and its partner protein Slx1 were first identified in a synthetic lethal 
screen for proteins that are required for cell viability in the absence of the Sgs1 
helicase (Mullen et al., 2001). Slx1-Slx4 is a structure-specific endonuclease that 
cleaves various types of branched DNA structures, including 5’- and 3’-flaps, RFs 
and HJs (Fricke and Brill, 2003). However, although Slx1-Slx4 can cleave HJs in 
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vitro, yeast slx1Δ and slx4Δ mutants do not exhibit severe meiotic defects, 
suggesting that Slx1-Slx4 may not function as a HJ resolvase in vivo (Mullen et al., 
2001). Slx1 is the catalytic subunit of the complex, harbouring a N-terminal GIY-
YIG nuclease domain and a C-terminal Plant Homeo Domain (PHD)-type zinc 
finger domain (Aravind and Koonin, 2001). Slx4 contains a SAF-A/B, Acinus and 
PIAS (SAP) DNA-binding domain in its C-terminus and, unlike Slx1, it does not 
have any catalytic domain (Aravind and Koonin, 2000). Slx4 promotes the targeting 
of the Slx1-Slx4 complex to DNA substrates and, given that Slx1 alone is inactive, it 
appears to be important for the endonucleolytic activity of the complex (Fricke and 
Brill, 2003).  
 
The human Slx4 ortholog, named BTBD12/SLX4, has an N-terminal BR-C, TTK 
and BAB (BTB)/Pox virus and Zinc finger (POZ) protein-protein interaction domain 
and C-terminal SAP and HtH DNA binding domains (Fekairi et al., 2009; Munoz et 
al., 2009; Svendsen et al., 2009). SLX4 interacts with SLX1 and with the MUS81-
EME1 and XPF-ERCC1 endonucleases, acting as a scaffold for the formation of a 
multi-endonuclease complex (Andersen et al., 2009; Fekairi et al., 2009; Munoz et 
al., 2009; Svendsen et al., 2009). Other SLX4-interacting partners include: TRF2-
RAP1, PLK1, MSH2-MSH3 (Svendsen et al., 2009) and hSNM1B/Apollo (Salewsky 
et al., 2012). The interaction between SLX1-SLX4 and MUS81-EME1 appears to 
be exclusive to higher eukaryotes, whereas the interaction between SLX4 and 
XPF-ERCC1 is conserved from yeast to humans. In yeast, Slx4 forms an Slx1-
independent complex with Rad1-Rad10, the yeast orthologs of XPF-ERCC1, which 
is important for the removal of 3’-flaps during SSA (Flott et al., 2007) (Section 
1.2.2). In human and mouse cells, both XPF-ERCC1 and SLX1-SLX4 have been 
implicated in ICL repair (Fekairi et al., 2009; Munoz et al., 2009; Svendsen et al., 
2009). Consistent with this observation, biallelic mutations of SLX4 have been 
found in FA patients and thus, SLX4 has been designated FANCP (Kim et al., 
2011; Stoepker et al., 2011). 
 
SLX4 immunoprecipitates from human cells cleave 3’-flaps, 5’-flaps, RFs and HJs 
(Munoz et al., 2009; Svendsen et al., 2009). However, when HJs were exposed to 
SLX4 immunoprecipitates, the cleavage product profile corresponded to the 
additional cleavage activities of SLX1-SLX4 and MUS81-EME1, suggesting that 
these two enzymes might co-operate for the resolution of HJs in vivo (Fekairi et al., 
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2009; Munoz et al., 2009; Svendsen et al., 2009). To test this hypothesis, the 
contribution of MUS81, SLX1-SLX4 and GEN1 to SCE formation in BS cells was 
studied (Wyatt et al., 2013). This analysis led to the observation that two pathways 
of HJ resolution exist in human cells: one mediated by GEN1 and the other 
mediated by the SLX-MUS complex (Wyatt et al., 2013). In particular, co-depletion 
of GEN1 with SLX1, SLX4 or MUS81 in BS cells resulted in a decrease in SCEs 
that was higher than that promoted by the single depletions. This additive effect 
was not observed when MUS81 was co-depleted with SLX4 or SLX1, suggesting 
that MUS81 and SLX1-SLX4 work in the same pathway of HJ resolution. 
Consistent with this observation, analysis of the HJ cleavage mechanism by the 
SLX-MUS complex revealed that SLX1-SLX4 and MUS81-EME1 cleave HJs by a 
coordinated nick and counter-nick mechanism, whereby SLX1-SLX4 performs the 
first, rate-limiting cut on the junction while MUS81-EME1 cleaves the nHJ 
by-product to produce nicked duplex DNA molecules (Wyatt et al., 2013). 
 
Regulation 
As observed with budding yeast Mms4, phosphorylation of human EME1 by CDK1 
correlates with increased HJ resolution at G2/M (Matos et al., 2011; Wyatt et al., 
2013). In contrast to yeast, however, phosphorylation does not directly activate the 
nuclease activity of the enzyme, but promotes the interaction between 
MUS81-EME1 and SLX1-SLX4 (Wyatt et al., 2013). Thus, these two heterodimers 
interact predominantly during the G2/M phase of the cell cycle and the activity of 
the SLX-MUS complex causes the observed increase in HJ resolution (Wyatt et al., 
2013). GEN1 also appears to be activated during mitosis, but its activity is mostly 
regulated by the subcellular localisation of the protein (Matos et al., 2011). Indeed, 
GEN1 is retained into the cytoplasm throughout the cell cycle and can gain access 
to DNA only during mitosis, when the nuclear envelope breaks down (Figure 1.7A). 
 
The activity of the MUS81 endonuclease is also negatively-regulated by the CDK1-
inhibitor WEE1 (Dominguez-Kelly et al., 2011). Cells depleted of WEE1 activate the 
DNA damage response (DDR) and exhibit an S-phase progression delay 
(Dominguez-Kelly et al., 2011). Loss of MUS81 in WEE1-depleted cells rescues the 
cell cycle progression and inhibits the DDR, indicating that the damage induced in 
the absence of WEE1 is dependent on the activity of the MUS81 endonuclease 
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(Dominguez-Kelly et al., 2011). In the proposed scenario, the direct inhibition 
exerted by WEE1 on MUS81 is lost in WEE1-depleted cells, thereby causing the 
de-regulated processing of RFs by MUS81 and resulting in DDR activation and 
S-phase delay (Dominguez-Kelly et al., 2011). However, the mechanism by which 
WEE1 regulates the activity of the MUS81 endonuclease is still undetermined. 
 
Together, these results reveal a complex mechanism in which cells restrict the 
crossover-promoting activity of HJ resolvases to late stages of the cell cycle. 
Indeed, in mitotic S-phase cells, dHJs are primarily processed by HJ dissolution, 
which, by promoting the formation of non-crossover products, decreases the 
incidence of potentially harmful genomic rearrangements. Hence, cells appear to 
use HJ resolution as a safeguard mechanism to process joint molecules that have 
escaped BTR-mediated processing (Figure 1.7B).  
 
Structural organisation of the MUS81-EME1 complex 
Structural analysis of MUS81-EME1 has been carried out on a chimeric complex 
composed of truncated forms of zebrafish MUS81 (zMUS81ΔN) and human EME1 
(hEME1ΔN), in which the N-terminal region of each subunit was removed (Chang 
et al., 2008). zMUS81ΔN and hEME1ΔN contain an N-terminal α/β nuclease 
domain and a C-terminal (HhH)2 domain (Figure 1.8A). The structure of 
zMUS81ΔN is more compact than the structure of hEME1ΔN because, while the 
interdomain region of zMUS81ΔN contains a helix H8 and a loop with four residues, 
the interdomain region of hEME1ΔN contains a helix H8’ and two loops, resulting in 
a more extended structure. Because of the differences between the linker regions 
of the two proteins, the interaction between zMUS81ΔN and hEME1ΔN results in 
an asymmetric dimer. Interestingly, unlike zMUS81ΔN, hEME1ΔN contains a highly 
flexible linker region (36R) that connects strand S5’ with helix H6’, which is required 
to stabilise the interaction between zMUS81ΔN and the substrate DNA. The 
nuclease and the (HhH)2 domain of zMUS81ΔN form a shallow groove, whose size 
(10 Å in height and 5 Å in depth) allows the accommodation of ssDNA. In addition, 
a deep cleft (approximately 15 Å in diameter) is formed between the nuclease 
domain of zMUS81ΔN and the (HhH)2 domain of hEME1ΔN, and between the 
inactive nuclease domain of hEME1ΔN and the (HhH)2 domain of zMUS81ΔN 
(Figure 1.8B). The GDXnERKX3D motif is located at the centre of the deep cleft, 
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with the Asp398 and Glu392 residues, which are required for divalent metal ion-
mediated catalysis, located at the bottom of the pocket (Figure 1.8C) (Chang et al., 
2008). 
 
zMUS81ΔN binds hEME1ΔN through three interfaces, which are equally important 
for dimerization and include: (i) one between the nuclease domain of zMUS81ΔN 
and the inactive nuclease domain of hEME1ΔN (Figure 1.8D), (ii) one between the 
(HhH)2 domains of zMUS81ΔN and hEME1ΔN (Figure 1.8E), and (iii) one between 
the nuclease and (HhH)2 domains of zMUS81ΔN and the 36R linker region of 
hEME1ΔN (Figure 1.8F). Briefly, the nuclease interface is formed by van der Waals 
contacts between Val413 and Leu417 of hEME1ΔN with the side chains of Tyr389, 
Met475, Tyr478 and Leu479 of zMUS81ΔN and by hydrophobic interactions 
between Phe435 and Phe439 of hEME1ΔN and Val449 and Val453 of zMUS81ΔN 
(Figure 1.8D). The (HhH)2 interface forms through the interaction between helices 
H9, H11 and H13 of zMUS81ΔN and helices H9’, H11’ and H13’ of hEME1ΔN 
(Figure 1.8E). Finally, the third interface mainly forms through ring stacking 
between the Phe459 ring of hEME1ΔN and the Phe413 ring of zMUS81ΔN, and 
between the Phe457 ring of hEME1ΔN and the side chain of Arg533 of zMUS81ΔN 
(Figure 1.8F) (Chang et al., 2008). 
 
Both human MUS81-EME1 and S. cerevisiae Mus81-Mms4 have been shown to 
exist as single heterodimers both in solution and when bound to DNA (Chang et al., 
2008; Schwartz et al., 2012). This observation is consistent with the biochemical 
data showing that both budding yeast and human heterodimers preferentially 
cleave three-way branched structures. Indeed, efficient cleavage of HJs would 
require the presence of two active sites at the branch point. Given that 
Mus81-Mms4 is activated by Cdc5-mediated phosphorylation, the possibility that 
the enzyme would form a heterotetramer following its phosphorylation was 
investigated (Schwartz et al., 2012). However, phosphorylation by Cdc5 was found 
to increase the overall activity of the enzyme without triggering its multimerization, 
thus excluding the possibility that the increased activity of phosphorylated 
Mus81-Mms4 is due to the coordinated action of two heterodimers on DNA.  
CHAPTER 1 - Introduction 
 57 
1.3.2 Role of MUS81 at stalled RFs 
The first evidence for a role of Mus81 in the repair of stalled RFs came from studies 
in both S. pombe and S. cerevisiae, where mus81Δ cells displayed hypersensitivity 
to DNA damaging agents that interfere with RF progression (Bastin-Shanower et al., 
2003; Boddy et al., 2000; Doe et al., 2002). Also, S. pombe mus81Δ showed 
synthetic lethality when combined with rqh1Δ, which is critical for the repair of 
damaged or stalled RFs (Boddy et al., 2000; Doe et al., 2002). In contrast to yeast 
cells, mouse and human cells depleted of MUS81 only exhibit hypersensitivity to 
ICL agents (e.g. cisplatin and MMC), while they show milder sensitivity to other 
DNA damaging agents such as CPT or HU (Abraham et al., 2003; Hanada et al., 
2006; Hiyama et al., 2006; McPherson et al., 2004). Although the DNA structures 
that form at stalled RFs are poorly understood, there is clear evidence for the role 
of the MUS81 endonuclease in the formation of DSBs after treatment with 
replication stalling agents (Fugger et al., 2013; Hanada et al., 2007; Hanada et al., 
2006; Regairaz et al., 2011). Given the hypersensitivity of Mus81-/- and Ercc1-/- 
mouse ES cells to ICL agents, Mus81-/- and Ercc1-/- mouse ES cells were treated 
with cisplatin or MMC and the formation of DSBs was analysed. Cells lacking 
Mus81 exhibited significantly fewer DSBs than wild-type cells, whereas no 
difference was observed between Ercc1-/- and wild-type cells, indicating that ICL-
associated DSB formation is dependent on the activity of the Mus81 endonuclease 
and not on that of Xpf-Ercc1 (Hanada et al., 2006). Similar results were obtained 
when Mus81-/- cells were exposed to increasing concentrations of HU or aphidicolin. 
DSB formation was significantly decreased in Mus81-depleted cells compared to 
wild-type cells, suggesting that, upon replication inhibition, murine Mus81-
associated endonuclease cleaves stalled RFs to generate a one-sided DSB, which 
is required for RF HR-mediated repair and DNA replication restart (Hanada et al., 
2007).  
 
In human cells, MUS81 was found to be required for the cleavage of stalled RFs 
after treatment with CPT or HU (Fugger et al., 2013; Regairaz et al., 2011). 
Interestingly, the formation of MUS81-dependent DSBs after HU treatment is 
affected by the activity of FBH1, a member of the UvrD family of 3’-5’ DNA 
helicases (Fugger et al., 2013). Owing to the fact that the substrate of MUS81 at 
stalled RFs is unknown, it is possible that the helicase activity of FBH1 contributes 
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Figure 1.7 Cell-cycle regulation of HJ dissolution and resolution pathways 
A. In normal mitotic human cells, dHJs encountered during S-phase of the cell cycle are primarily processed by the BTR-mediated dHJ 
dissolution pathway into non-crossover products (few SCEs). The activities of the crossover-promoting enzymes SLX-MUS and GEN1 
are restricted to the G2 and M phase of the cell cycle, respectively and only dHJs that escape the BTR-mediated dissolution are 
processed by the HJ resolution pathways. B. In BS cells, the dHJ dissolution pathway is not functional and dHJs are exclusively 
processed by the resolution pathway, which generates both crossovers (i.e. SCEs) and non-crossover products.  
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Figure 1.8 Structural organisation of the MUS81-EME1 complex 
A. Structure of the zMUS81ΔN- hEME1ΔN complex determined at 2.7 Å resolution. zMUS81ΔN is coloured in yellow with the active site 
residues and the interdomain linker helix H8 shown in magenta and orange, respectively. hEME1ΔN is coloured in cyan, with the 
interdomain linker helix H8’ shown in blue. The dotted green line represents the 36R linker region. B. Surface representation of the deep 
cleft and central groove of the complex. The active site cleft and groove are marked. The red sphere represents the divalent metal ion 
required for catalysis. C. Structure of the active site of the complex. The side chains of zMUS81ΔN are coloured in magenta and the 
green sphere indicates modelled Mn2+ from the structure of the Hef nuclease domain. Oxygen and nitrogen atoms are shown in red and 
blue, respectively. The dotted green lines indicate hydrogen bonds. D. View of the interface between the nuclease domain of zMUS81ΔN 
and the nuclease-like domain of hEME1ΔN. E. View of the interface between the (HhH)2 domain of zMUS81ΔN and the (HhH)2 domain of 
hEME1ΔN. F. View of the interface between the nuclease and (HhH)2 domains of zMUS81ΔN and the 36R linker region of hEME1ΔN. 
Figures taken from (Chang et al., 2008). 
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to the generation of the DNA structure required for MUS81-mediated cleavage 
(Fugger et al., 2013). Whether the action of MUS81 at stalled RFs is required for 
DNA replication restart in human cells is still controversial (Naim et al., 2013; 
Petermann et al., 2010; Ying et al., 2013).  
 
Furthermore, MUS81 plays a role in the repair of damage-induced stalled RFs that 
arise after depletion of WRN (Franchitto et al., 2008). As described in Section 1.2.3, 
the activity of the WRN helicase is required for efficient progression of restarted 
RFs after DNA damage (Sidorova et al., 2008). Treatment of WRN-depleted cells 
with HU causes the accumulation of DSBs that are dependent on the activity of 
MUS81 (Franchitto et al., 2008). Also, depletion of MUS81 in Werner syndrome 
(WS) cells results in decreased levels of RAD51 focus formation and reduces the 
recovery of WS cells after replication arrest, indicating that cleavage by MUS81 
endonuclease is required for HR-mediated repair of stalled RFs in the absence of 
WRN (Franchitto et al., 2008). More recently, similar results were obtained in wild-
type cells following oncogene activation (Murfuni et al., 2013). Several studies have 
shown that over-expression of some oncogenes (e.g. E2F) induces replication 
stress (Halazonetis et al., 2008). In the context of oncogene-induced replication 
stress, WRN depletion results in the formation of DSBs that are dependent on the 
activity of the MUS81 endonuclease (Murfuni et al., 2013). Hence, taken together, 
these observations indicate that MUS81 endonuclease activity is required following 
replication stress, when the cleavage of the structures arising at stalled RFs is 
essential for DNA repair. 
 
Importantly, two recent studies have reported a role for MUS81 in the processing of 
late replication intermediates at common fragile sites (CFSs) (Naim et al., 2013; 
Ying et al., 2013). CFSs are large genomic loci that are particularly difficult to 
replicate and often display gaps and breaks, especially after exposure to the DNA 
polymerase inhibitor aphidicolin (Debatisse et al., 2012). Also, CFSs are the source 
of a subset of ultrafine DNA bridges (UFBs), i.e. BLM- and PICH-positive DNA 
bridges that arise during anaphase (Baumann et al., 2007; Chan et al., 2007; Chan 
et al., 2009). These CFS-derived UFBs are denoted by the presence of FANCI-
FANCD2 foci at the bridge termini, with one focus located on each sister chromatid 
(Chan et al., 2009; Naim and Rosselli, 2009). MUS81 has been shown to co-
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localise with such FANCD2 foci at CFSs and its depletion in aphidicolin-treated 
cells resulted in a significant increase in fragile sites-associated chromosome mis-
segregation compared to wild-type cells (Naim et al., 2013; Ying et al., 2013). 
These results indicate that the activity of MUS81 might be required for the cleavage 
of unreplicated CFSs in order to allow the correct segregation of sister chromatids 
during anaphase. 
 
1.4 Telomere maintenance and DNA repair 
Telomeres are nucleoprotein structures that define and protect the ends of linear 
chromosomes (Sfeir, 2012). Human telomeres are composed of tandem double-
stranded (TTAGGG/AATCCC) hexanucleotide repeats (between 5 and 15 
kilobases (kb) in length) and a shorter single-stranded G-rich overhang at the 
3’-end that is approximately 30 to 500 nucleotides long (Chai et al., 2005; Sfeir, 
2012). The 3’-single-stranded overhangs are found on lagging-strands after the 
removal of the RNA primer of the last Okazaki fragment (Makarov et al., 1997; 
McElligott and Wellinger, 1997). Conversely, leading strands have blunt ends. 
However, EXO1- and Apollo-mediated post-replicative resection generates 
3’-single-stranded overhangs (Lam et al., 2010; Wu et al., 2012; Wu et al., 2010). 
The double-stranded/single-stranded structure of telomere ends is essential to 
overcome two main problems that arise from the linearity of eukaryotic 
chromosomes: the ‘end-protection’ and the ‘end-replication’ problem.  
 
The ‘end-protection’ problem stems from the risk of chromosome ends being 
recognised as DSBs by the cellular DNA damage response and repair pathways. 
The ability of telomeres to protect chromosome ends mainly relies on the binding of 
a protective six-subunit protein complex called shelterin (Palm and de Lange, 2008). 
The shelterin complex includes TRF1 and TRF2 (telomeric repeat binding factors 1 
and 2), which bind to the double-stranded region of telomeres, TIN2 (i.e. TRF1- 
and TRF2-interacting nuclear protein 2), RAP1 (i.e. repressor/activator protein 1, 
also known as TRF2-interacting protein or TERF2IP), TPP1 (i.e. TIN2- and POT1-
interacting protein 1, also known as adrenocortical dysplasia homolog or ACD) and 
POT1 (i.e. protection of telomere 1 protein), which binds the single-stranded 
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TTAGGG repeats of the 3’-overhang (Baumann and Cech, 2001; Bianchi et al., 
1997; Bilaud et al., 1997; Broccoli et al., 1997; Lei et al., 2002; Loayza and De 
Lange, 2003). TIN2 is an essential component of the shelterin complex as it binds 
TRF2 through its N-terminus and TRF1 through its C-terminus, thereby acting as a 
bridge between the two proteins (Chen et al., 2008b; Ye et al., 2004a). Also, TIN2 
connects TRF1 and TRF2 to the POT1-TPP1 heterodimer by binding to the C-
terminus of TPP1, thus recruiting it to telomeres (Liu et al., 2004; Ye et al., 2004b). 
By binding specifically to telomeres throughout the cell cycle, the shelterin complex 
constitutes a protective cap that allows cells to distinguish between natural 
chromosome ends and DNA DSBs (Palm and de Lange, 2008). Indeed, removal of 
the shelterin complex by conditional knockout of TRF1 and TRF2 revealed that 
shelterin-free telomeres are processed by six independent DNA damage response 
pathways (Sfeir and de Lange, 2012). Moreover, some shelterin subunits have 
been implicated in the repression of DNA signalling and repair reactions. For 
example, TRF2 suppresses the activation of ATM-mediated DNA damage 
signalling, as indicated by the accumulation of DNA damage factors like γH2AX 
and 53BP1 on telomeres of TRF2-/- cells (Celli and de Lange, 2005; Denchi and de 
Lange, 2007; Dimitrova and de Lange, 2009). Also, depletion of TRF2 promotes 
the activation of the Ku-dependent NHEJ pathway of DSB repair and results in 
telomere end-to-end fusions (Celli and de Lange, 2005). On the same note, POT1 
blocks the activity of ATR by preventing the binding of the DNA damage sensor 
protein RPA to the single-stranded telomeric overhangs (Gong and de Lange, 
2010). 
 
A second level of end protection is provided by the presence of a lariat-like 
structure called a T-loop (Griffith et al., 1999), whose formation requires the activity 
of HR factors such as RAD51, RAD52 and XRCC3 (Verdun and Karlseder, 2006). 
Electron microscopic analysis of psoralen cross-linked telomeric DNA from human 
and mouse cells provided the first physical evidence for the existence of T-loops 
(Griffith et al., 1999). T-loops are generated when the G-rich 3’-overhang loops 
back on itself and invades the duplex telomeric DNA. Importantly, the T-loop 
architecture is thought to hide the telomere single-stranded termini from the end-
recognition components of the DNA repair machinery (e.g. the Ku complex) and 
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thus, it prevents illegitimate processing of the telomere as a DNA DSB. However, 
the molecular mechanisms that regulate T-loop formation remain to be determined.  
 
The ‘end-replication’ problem refers to the inability of semi-conservative DNA 
replication to completely duplicate the ends of linear chromosomes. When the RF 
reaches the end of the chromosome, the removal of the RNA primer of the last 
Okazaki fragment on the lagging strand results in the incomplete replication of the 
terminal sequence of the telomeric DNA. Hence, part of the telomere is lost during 
each cell cycle (Olovnikov, 1971, 1973; Watson, 1972). This proliferation-
dependent telomere shortening process ultimately generates telomeres that are too 
short to be protected by the binding of the shelterin complex or by formation of T-
loops. As a consequence, the DNA damage response machinery recognises 
telomere ends as DSBs and causes a permanent growth arrest called replicative 
senescence (or M1, mortality stage 1) (d'Adda di Fagagna et al., 2003; Harley et al., 
1990; Wright et al., 1989). As such, telomere attrition controls the proliferative 
lifespan of human somatic cells (Harley et al., 1990; Olovnikov, 1971, 1973; 
Watson, 1972). However, replicative senescence can be overcome through the 
inactivation of the tumour suppressors p53 and pRB (Retinoblastoma protein), 
which allow cells to continue proliferating before reaching crisis (or M2, mortality 
stage 2). At M2, most of the cells undergo apoptosis but rare clones (approximately 
1 x 107) can escape this process and generate an immortal culture (Harley et al., 
1990). Cancer cells have developed two mechanisms that allow them to maintain 
functional telomeres and proliferate indefinitely: telomerase-mediated telomere 
elongation and alternative lengthening of telomeres (ALT). 
 
1.4.1 Telomerase-mediated telomere elongation 
Telomerase is a ribonucleoprotein reverse transcriptase (RT) composed of a 
catalytic protein subunit, the telomerase RT (TERT), a telomerase RNA (TR) 
subunit (Cohen et al., 2007; Greider and Blackburn, 1985) and species-specific 
accessory proteins (Fu and Collins, 2007; Venteicher et al., 2009; Venteicher et al., 
2008). The main function of telomerase in vivo is the de novo synthesis of telomeric 
DNA, which counteracts progressive telomere shortening that occurs during 
consecutive cell divisions. Telomerase activity can be reconstituted in vitro by co-
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expressing hTERT and hTR in rabbit reticulocyte lysates, demonstrating that 
hTERT and hTR represent the minimal catalytic core of human telomerase (Beattie 
et al., 1998; Weinrich et al., 1997). Telomerase is recruited to telomeres by binding 
to the OB-fold domain of the shelterin component TPP1 (Abreu et al., 2010). 
Indeed, human cells depleted of TPP1 or TIN2 fail to recruit telomerase to 
chromosome ends. Similarly, the conditional deletion of TPP1 in mice prevented 
the recruitment of telomerase to telomeres (Nandakumar et al., 2012; Tejera et al., 
2010; Zhong et al., 2012). Since telomerase is observed at telomeres 
predominantly during S-phase (Jady et al., 2006; Tomlinson et al., 2006), it is likely 
that its recruitment to chromosome ends is cell cycle-regulated. However, the 
mechanism of regulation is still undetermined. 
 
Unlike prototypical RTs, which convert genomic RNA into a single molecule of 
complementary DNA (cDNA), telomerase catalyses multiple rounds of telomere 
extension using an RNA template embedded in the TR subunit. As shown in Figure 
1.9, processive telomere elongation involves multiple steps, including: (i) 
recognition and alignment of the telomeric DNA primer with the RNA template and 
the TERT subunit, (ii) synthesis of the first telomeric repeat and (iii) translocation of 
the telomerase in order to re-position the DNA 3’-end and initiate the next round of 
telomere synthesis (Wyatt et al., 2010). Recent studies have determined that both 
telomerase processivity and telomere elongation in vivo are stimulated by the same 
OB-fold domain of TPP1 that is required for telomerase recruitment (Nandakumar 
et al., 2012; Zhong et al., 2012). Indeed, in vitro analysis of the effect of TPP1-
POT1 on telomerase reaction cycle showed that binding of TPP1-POT1 increases 
telomerase processivity by decreasing the primer dissociation rate and by 
increasing the efficiency and rate of the template-primer translocation (Latrick and 
Cech, 2010). 
 
Depletion of TERT or TR from mice results in telomere shortening and end-to-end 
fusions, genomic instability, aneuploidy, and premature ageing (Blasco et al., 1996; 
Liu et al., 2000). Conversely, overexpression of TERT dramatically increased the 
lifespan of mice that are made cancer-resistant by enhanced expression of the 
tumour suppressor proteins p53, p16 and p19ARF (Tomas-Loba et al., 2008). In 
humans, telomerase is expressed in highly proliferative tissues such as ovaries and 
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testis and during embryogenesis (Wright et al., 1996). In somatic tissues, however, 
hTERT transcription is strongly repressed and thus, cells experience proliferation-
dependent telomere erosion (Cong et al., 1999; Horikawa et al., 1999; Takakura et 
al., 1999). Given the highly proliferative nature of cancer cells, it is not surprising 
that telomerase has been found to be up-regulated in 85% of human cancers and 
telomerase inhibitors have entered clinical trials (Kim et al., 1994; Ruden and Puri, 
2013; Shay and Bacchetti, 1997). Cells that re-activate telomerase to retain an 
infinite proliferative potential are referred to as ‘telomerase-positive’, in order to 
distinguish them from cells that employ the telomerase-independent ALT pathway 
of telomere elongation. 
 
1.4.2 Alternative Lengthening of Telomeres (ALT) pathway 
The existence of a telomerase-independent mechanism of telomere elongation was 
inferred from the observation that human telomerase-negative cells could maintain 
telomere lengths after hundreds of population doublings (Bryan et al., 1995). This 
mechanism is referred to as ALT and is found in approximately 15% of human 
cancer types, although ALT activity has also been detected in normal mouse 
somatic tissues (Neumann et al., 2013). Examples of tumours that utilise the ALT 
pathway include osteosarcomas, liposarcomas, astrocytomas and glioblastoma 
multiforme and they all share a very poor prognosis (Henson and Reddel, 2010). 
 
ALT cells are characterised by several distinct features, some of which are used as 
diagnostic assays to detect ALT in human tumours. One of the most striking feature 
is the abundance of extra-chromosomal telomeric DNA in the form of 
double-stranded telomeric circles (T-circles) (Cesare and Griffith, 2004; Wang et al., 
2004), linear dsDNA, partially single-stranded circles (called C- or G-circles 
depending on the nature of the continuous sequence) and ‘t-complexes’, a form of 
highly branched telomeric DNA (Nabetani and Ishikawa, 2009). C-circles are highly 
specific to ALT cells and can be detected in patient’s blood samples, thereby 
serving as a diagnostic marker of ALT-positive tumours (Henson et al., 2009). Their 
origin, however, is still unclear. Conversely, T-circles might be generated through 
the resolution of T-loops in order to counteract excessive ALT-mediated telomere 
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elongation (Compton et al., 2007; Wang et al., 2004). Other hallmark features of 
ALT-positive cells include the heterogeneity of telomere lengths, which range from 
5 to 50 Kb, and the presence of ALT-associated promyelocytic leukaemia bodies 
(APBs) (Bryan et al., 1995; Yeager et al., 1999). 
 
APBs are a subset of promyelocytic leukaemia (PML) nuclear bodies that co-
localise with telomeric DNA. Their formation is triggered by the sumoylation of the 
shelterin components TRF1, TRF2, TIN2 and RAP1 by the SUMO E3 ligase 
MMS21 (Potts and Yu, 2007). Indeed, cells expressing mutants of TRF1 and TRF2 
that cannot be sumoylated do not form APBs. These sumoylation events are 
required for the binding of PML and SP100 proteins, which constitute the shell of 
the APBs and promote the recruitment of DNA repair and recombination factors 
(Lang et al., 2010). Several lines of evidence suggest that APBs are involved in the 
ALT pathway of telomere elongation. First, APBs are highly specific to ALT-positive 
cells and constitute a strong marker for the identification of ALT-tumours (Henson 
et al., 2005). Second, the repression of the ALT pathway in cell hybrids of ALT-
positive with telomerase-positive cells resulted in the disappearance of APBs, 
whereas activation of the ALT-pathway promoted their formation (Perrem et al., 
2001). Third, the HR-associated MRN complex is required for APB assembly (Jiang 
et al., 2007; Wu et al., 2000). Despite the strong correlation between the formation 
of APBs and ALT-mediated telomere elongation, the function of APBs in the ALT 
pathway is still unclear. Interestingly, analysis of artificially enlarged APBs showed 
that these bodies contain clusters of telomeres and are sites of inter-telomeric 
recombination, as indicated by the presence of filamentous telomere bridges in 
metaphase spreads (Draskovic et al., 2009). Also, many DNA repair and 
recombination proteins, including the MRN complex, FANCA, FANCD2, BLM, 
RAD51, RAD51D, FEN1 and MUS81, are recruited to APBs (Bhattacharyya et al., 
2009; Draskovic et al., 2009; Fan et al., 2009; Jiang et al., 2007; Saharia and 
Stewart, 2009; Tarsounas et al., 2004; Zeng et al., 2009). Hence, APBs might be 
sites of telomere elongation that provide both the physical proximity between 
telomeres and the proteins required for HR-mediated telomere lengthening. 
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Figure 1.9 Telomerase-mediated telomere elongation 
The processive extension of the telomeric DNA is a multi-step process that 
involves: (i) the binding and alignment of telomerase (hTERT is indicated in pink, 
hTR is depicted as a blue line for simplicity) to the single-stranded G-rich overhang 
at the telomere 3’-end; (ii) synthesis of the first telomeric repeat (i.e. GGTTAG) and 
(iii) translocation of telomerase and initiation of the next round of telomere 
synthesis. Adapted from (Autexier and Lue, 2006) 
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The ALT mechanism involves the HR-dependent synthesis of new telomeric DNA. 
The first evidence of HR at telomeres resulted from a study where a DNA tag 
inserted in the telomere repeats of one chromosome was duplicated to other 
chromosome ends in ALT-positive cells and not in telomerase-positive cells 
(Dunham et al., 2000). Also, ALT-positive cells display a level of telomere sister 
chromatid exchanges (T-SCEs) that is several orders of magnitude higher than that 
displayed by ALT-negative cells, without showing any increase in SCE frequency 
elsewhere in the genome (Londono-Vallejo et al., 2004). However, the origin of the 
template DNA used in the HR reaction remains uncertain and several HR-
dependent elongation models have been proposed. The duplication of a DNA tag 
from one telomere to other chromosome ends suggests that the synthesis of new 
telomeric DNA occurs using an adjacent chromosome telomere as a template 
(inter-telomeric recombination) (Dunham et al., 2000) (Figure 1.10A). However, 
telomere elongation can also occur via intra-telomeric recombination, whereby 
T-loops and sister-chromatid telomeres can be used as templates (Muntoni et al., 
2009) (Figure 1.10B-C). In the context of a T-loop, the branch migration of the 
junction could prime the leading strand synthesis of new DNA using the 
complementary strand as a template (Figure 1.10C). Also, given the high 
concentration of extra chromosomal telomeric DNA, it is possible that C-circles, 
T-circles and linear duplex DNA could be involved in the HR-dependent replication 
of telomeres (Figure 1.10D-E). In yeast, telomere lengthening occurs through a 
rolling-circle mechanism in which 3’-telomeric overhangs invade the extra 
chromosomal T-circles and use them as templates for telomeric extension 
(Tomaska et al., 2009). In vitro, C-circles from human ALT-positive cells are 
excellent substrates for rolling circle amplification of telomeres, suggesting that 
they might fulfil the same function in vivo (Henson et al., 2009) (Figure 1.10E). 
 
Interestingly, a recent study revealed that ALT-positive cells contain single-
stranded 5’-C-rich overhangs in amounts that are comparable to 3’-G-rich 
overhangs (Oganesian and Karlseder, 2011). Notably, the abundance of these 5’-
C-rich overhangs in ALT cells correlated with aberrant recombination as depletion 
of RAD51, RAD52 and XRCC3 resulted in an increase of C-overhang levels at the 
expense of the number of G-overhangs. Although such 5’-C-rich overhangs have 
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been proposed to be a mark of cells undergoing aberrant HR, their origin remains 
undetermined (Oganesian and Karlseder, 2011). 
 
The ability of telomeres of ALT cells to undergo HR-mediated lengthening is an 
indication of defective telomere protection by the shelterin complex that is essential 
for ALT cells survival. Such defects do not arise from mutations of TRF2, RAP1 or 
POT1, as they are all wild type and expressed at a normal level in ALT cells 
(Lovejoy et al., 2012). However, the total quantity of telomeric DNA is significantly 
higher in ALT cells compared to telomerase-positive cells (Lau et al., 2013). Hence, 
it is likely that the ratio between the shelterin components and telomeric DNA is 
significantly decreased in ALT cells, which might result in a functional deficiency 
and in a more HR-permissive telomeric state. For example, given the role of TRF2 
in T-loop formation and protection against enzymatic cleavage (Fouche et al., 
2006; Poulet et al., 2009), a decreased TRF2:telomeric DNA ratio would cause an 
increased frequency of unprotected chromosome ends. In addition, telomeres of 
ALT cells carry high levels of interspersed variant repeats, with the more abundant 
being the C-type variant (i.e. TCAGGG) (Conomos et al., 2012). C-type variant 
repeats are bound with high affinity by nuclear receptors such as TR4 and COUP-
TF2. The interaction between nuclear receptors and telomeric DNA is usually 
hindered by the binding of shelterin components because, for example, TRF2 binds 
the canonical G-type variant repeats more strongly than TR4. Hence, in the 
presence of C-type variant sequences it is likely that the amount of shelterin 
components bound to telomeres is altered by the binding of nuclear receptors. 
Importantly, depletion of TR4 or COUP-TF2 diminishes several ALT characteristics, 
such as the generation of APBs, T-SCEs and extrachromosomal C-circles 
(Conomos et al., 2012). Conversely, insertion of C-type variants in the telomeres of 
telomerase-positive cells results in the recruitment of nuclear receptors and in the 
appearance of ALT hallmark features, but does not trigger HR-mediated elongation, 
indicating that the presence of variant repeats and nuclear receptors is not 
sufficient to activate the ALT mechanism in telomerase-positive cells (Conomos et 
al., 2012). 
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Figure 1.10 Schematic representation of ALT-dependent telomere elongation models 
The origin of the template DNA used for ALT-mediated telomere elongation is still unclear. The various models that have been proposed 
involve: (A) intratelomeric recombination, in which an adjacent chromosomal telomere is used as template, (B and C) intratelomeric 
recombination, in which either the telomere of the sister chromatid (B) or the T-loop (C) can be used as templates and (D and E) 
recombination with extrachromosomal telomeric DNA, in which any of the forms of extrachromosomal telomeric DNA present in ALT cells 
can be used as template. For example, (D) illustrates recombination with a linear DNA template while (E) summarises recombination with 
a C-circle template. Adapted from (Cesare and Reddel, 2010) 
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1.4.3 Telomere maintenance proteins in ALT-cells 
Telomere maintenance encompasses mechanisms for telomere elongation as well 
as processes that prevent telomere loss. The repetitive nature of the telomeric DNA 
makes telomeres a difficult substrate for the DNA replication machinery and their 
incomplete duplication can result in rapid telomere shortening. Because replication 
of telomeres is unidirectional and starts from the sub-telomeric region, the 
presence of unrepaired stalled or collapsed RFs can result in the complete loss of 
the distal telomeric sequences. Hence, it is not surprising that many proteins 
involved in the repair of stalled or collapsed RFs are also involved in telomere 
maintenance. The first proteins to be identified as essential for telomere 
maintenance in ALT-positive cells were the components of the MRN complex 
(Jiang et al., 2005; Zhong et al., 2007). Indeed, the inhibition of the MRN function 
by siRNA-mediated knockdown of the individual proteins or by sequestration of 
NBS1 by SP100 overexpression resulted in telomere shortening (Jiang et al., 2005; 
Zhong et al., 2007). Also, two members of the RecQ family of DNA helicases, 
namely WRN and BLM, are involved in telomere maintenance of ALT cells and 
their individual depletion results in rapid telomere shortening (Bhattacharyya et al., 
2009; Crabbe et al., 2004; Du et al., 2004; Stavropoulos et al., 2002). This 
phenotype may be related to the ability of BLM and WRN to unwind four-stranded 
DNA secondary structures called G4 quadruplexes in vitro (Mohaghegh et al., 
2001). These structures contain four guanine bases that associate through 
Hoogsten hydrogen bonds to form a square planar structure termed the guanine 
tetrad. G4 quadruplexes are formed when two tetrads stack on top of each other 
(Biffi et al., 2013; Sundquist and Klug, 1989; Williamson et al., 1989) and represent 
the most frequent impediment to RF progression at telomeres (Rizzo et al., 2009). 
However, studies performed on mouse cells showed that G4 quadruplexes are 
processed by RTEL1 (Vannier et al., 2012) and DNA2 (Lin et al., 2013) in vivo. 
Indeed, Rtel-/- and Dna2-/- cells exhibit telomere replication defects, as indicated by 
the presence of elevated telomere fragility and telomere loss (Lin et al., 2013; 
Vannier et al., 2012). However, their contribution to telomere maintenance of 
human ALT cells remains undetermined. 
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Additional proteins that have been implicated in the ALT mechanism include: (i) 
RPA, which prevents the accumulation of G-rich single-stranded DNA (Fan et al., 
2009; Grudic et al., 2007), (ii) BRCA2, whose depletion decreases the frequency of 
T-SCEs (Sapir et al., 2011), (iii) flap endonuclease 1 (FEN1), a structure-specific 
endo/exonuclease that functions in lagging strand DNA replication by processing 
the 5’-end of the Okazaki fragments (Balakrishnan and Bambara, 2013), (iv) 
FANCA, a component of the FA core complex (Joenje et al., 1997), and FANCD2 
(Section 1.2.3) (Fan et al., 2009). Importantly, FEN1 interacts directly with WRN 
and ALT-positive cells depleted of FEN1 exhibit telomere dysfunction (Saharia and 
Stewart, 2009). Similarly, the depletion of either FANCA or FANCD2 results in 
decreased T-SCEs level and increased frequency of telomere-free chromosome 
ends (Fan et al., 2009). 
 
1.4.4 The role of MUS81 in telomere maintenance of ALT-positive cells 
In mitotic human cells, the MUS81 endonuclease is required for HJ resolution and 
for the HR-mediated repair of stalled RFs (Sections 1.3.1 and 1.3.2). Human 
MUS81 also has an important role in telomere maintenance in ALT, but not 
telomerase-positive cells (Zeng et al., 2009). More specifically, MUS81 localises to 
APBs during the G2-phase of the cell cycle and its depletion is associated with a 
significant increase in telomere-free chromosome ends (Zeng et al., 2009). 
Moreover, the high frequency of T-SCEs characteristic of ALT-positive cells is 
significantly reduced in the absence of MUS81, which could reflect defects in the 
repair of RFs that stall in telomeric DNA (Zeng et al., 2009). Interestingly, MUS81 
interacts with telomeric DNA in ALT cells but not in telomerase-positive cells. Also, 
telomere loss was not observed following its depletion in telomerase-positive cells, 
indicating that the function of MUS81 is restricted to telomere maintenance in ALT-
cells. In agreement with these observations, MUS81 knockdown resulted in 
reduced viability in ALT-positive but not in ALT-negative cells. The overexpression 
of the human TERT subunit of the telomerase partially rescued the viability of the 
MUS81-depleted ALT cells but did not restore the high T-SCEs frequency, 
suggesting that the rescue of the cellular viability is independent from the telomeric 
recombination pathway (Zeng et al., 2009). 
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It has been proposed that the telomeric functions of MUS81 could be related to its 
ability to cleave recombination intermediates. Hence, synthetic D-loop substrates 
were exposed to MUS81 immunoprecipitates from ALT-positive cells (Zeng et al., 
2009). Interestingly, the activity of the immunoprecipitated MUS81 was increased 
by depletion of TRF2. TRF2 has a well-known function in the suppression of 
telomere recombination in ALT-positive cells, as indicated by the increased 
frequency of T-SCEs in TRF2-depleted cells, and it interacts with MUS81 to 
regulate its binding to telomeric secondary structures (Zeng et al., 2009). However, 
because both MUS81 and TRF2 interact with SLX4 in vivo and in vitro, it is likely 
that their interaction is mediated through SLX4 (Svendsen et al., 2009). 
 
1.5 Aim of the study 
As detailed in the previous sections, the activity of the MUS81 endonuclease is 
required for HR-mediated repair of DSBs (Section 1.3.1), repair and restart of 
stalled RFs (Section 1.3.2) and telomere maintenance (Section 1.4.4). In 
mammalian cells, MUS81 can form two heterodimeric complexes, one with EME1 
and another with EME2 (Section 1.3). The studies conducted so far on the function 
of the MUS81 endonuclease in human cells have often disregarded whether the 
activity and/or phenotype being observed was related to the function of the MUS81-
EME1 or MUS81-EME2 complex. With particular attention to what is known about 
the cellular roles of the MUS81-associated endonuclease, this study was aimed to 
determine what are the differences (if any) in the biochemical activities and the 
biological functions of the MUS81-EME1 and MUS81-EME2 complexes. 
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CHAPTER 2 
Materials and methods 
 
2.1 Enzymes and reagents 
2.1.1 Enzymes 
All the restriction enzymes used in this study and T4 polynucleotide kinase were 
purchased from New England Biolabs Inc. (NEB). Exonuclease III was purchased 
from Promega. Proteinase K, recombinant PCR grade, was purchased from Roche. 
RNase A was purchased from Qiagen. 
 
2.1.2 General reagents 
All chemical reagents were purchased from Sigma unless stated otherwise. 
Amersham: HyperfilmTM ECL High Performance Chemiluminescence film 
Bio-Rad: 30% Acrylamide/Bis Solution, 37.5:1; 40% Acrylamide/Bis Solution 19:1; 
bromophenol blue and xylene cyanol; All Blue Precision Plus ProteinTM Standards. 
bioSYNTHESIS: TelG-TMR probe and TelC-FITC probe 
Chromotek: GFP-TRAP®_A beads 
Clontech: In-Fusion® cloning kit  
EMD Millipore: KOD Hot Start DNA polymerase  
Electron Microscopy Sciences: Paraformaldehyde 16%  
Expedeon: InstantBlueTM  
Fermentas: GeneRuler 1kb DNA ladder 
Fisher BioReagents: DPX mounting medium; urea. 
FLUKE: GIEMSA stain, modified solution 
GE Healthcare: HiTrapTM Heparin HP 1ml columns; ECL western blotting detection 
reagents 
Gene Bridges: Quick & Easy BAC Modification Kit  
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GIBCO: Tetracycline-free Fetal Bovine Serum (FBS) 
IBA: Strep-Tactin® Superflow®  
Kodak: BioMax MR films  
Life technologiesTM: SYPRO® Ruby Protein gel stain; NuPAGE® 10% Bis-Tris 
gels and NuPAGE® 7% Tris-Acetate gels; NuPAGE® MOPS and Tris-Acetate SDS 
running buffer (20x); UltraPureTM agarose; NuPAGE® LDS sample buffer; 
ProLong® Gold Antifade Reagent with DAPI; Lipofectamine RNAiMAX; zeocin; 
geneticin; SOC medium; Gateway® LR and BP reactions 
Macherey-Nagel: Polygram® CEL 300 PEI/UV245  
Millipore: Immobilon®-P transfer membrane  
NBS Biologicals: SafeView  
Promega: Fugene HD transfection reagent 
Roche: Colcemid; complete EDTA-free protease inhibitor cocktail tablets; blocking 
reagent (11096176001);  
Stratagene: QuickChange Lightning Multi Site-Directed Mutagenesis Kit  
Qiagen: Effectene® transfection reagent  
Sigma: Anti-FLAG M2 Affinity Gel resin; Hoechst 33342; 5-bromo-2'-deoxyuridine 
(BrdU); phosphatase inhibitor cocktail 2 and 3; propidium iodide (PI); formamide, 
>99.5%; Fetal Bovine Serum (FBS); pepsin from porcine gastric mucosa; Stains-all; 
polyethylene glycol (PEG)-3350; dimethyl sulfoxyde (DMSO); thymidine. 
 
2.1.3 Antibodies 
Primary antibodies 
FITC mouse anti-BrdU (BD PharmingenTM); mouse anti-Phospho Histone H3 
(Ser10) (9701, Cell Signalling); rabbit anti-FLAG (Sigma, 1:500); mouse anti-XPF 
(Ab-1 clone 219, Thermo Scientific, 1:1000); mouse anti-TRF1 (ab10579, Abcam, 
1:200); mouse anti-TRF2 (ab13579, Abcam, 1:200); mouse anti-CENPF (ab90, 
Abcam, 1:1000); mouse anti-MUS81 (ab14387, Abcam, 1:500); mouse anti-EME1 
(clone MTA31 7H2, Santa Cruz, 1:500); mouse anti-β-Actin (ab8226, Abcam, 
1:10000). Sheep anti-SLX1 (1:500) and sheep anti-SLX4 (1:2000) were a kind gift 
from Prof. John Rouse.  
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Secondary antibodies 
Polyclonal swine anti-rabbit immunoglobulins/HRP and polyclonal goat anti-mouse 
immunoglobulins/HRP (Dako); polyclonal rabbit to sheep IgG (HRP) (ab6747, 
Abcam); Alexa Fluor® 488 goat anti-mouse IgG (H+L), Alexa Fluor® 488 F(ab’)2 
fragment of goat anti-rabbit IgG (H+L), Alexa Fluor® 555 donkey anti-mouse IgG 
(H+L) and Alexa Fluor® 546 goat anti-rabbit IgG (H+L) (Molecular probes). 
 
2.2 Buffers and solutions 
2.2.1 Media and protein buffers 
Western blot blocking buffer: 4% (w/v) skimmed milk powder in PBS + 0.1% (v/v) 
Tween-20 
PBS: 140 mM NaCl, 3.4 mM KCl, 10 mM Na2HPO4, 18 mM KH2PO4 
Luria broth (LB): 1% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 0.05% (w/v) 
NaCl 
Tris-buffered saline (TBS): 30 mM Tris-HCl (pH 7.4), 150 mM NaCl 
Lysis buffer: TBS supplemented with 1x phosphatase inhibitor cocktail 2, 1x 
phosphatase inhibitor cocktail 3, 1x protease inhibitor cocktail, 0.5% (v/v) NP-40 
Immunoprecipitation (IP) wash buffer: TBS supplemented with 0.5% (v/v) NP-40 
FLAG elution buffer: TBS supplemented with 200 µg/ml 3xFLAG peptide (Peptide 
synthesis facility, Cancer Research UK) 
Western blot transfer buffer: 25 mM Tris base, 190 mM glycine, 20% (v/v) methanol 
Protein loading buffer (2x): NuPAGE® LDS loading buffer supplemented with 10% 
(v/v) β-mercaptoethanol 
TGN buffer: 20 mM Tris-HCl (pH 7.5), 10% (v/v) glycerol, 0.01% (v/v) NP-40 
Storage buffer: 50 mM Tris-HCl (pH 8.0), 10% (v/v) glycerol, 100 mM NaCl, 1 mM 
DTT 
Protein dilution buffer: 50 mM Tris-HCl (pH 8.0), 10% (v/v) glycerol, 100 mM NaCl, 
1 mM DTT, 0.1 mg/ml purified BSA 
TSB: 10% (w/v) PEG-3350, 5% (v/v) DMSO, 10 mM MgCl2, 10 mM MgSO4, LB (pH 
6.1) 
KCM (5x): 0.5 M KCl, 0.15 M CaCl2, 0.25 M MgCl2 
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2.2.2 DNA buffers 
Formamide loading buffer: 90% (v/v) deionised formamide, 0.05% (w/v) xylene 
cyanol, 0.05% (w/v) bromophenol blue, 1% (v/v) TBE 
TBE: 89 mM Tris base, 89 mM boric acid, 2 mM EDTA 
TE: 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
DNA loading buffer (6x): 0.35% (w/v) bromophenol blue, 0.35% (w/v) xylene cyanol, 
30% (v/v) glycerol 
Stains-all solution: 20% (v/v) isopropanol, 10% (v/v) formamide, 0.01% (w/v) 
Stains-all 
Annealing buffer: 150 mM NaCl, 15 mM sodium citrate 
TN buffer: 10 mM Tris-HCl (pH 8.0), 50 mM NaCl 
TNE buffer: 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.1 mM EDTA 
 
2.2.3 Reaction buffers 
Cleavage buffer: 50 mM Tris-HCl (pH 8.0), 0.1 mg/ml purified BSA, 3 mM MgCl2, 1 
mM DTT 
Stop buffer (5x): 100 mM Tris-HCl (pH 7.5), 10 mg/ml proteinase K, 50 mM EDTA, 
2.5% (v/v) SDS 
 
2.2.4 Immunofluorescence (IF), sister chromatid exchanges (SCEs) and 
telomeric fluorescence in situ hybridisation (FISH) buffers 
Pre-extraction buffer: PBS supplemented with 0.1% (v/v) Triton X-100 
Permeabilisation buffer: 0.1% (w/v) sodium citrate, 0.1% (v/v) Triton X-100 
IF washing solution: PBS supplemented with 0.25% (w/v) BSA and 0.1% (v/v) 
Tween-20 
IF blocking solution: PBS supplemented with 2.65% (w/v) BSA, 0.1% (v/v) Tween-
20 and 10% (v/v) FBS 
FISH blocking solution (10%): blocking reagent dissolved in 100 mM maleic acid 
and 150 mM NaCl (pH 7.5). 
Hybridising solution: 10 mM Tris-HCl (pH 7.2), 70% (v/v) deionised formamide, 
0.5% (w/v) FISH blocking solution 
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Hybridisation wash #1: 10 mM Tris-HCl (pH 7.2), 70% (v/v) formamide 
Hybridisation wash #2: 100 mM Tris-HCl (pH 7.2), 150 mM NaCl, 0.08% (v/v) 
Tween-20 
Soerensen buffer (pH 6.8): 38% (v/v) 133 mM Na2HPO4, 62% (v/v) 133 mM 
KH2PO4. 
20x SSC: 3 M sodium citrate (pH 7.0), 0.3 M NaCl 
 
2.2.5 Pulse-field gel electrophoresis (PFGE) buffers 
Washing buffer: 10 mM Tris-HCl (pH 8.0), 100 mM EDTA 
Lysis buffer: 10 mM Tris-HCl (pH 8.0), 100 mM EDTA, 1% (w/v) sodium lauryl 
sarcosine, 0.2% (w/v) sodium deoxycholate, 1 mg/ml proteinase K 
RNase buffer: 10 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1 mg/ml RNase A (Section 
2.1.2) 
 
2.3 Bacterial strains 
2.3.1 Bacterial strains 
E. coli DH5α competent cells were used for all plasmid transformations. 
E. coli One Shot® TOP10 chemically competent cells (Life TechnologiesTM) were 
used for the transformation of DNA ligation reactions. 
E. coli  MAX Efficiency DH10BAC chemically competent cells (Life TechnologiesTM) 
were used to generate recombinant baculovirus DNA. 
 
2.3.2 Transformation of chemically competent cells 
E. coli cells were grown to an OD~0.5, centrifuged, resuspended in 500 µl of ice-
cold TSB (Section 2.2.1) and incubated on ice for 10 min or aliquoted at -80°C.  
For transformation with 1 µg of plasmid DNA, 50 µl of competent cells were 
incubated with DNA, 1x KCM (Section 2.2.1) and water (up to 50 µl) on ice for 20 
min and then at RT for 20 min. Cells were incubated with 500 µl of SOC media 
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(Section 2.1.2) for 40-60 min in a shaking 37°C incubator and plated on LB agar 
plates. 
 
2.4 DNA primers 
1. 5’GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGCTCTAAAGAAGTCAT
A3’ 
2. 5’GGGGACCACTTTGTACAAGAAAGCTGGGTCGTCAGCACTATCTAAAGA3’ 
3. 5’GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGCGCGGGTTGGACCC
GGG3’ 
4. 5’GGGGACCACTTTGTACAAGAAAGCTGGGTCGGAGCCCAGGTCCAGCAG3’ 
5. 5’GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGCGGCCCCGGTCCGC
CTG3’   
6. 5’GGGGACCACTTTGTACAAGAAAGCTGGGTCGGTCAAGGGGCCGTAGCT3’ 
7. 5’CTCTGAGCAGGACCTTATCCCAGCTCTACTGCAGCTACGGCCCCTTGAC
CGATTATGATATTCCAACTACTG3’ 
8. 5’CCTGGGTTGGGGGACAGACGGGGGCTGGGGGCTGTTTCACGGCATAAG
CTTCAGAAGAACTCGTCAAGAAG3’ 
9. 5’CAGAGGTGAGGGCAAGAGAC3’ 
10. 5’ATGAGCCCTCTGCACTCCTA3’ 
11. 5’CACCCGGGATCTCGAGATGGCGGCCCCGGTCCG3’ 
12. 5’AGCACCATGGCTCGAGTCAGGTCAAGGGGCCGTAG3’ 
13. 5’GAAGCGCGGAATTCATGGCTCTAAAGAAGTCATCAC3’ 
14. 5’GTAGGCCTTTGAATTCTCAGTCAGCACTATC3’ 
15. 5’GAAGCGCGGAATTCATGGATTATAAAGATGATGATG3’ 
16. 5’GTAGGCCTTTGAATTCTCAGGAGCCCAGGTC3’ 
17. 5’AAGCTGCACGTTGGAGCTTTTGTGTGGGTGGCC3’ 
18. 5’GGCCACCCACACAAAAGCTCCAACGTGCAGCTT3’ 
19.  5’ATGGCGCGGGTTGGACCCGGGAGGG3’ 
20.  5’TCAGGAGCCCAGGTCCAGCAGGAGA3’ 
All oligonucleotides used in this study were synthesised by SIGMA. 
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2.5 Plasmids 
Table 2.1 List of plasmids  
PLASMID DESCRIPTION 
pDONR221-EME1 
Gateway® entry vector generated by Gateway® 
recombination between pDONR221 (Life 
technologiesTM) and a PCR fragment (amplified 
with primers 1 and 2, Section 2.4) coding for 
EME1 cDNA 
pDONR221-EME2A 
Gateway® entry vector generated by Gateway® 
recombination between pDONR221 (Life 
TechnologiesTM) and a PCR fragment (amplified 
with primers 3 and 4, Section 2.4) coding for 
EME2A cDNA 
pDONR221-EME2B 
Gateway® entry vector generated by Gateway® 
recombination between pDONR221 (Life 
TechnologiesTM) and a PCR fragment (amplified 
with primers 3 and 4, Section 2.4) coding for 
EME2B cDNA 
pDONR221-MUS81 
Gateway® entry vector generated by Gateway® 
recombination between pDONR221 (Life 
TechnologiesTM) and a PCR fragment (amplified 
with primers 5 and 6, Section 2.4) coding for 
MUS81 cDNA 
pDEST-N-SF-TAP 
Gateway® vector for mammalian expression of 
proteins with N-terminal STREP/FLAG (SF) tag 
pDEST-N-SF-TAP-EME1 
Gateway® vector for mammalian expression 
obtained by Gateway® recombination between 
pDEST-N-SF-TAP and pDONR221-EME1 
pDEST-N-SF-TAP-EME2A 
Gateway® vector for mammalian expression 
obtained by Gateway® recombination between 
pDEST-N-SF-TAP and pDONR221-EME2A 
pDEST-N-SF-TAP-EME2B Gateway® vector for mammalian expression 
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obtained by Gateway® recombination between 
pDEST-N-SF-TAP and pDONR221-EME2B 
pDEST-N-SF-TAP-MUS81 
Gateway® vector for mammalian expression 
obtained by Gateway® recombination between 
pDEST-N-SF-TAP and pDONR221-MUS81 
pcDNA4-TO-SFEME1 
Vector for tetracycline-inducible expression of 
proteins in mammalian cells generated by cloning 
SFEME1 from pDEST-N-SF-TAP-EME1 (HindIII 
and XbaI digested) into HindIII and XbaI sites of 
pcDNA4-TO (Life TechnologiesTM) 
pcDNA4-TO-SFEME2A 
Vector for tetracycline-inducible expression of 
proteins in mammalian cells generated by cloning 
SFEME2A from pDEST-N-SF-TAP-EME2A (HindIII 
and XbaI digested) into HindIII and XbaI sites of 
pcDNA4-TO (Life TechnologiesTM) 
pcDNA4-TO-SFEME2B 
Vector for tetracycline-inducible expression of 
proteins in mammalian cells generated by cloning 
SFEME2B from pDEST-N-SF-TAP-EME2B (HindIII 
and XbaI digested) into HindIII and XbaI sites of 
pcDNA4-TO (Life TechnologiesTM) 
pcDNA4-TO-SFMUS81 
Vector for tetracycline-inducible expression of 
proteins in mammalian cells generated by cloning 
SFMUS81 from pDEST-N-SF-TAP-MUS81 (HindIII 
and XbaI digested) into HindIII and XbaI sites of 
pcDNA4-TO (Life TechnologiesTM) 
pFL-MUS81 
Bicistronic vector for baculovirus expression 
generated by cloning PCR amplified MUS81 into 
the pFL vector with In-Fusion® primers 11 and 12 
(Section 2.4) 
pFL-MUS81 -SFEME1 
Bicistronic vector for baculovirus co-expression of 
MUS81 and EME1 generated by cloning PCR 
amplified SFEME1 in pFL-MUS81 with In-Fusion® 
primers 13 and 14 (Section 2.4) 
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pFL-MUS81 -SFEME2A 
Bicistronic vector for baculovirus co-expression of 
MUS81 and EME2A generated by cloning PCR 
amplified SFEME2A in pFL-MUS81 with In-
Fusion® primers 15 and 16 (Section 2.4) 
pFL-MUS81 -SFEME2B 
Bicistronic vector for baculovirus co-expression of 
MUS81 and EME2B generated by cloning PCR 
amplified SFEME2B in pFL-MUS81 with In-
Fusion® primers 15 and 16 (Section 2.4) 
pFL-MUS81D307A -SFEME2A 
Bicistronic vector for baculovirus co-expression of 
MUS81D307A and EME2A generated by alanine 
substitution of MUS81 D307 using pFL-MUS81-
SFEME2A as a template, the QuickChange 
Lightning Multi Site-Directed Mutagenesis Kit 
(Section 2.1.2) and primers 17 and 18 (Section 
2.4) 
 
The plasmid pDEST-N-SF-TAP was a kind gift from Dr Christian Gloeckner and 
Prof Marius Ueffing from the Department of Protein Science, Helmholtz Zentrum 
München-German Research Center for Environmental Health, Nuremberg, 
Germany.  
 
2.6 Cell lines and cell culture methods 
Table 2.2 List of cell lines used in this study 
CELL LINE DESCRIPTION 
HeLa 
Homo sapiens cervix adenocarcinoma cell 
line 
HeLa Kyoto 
Homo sapiens cervix adenocarcinoma cell 
line, Kyoto clone 
U2OS Homo sapiens osteosarcoma cell line 
U2OS-TRExTM 
Homo sapiens osteosarcoma cell line 
designed for tetracycline-regulated 
mammalian expression of proteins of interest 
CHAPTER 2 – Materials and methods 
 86 
HEK 293-TRExTM 
Homo sapiens embryonic kidney cells 
designed for tetracycline-regulated 
mammalian expression of proteins of interest 
HT1080 Homo sapiens fibrosarcoma cell line 
GM847 
Homo sapiens SV40-transformed skin 
fibroblasts 
RPE-1 hTERT 
Homo sapiens human TERT-immortalised 
retinal pigment epithelial cell line 
GM08505 
Homo sapiens SV40-transformed Bloom’s 
syndrome skin fibroblasts 
MCF-7 
Homo sapiens breast adenocarcinoma cell 
line 
 
All cells were cultured in Dulbecco’s Modified Eagle Media (DMEM) supplemented 
with 10% (v/v) FBS (Section 2.1.2). The cultures were incubated in a 10% CO2 
humidified incubator at a temperature of 37°C. 
 
2.6.1 siRNA transfection 
The short-interfering RNAs (siRNAs) used in this study were purchased from 
Eurofins. EME2 siRNAs were designed using Sfold (http://sfold.wadsworth.org/cgi-
bin/index.pl). The siRNAs sequences (written 5’ to 3’) are as follows: 
Luciferase GL2: CGTACGCGGAATACTTCGA 
EME1: GCUAAGCAGUGAAAGUGAA (Dharmacon) (Naim et al., 2013) 
EME2 #1: GCGAGCCAGUGGCAAGAGA 
EME2 #2: UGGAGCCCGAGGAGUUUCU 
MUS81: CAGCCCUGGUGGAUCGAUA (Wechsler et al., 2011) 
 
One day before transfection, 3 x 105 or 7 x 105 cells were seeded in 6 cm or 10 cm 
cell culture plates respectively. EME1 (40 nM), EME2 #1 (80 nM), EME2 #2 (80 
nM) and MUS81 (60 nM) siRNAs were transfected using Lipofectamine® 
RNAiMAX (Section 2.1.2) according to the manufacturer’s instructions. Cells were 
transfected with MUS81 siRNA 2x within 24 hr. All the other transfections were 
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performed once. Control Luciferase GL2 siRNA was used at equivalent 
concentrations. Cells were collected 72 hr after the first transfection, unless stated 
otherwise.  
 
2.6.2 Establishment of stable tetracycline-inducible cell lines 
One day before transfection, U2OS-TRExTM and HEK 293-TRExTM cells were 
plated at 50% confluency in DMEM supplemented with 10% (v/v) tetracycline-free 
FBS (Section 2.1.2). Cells were transfected with 500 ng of pcDNA4-TO-SFEME1, 
pcDNA4-TO-SFEME2A, pcDNA4-TO-SFEME2B or pcDNA4-TO-SFMUS81 (Section 
2.5) using Effectene® (Section 2.1.2) and following the manufacturer’s instructions. 
Stable clones were isolated after selection with 500 µg/ml zeocin (Section 2.1.2) 
and were tested for protein expression by western blotting (Section 2.8.7). 
 
2.6.3 Bacterial Artificial Chromosome (BAC)-mediated expression of MUS81 
in HeLa Kyoto cells 
The BAC clone CTD-2084A20 encoding MUS81 was purchased from Life 
TechnologiesTM. 
 
BAC modification by pRed/ET recombination 
BAC modification was performed as described in (Poser et al., 2008) with some 
variations. The BAC clone encoding for MUS81 was modified by insertion of an 
affinity purification cassette (FLAP) encoding green fluorescent protein (GFP) at the 
C-terminus of the gene (Figure 2.1). BAC modification was performed by 
recombineering using the Quick&Easy BAC modification kit (Section 2.1.2). Briefly, 
the bacteria containing the BAC clone were transformed with the pRed/ET plasmid 
(Quick&Easy BAC modification kit) using the protocol described in Section 2.3.2. 
The FLAP cassette was PCR amplified with primers 7 and 8 (Section 2.4) and 
transformed into pRed/ET-transformed cells in the presence of 10% (w/v) L-
Arabinose. The successful integration of the FLAP cassette was checked by PCR 
using primers 9 and 10 (Section 2.4). 
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BAC transfection and generation of stable cell lines 
One day before transfection, 2 x 105 HeLa Kyoto cells were seeded in a 6 cm cell 
culture plate. Cells were transfected with isolated BAC-MUS81FLAP using 
Effectene® (Section 2.1.2), according to the manufacturer’s instructions. Stable 
clones were isolated after selection with 500 µg/ml Geneticin (Section 2.1.2) and 
were tested for protein expression by western blotting (Section 2.8.9). 
 
2.6.4 Cell synchronisation with double-thymidine block 
In order to synchronise cells at the G1/S-phase of the cell cycle, 2 x 106 BAC-
MUS81FLAP HeLa Kyoto cells (Section 2.6.3.2) were seeded in 15 cm plates and 
treated with 2.5 mM thymidine for 16 hr. Cells were washed with PBS and released 
in fresh media for 8 hr and incubated again with the same concentration of 
thymidine. After 16 hr, cells were washed in PBS, treated with trypsin and 
harvested. 
 
2.7 Gel electrophoresis   
2.7.1 SDS-polyacrylamide gel electrophoresis (PAGE) 
SDS-PAGE was performed as described (Laemmli, 1970). Briefly, protein samples 
were prepared by adding an equal volume of protein loading buffer (2x) (Section 
2.2.1) and boiling for 5 min prior to electrophoresis. Gel electrophoresis was 
performed with NuPAGE® 10% Bis-Tris gels or NuPAGE® 7% Tris-Acetate gels in 
an XCell SureLock™ Mini-Cell Electrophoresis System (Life TechnologiesTM) using 
NuPAGE® MOPS or Tris-Acetate SDS running buffer (20x). Gels were run at RT 
for 90 min at 180 V or 150 V. Proteins were visualised by western blotting (Section 
2.8.7) or by staining with InstantBlue (Section 2.8.4) or SYPRO® Ruby (Section 
2.8.5). 
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2.7.2 Agarose gel electrophoresis 
Gels were prepared in Sub-Cell® GT Agarose Gel Electrophoresis System (Bio-
Rad) and contained 1% (w/v) Agarose in TBE buffer supplemented with a 1:10 
dilution of SafeView (Section 2.1.2). Samples were loaded in 1x DNA loading buffer 
(Section 2.2.2) and run at 100 V for 1 hr at RT. Gels were imaged and 
photographed using the Molecular Imager® GelDocTM XR+ (Bio-Rad). 
 
2.7.3 Neutral PAGE 
Gels were prepared using a Cambridge gel apparatus and contained 10% 
acrylamide (30% Acrylamide/Bis Solution, 37.5:1) in TBE, supplemented with 
0.12% (v/v) of ammonium persulfate and 0.06% (v/v) of TEMED. Samples were 
prepared by addition of 1/6 vol DNA loading buffer (Section 2.2.2). Gels were run at 
RT in TBE for 75 min at 150 V and then dried onto 3MM filter paper (Whatman). 
Following electrophoresis, 32P-labelled DNA was detected by autoradiography 
(Section 2.7.5) or phosphorimaging (Section 2.7.6). 
 
2.7.4 Denaturing PAGE 
Gels were prepared in a Sequi-Gen® sequencing gel apparatus (Bio-Rad) and 
contained 7 M urea, 12% acrylamide (40% Acrylamide/Bis Solution 19:1), 0.035% 
(v/v) APS and 0.075% (v/v) TEMED in TBE. Samples were supplemented with an 
equal volume of formamide loading buffer (Section 2.2.2) and boiled for 3 min prior 
to loading. Before electrophoresis of DNA samples, the sequencing gels were 
preheated to 50°C and run in TBE buffer. After sample loading, gels were run for 
90 min at 60 W and then dried onto anion exchanger filter paper (Whatman). 32P-
labelled DNA was detected by autoradiography (Section 2.7.5) or phosphorimaging 
(Section 2.7.6). 
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2.7.5 InstantBlue staining 
After SDS-PAGE (Section 2.7.1), gels were incubated with InstantBlue® for up to 
12 hr and destained in water. 
 
2.7.6 SYPRO® Ruby staining 
After SDS-PAGE (Section 2.7.1), protein gels were incubated in a solution 
containing 50% (v/v) methanol and 7% (v/v) acetic acid for 15 min at RT. SYPRO® 
Ruby Protein gel stain was added to cover the gels, microwaved for 30 s, agitated 
for 30 s at RT and then microwaved for an additional 30 s. The gel was covered 
with aluminium foil and incubated in the SYPRO® Ruby Protein gel stain for 30 min 
at RT before washing with a solution containing 10% (v/v) methanol and 7% (v/v) 
acetic acid (3x for 15 min each). Proteins were visualised using the Molecular 
Imager® GelDocTM XR+ (Bio-Rad). 
 
2.7.7 Autoradiography 
Dried polyacrylamide gels were exposed to Biomax® MR films. When necessary, 
dried gels were exposed to intensifying screens and placed at -80°C. Exposed films 
were developed using a JPI automatic X-ray film processor (model JP-33). 
 
2.7.8 Phosphorimager analysis 
Dried gels were exposed to GE Healthcare storage phosphor screens for up to 5 hr. 
Screens were analysed on a Molecular Dynamics Phosphorimager (model 425E) 
and quantified using ImageQuant software. 
 
2.7.9 Pulse-field gel electrophoresis  
PFGE was performed essentially as described (Hanada et al., 2007). HeLa cells 
were transfected with siRNAs targeting Luciferase control, EME1, EME2 or MUS81 
as described in Section 2.6.1. Various concentrations of hydroxyurea (HU) (0, 1, 2, 
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4, 8 mM) were added to the cells 48 hr post-transfection. After 24 hr, cells were 
collected, washed in PBS and 1 x 106 cells/each condition were used to make low 
melting point agarose plugs using CHEF Mapper® XA system plug molds (Bio-
Rad). Briefly, 1 x 106 cells were centrifuged, resuspended in 50 µl of PFGE 
washing buffer (Section 2.2.5) and mixed with 50 µl 1% (w/v) low melting point 
agarose in water. Agarose plugs were allowed to polymerise for 30-40 min at 4°C 
and then lysed at 37°C in lysis buffer (Section 2.2.5). After 48 hr, plugs were 
washed 2x in washing buffer and incubated overnight in RNase buffer (Section 
2.2.5). The next day, the plugs were washed once in washing buffer and loaded on 
a 1% (w/v) agarose gel in 0.5% (v/v) TBE. After the plugs were positioned, the gel 
was sealed with 0.5% (w/v) low melting point agarose in 0.5% (v/v) TBE and run for 
23 hr at 13°C in a Gene Navigator PFGE apparatus (Amersham Biosciences) using 
the following parameters: voltage 180–120 V log; angle from 1201 to 1101 linear; 
interval 30 s to 5 s log. Gels were stained with 1.25 µg/ml ethidium bromide in 0.5% 
(v/v) TBE for 1 hr and visualized using the Molecular Imager® GelDocTM XR+ (Bio-
Rad). Data analysis was performed using ImageLab software. 
 
2.8 General methods of DNA and protein manipulation 
2.8.1 Amplification of EME2 isoforms 
RNA was extracted from MCF-7 cells (Table 2.2) using the RNeasy kit (Qiagen), 
according to the manufacturer’s instructions. cDNA synthesis was performed using 
IllustraTM Ready-To-GoTM RT-PCR beads (GE Healthcare), following the 
manufacturer’s instructions. EME2 isoforms were amplified from MCF-7 cDNA 
using KOD Hot Start DNA polymerase (Section 2.1.2) and primers 19 and 20 
(Section 2.4). PCR products were analysed by agarose gel electrophoresis 
(Section 2.7.2). 
 
2.8.2 DNA concentration determination 
DNA concentrations were determined by measuring the sample absorbance at 260 
nm using a NanoDrop® ND-1000 Spectrophotometer. 
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2.8.3 Ethanol precipitation 
DNA samples were mixed with 0.1 vol of 3 M sodium acetate (pH 5.2) and two 
volumes of 100% ice-cold ethanol. After 20 min incubation in dry ice, samples were 
centrifuged at 14000 rpm for 30 min. The precipitated DNA was washed in 70% 
(v/v) ethanol, air-dried and resuspended in TE buffer (Section 2.2.2). 
 
2.8.4 Whole cell extracts (WCEs) 
Cells were washed in PBS, treated with trypsin, harvested and centrifuged at 1200 
rpm for 4 min. Cell pellets were washed with 5 ml of PBS, resuspended in lysis 
buffer (Section 2.2.1) and incubated on ice for 15 min. Lysates were sonicated in a 
Bioruptor® Plus (Diagenode) 3x (30 s pulses) with 30 s rest on ice between the 
pulses and centrifuged at 4°C for 30 min at 14000 rpm. Soluble extracts were 
transferred to a fresh tube and quantified as described in Section 2.8.5. 
 
2.8.5 Protein concentration determination 
Protein concentrations were quantified using Bio-Rad Dc protein assay kit. The 
absorbance at 750 nm was determined using µQuant (BIO-TEK instruments Inc.) 
and compared to a standard curve obtained with known concentrations of BSA. 
 
2.8.6 Generation of polyclonal antibodies 
Synthetic peptides for EME2 (amino acids 1-13, 13-36, 208-218 and 401-418) were 
generated by the Peptide Synthesis Facility, Cancer Research UK. The mixture of 
peptides was injected into two rabbits by Pettingill Technology Ltd. The final bleeds 
were tested against HeLa extracts, used as a stock antibody and designated 
APEP13 and APEP14. The antibody used in this study (APEP13) was purified 
using protein A-agarose by Cell Services, Cancer Research UK. 
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2.8.7 Western blotting 
After SDS-PAGE (Section 2.7.1), gels were transferred onto Immobilon®-P transfer 
membrane (Section 2.1.2) (pre-activated in 100% methanol for 5 min at RT) in 
western blot transfer buffer (Section 2.2.1) at 100 V for 90 min at 4°C. Membranes 
were incubated in blocking buffer (Section 2.2.1) for 1 hr at RT. Primary antibodies 
(Section 2.1.3.1) were diluted in blocking buffer and added to the membranes. All 
incubations with primary antibodies were performed overnight at 4°C. The next day, 
membranes were washed 3x in TBS supplemented with 0.05% (v/v) Tween-20 for 
10 min each. Secondary antibodies (Section 2.1.3.2) were diluted in blocking buffer 
(1:5000) and added to the membranes for 1 hr at RT. The membranes were then 
washed 3x with TBS supplemented with 0.05% (v/v) Tween-20 for 10 min (RT). 
Following the application of ECL western blotting detection reagents (Section 2.1.2), 
membranes were exposed to Amersham HyperfilmTM ECL High Performance 
Chemiluminescence film (Section 2.1.2) for 30 s to 10 min. 
 
2.9 Baculovirus and insect cells 
2.9.1 Production of the bacmid DNA 
pFL-MUS81-SFEME1, pFL-MUS81-SFEME2A, pFL-MUS81-SFEME2B and pFL-
MUS81D307A-SFEME2A were transformed into E. coli MAX Efficiency® DH10BACTM 
chemically competent cells (Section 2.3.1) according to the manufacturer’s 
instructions. Recombinant bacmids were generated by transposing a DNA 
fragment (containing MUS81-SFEME1, MUS81-SFEME2A, MUS81-SFEME2B or 
MUS81D307A-SFEME2A) flanked by Transposon 7 (Tn7) sites into the mini Tn7 of the 
bacmid DNA. Transformants were selected on LB plates containing 10 µg/ml 
tetracyline, 50 µg/ml kanamycin, 7 µg/ml gentamicin, 40 µg/ml IPTG and 100 µg/ml 
X-gal. As the mini Tn7 sites are placed in the middle of the lacZ gene, white 
colonies were generated by successful transposition. Bacmid DNA was purified by 
ethanol precipitation (Section 2.8.3). 
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2.9.2 Baculovirus production 
Isolated bacmid DNA (1 µg) was transfected into two wells of a 6-well plate 
containing 2 x 106 Spodoptera frugiperda Sf9 cells using Fugene HD transfection 
reagent (Section 2.1.2) and FBS-free Grace’s media. Transfection was performed 
according to Fugene HD’s manufacturer’s protocol and cells were cultured at 27°C. 
After 5 to 6 hr, FBS was added to a final concentration of 10% (v/v). The next day, 
growth media was replaced with fresh Grace’s media supplemented with 10% (v/v) 
FBS. The supernatant of transfected Sf9 cells was collected 72 hr after transfection 
(P1 virus), centrifuged 5 min at 3000 rpm and transferred to a fresh tube covered 
with aluminium foil. Cells were pelleted by centrifugation, lysed in 300 µl of protein 
loading buffer (Section 2.2.1) and screened for optimal protein expression by 
western blotting (Section 2.8.7). The P1 virus from the clone with the optimal 
protein expression (400 µl) was used to infect 20 ml of Sf9 cells (at a density of 1 x 
106 cells/ml). Seventy-two hours post-infection, the supernatant of Sf9 cells was 
harvested as described above (P2 virus). The P2 baculovirus (4 ml) was used to 
infect 200 ml of Sf9 cells (at 1 x 106 cells/ml). Seventy-two hours post-infection, the 
P3 baculovirus was harvested as described above and used to infect High Five 
cells (Hi5). 
 
2.10  Protein purification 
2.10.1 Purification of MUS81-SFEME1, MUS81-SFEME2A, MUS81-SFEME2B and 
MUS81D307A-SFEME2A 
MUS81-SFEME1, MUS81-SFEME2A, MUS81-SFEME2B and MUS81D307A-SFEME2A 
complexes were purified from 600 ml of Hi5 cells (at 1 x 106 cells/ml) infected with 
24 ml of P3 baculovirus for 72 hr. Cells were harvested by centrifugation at 3000 
rpm, washed in ice-cold PBS and resuspended in 30 ml of TGN buffer (Section 
2.2.1) supplemented with 500 mM NaCl, 1x protease inhibitor cocktail, 1x 
phosphatase inhibitor cocktail 2 and 3 and 1mM DTT (Section 2.1.2). Cells were 
lysed on ice for 45 min and homogenised with a Dounce using pestle B (20 
strokes). The lysate was ultracentrifuged for 45 min at 35000 rpm (Beckman Type 
45 Ti rotor) and the clarified extract was loaded overnight (0.2 ml/min) on a 1 ml 
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Strep-Tactin Superflow column (Section 2.1.2) using a ÄKTAprime plus 
chromatography system (GE Healthcare) at 4°C. The column was washed with 20 
column volumes of TGN buffer (0.5 ml/min) containing 500 NaCl and proteins were 
eluted with the same buffer supplemented with 2.5 mM Desthiobiotin (40 x 0.5ml 
elution fractions, 0.5 ml/min). Eluted proteins were identified by SDS-PAGE 
(Section 2.7.1). Peak fractions were pooled and loaded on a 1 ml anti-FLAG M2 
column (Section 2.1.2) for 2 hr at 4°C using a ÄKTAprime plus chromatography 
system (GE Healthcare). The column was washed with 20 column volumes of TGN 
buffer containing 500 mM NaCl and proteins were eluted in the same buffer 
containing 500 µg/ml of 3xFLAG peptides. Before eluting MUS81-SFEME2B, the 
FLAG column was washed with additional 20 ml of TGN buffer (0.5 ml/min) 
containing 500 mM NaCl and supplemented with 1 mM ATP and 3 mM MgCl2. 
Eluted proteins were identified by SDS-PAGE (Section 2.7.1) and the fractions 
containing MUS81-SFEME2B were pooled and diluted to 100 mM NaCl using four 
volumes of TGN buffer. The sample was loaded on a 1 ml HiTRAPTM heparin 
column (0.5 ml/min, Section 2.1.2) for 30 min and the column was washed with 30 
ml of TGN buffer containing 100 mM NaCl (0.5 ml/min). Proteins were eluted using 
a 30 ml linear salt gradient that ranged between 100 mM and 1 M NaCl (30 x 1ml 
elution fractions, 0.5 ml/min) and an additional ten 1 ml fractions were collected at 1 
M NaCl. Fractions containing MUS81-SFEME1, MUS81-SFEME2A, MUS81-
SFEME2B or MUS81D307A-SFEME2A were dialysed 2x for 2 hr against 2 L of storage 
buffer (Section 2.2.1) at 4°C, aliquoted and stored at -80°C. The described 
purifications yielded approximately 2ml of MUS81-SFEME1at 7.5 µg/ml, 2 ml of 
MUS81-SFEME2A at 12 µg/ml, 2ml of MUS81-SFEME2B at 8.5 µg/ml and 600µl of 
MUS81D307A-SFEME2A at 15 µg/ml. 
 
2.10.2 GFP-pull-down of BAC-MUS81FLAP 
BAC-MUS81FLAP HeLa Kyoto cells (Section 2.6.3.2) were synchronised in 
G1/S-phase of the cell cycle with a double thymidine block, as described in Section 
2.6.4. Cells were washed with PBS, treated with trypsin and harvested. Cell pellets 
were washed with PBS and resuspended in 500 µl of lysis buffer (Section 2.2.1). 
DNA was sheared using a 1 ml syringe and a 0.8 mm x 40 mm needle (20 strokes 
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on ice). Samples were incubated on ice for 30 min and then centrifuged for 30 min 
at 14000 rpm at 4°C. Cleared lysates were transferred to a fresh Eppendorf tube 
and quantified by Bio-Rad Dc protein assay (Section 2.8.5). GFP-TRAP® beads 
(Section 2.1.2) were washed four times in lysis buffer and incubated in lysis buffer 
+ 1 mg/ml BSA for 30 min on a rotating wheel at 4°C. The volumes and 
concentrations of the samples were normalised and 15 µl of GFP-TRAP® packed 
beads were added to each sample. Beads were incubated with the lysates for 1.5 
hr on a rotating wheel at 4°C, washed four times with IP buffer and boiled in 25 µl 
of 1x protein loading buffer (Section 2.2.1) for 5 min. The pull-down of BAC-
MUS81FLAP was analysed by loading 20 µl of the protein sample on a NuPAGE® 
7% Tris-Acetate gels (Section 2.1.2) and by western blotting (Section 2.8.7). 
 
2.10.3 FLAG pull-downs of SFMUS81, SFEME1, SFEME2A and SFEME2B 
The expression of SFMUS81, SFEME1, SFEME2A and SFEME2B was induced for 24 
hr in HEK 293-TRExTM or U2OS-TRExTM cells by addition of 1 µg/ml tetracycline. 
Cells were washed in PBS, treated with trypsin and harvested. After centrifugation 
(1200 rpm, 5 min), the cell pellets were washed in PBS and resuspended in 500 µl 
of lysis buffer (Section 2.2.1). DNA was sheared by using a 1 ml syringe and a 0.8 
mm x 40 mm needle (20 strokes on ice). Samples were incubated on ice for 30 min 
and then centrifuged for 30 min at 14000 rpm at 4°C. Cleared lysates were 
transferred to a fresh Eppendorf tube and quantified by Bio-Rad Dc protein assay 
(Section 2.8.5). Anti-FLAG M2 resin was washed four times with 1 ml of lysis buffer 
and incubated with 1 ml of lysis buffer containing 1 mg/ml BSA for 30 min on a 
rotating wheel at 4°C. The volumes and concentrations of the samples were 
normalised and 30 µl of FLAG M2 packed resin were added to each sample. The 
resin-lysate mixture was incubated for 1.5 hr on a rotating wheel at 4°C and then 
washed four times with IP wash buffer (Section 2.2.1). Proteins were eluted by 
incubating the resin with 60 µl of TBS supplemented with 200 µg/ml 3xFLAG 
peptides. Elutions were boiled in 30 µl of 1x loading buffer (Section 2.1.2) for 5 min 
and loaded on a NuPAGE® 10% Bis-Tris gel (Section 2.1.2). Co-
immunoprecipitated proteins were detected by western blotting (Section 2.8.9). 
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2.11   Preparation of DNA substrates and cleavage assays 
2.11.1 Gel purification of oligonucleotides 
Dried oligonucleotides (Table 2.3) were resuspended in water to give a final 
concentration of 200 µM. In order to purify them from shorter oligonucleotides 
species, approximately one third of the total volume was mixed with one volume of 
formamide loading buffer (Section 2.2.2), boiled for 5 min and loaded on a 15% 
polyacrylamide denaturing gel (Bio-Rad Protean® II xi system). The gel was run at 
400 V for 2 hr, stained with Stains-all solution (Section 2.2.2) for 10 min at RT (in a 
glass dish) and then destained in water for 15 min at RT. In order to remove shorter 
DNA products, only the upper third of the oligonucleotide band was excised from 
the gel. DNA was eluted overnight in TE buffer (Section 2.2.2) on a rotating wheel 
at 4°C. The next day, the supernatant was collected, the oligonucleotides were 
ethanol-precipitated (Section 2.8.3) and the pellet was dissolved in 60 µl TE 
(Section 2.2.2). The concentration of each oligonucleotide was determined as 
described in Section 2.8.2. 
 
Table 2.3 List of oligonucleotides 
OLIGONUCLEOTIDE SEQUENCE (5’-3’) 
X0.1 
ACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTTGCC
CACCTGCAGGTTCACCC 
X0.2 
GGGTGAACCTGCAGGTGGGCAAAGATGTCCATCTGTTGTAAT
CGTCAAGCTTTATGCCGT 
X0.3 
ACGGCATAAAGCTTGACGATTACAACAGATCATGGAGCTGTCT
AGAGGATCCGACTATCG 
X0.4 
CGATAGTCGGATCCTCTAGACAGCTCCATGTAGCAAGGCACT
GGTAGAATTCGGCAGCGT 
X0.2 1/2 GGGTGAACCTGCAGGTGGGCAAAGATGTCC 
X0.3 1/2 ATGGAGCTGTCTAGAGGATCCGACTATCGA 
X0.3 2/2 ACGGCATAAAGCTTGACGATTACAACAGATC 
X26.1 
GCGCTACCAGTGATCACCAATGGATTGCTAGGACATCTTTGCC
CACCTGCAGGTTCACCC 
X26.2 
GGGTGAACCTGCAGGTGGGCAAAGATGTCCTAGCAATCCATT
GTCTATGACGTCAAGCTC 
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X26.3 
GAGCTTGACGTCATAGACAATGGATTGCTAGGACATCTTTGCC
GTCTTGTCAATATCGGC 
X26.4 
GCCGATATTGACAAGACGGCAAAGATGTCCTAGCAATCCATTG
GTGATCACTGGTAGCGC 
DL-0 
CGTTGGACGCTGCCGAATTCTACCACTGCGTGCCTTGCTAGG
ACATCTTTGCCCACCTGCAGGTTCACCCATCGC 
DL-1 
GCGATGGGTGACCTGCAGGTGGGCGGCTGCTCATCGTAGGT
TAGTGAATTGGTAGAATTCGGCAGCGTCCAACG 
DL-2 
GATCGTAAGAGCAAGATGTTCTATAAAAGATGTCCTAGCAAGG
CACGCAG 
DL-3 TATAGAACATCTTGCTCTTACGATC 
 
2.11.2 Preparation of non-radiolabelled DNA substrates 
Purified oligonucleotides were mixed (600 pmol of 60-mers and 1200 pmol of 30-
mers, Table 2.3) in 60 µl of annealing buffer (Section 2.2.2), placed in boiling water 
for 2 min and annealed overnight at RT. Annealed substrates were mixed with 1x 
DNA loading buffer (Section 2.2.2) and analysed on a native 12% polyacrylamide 
gel (Bio-Rad Protean® II xi system) in TBE at 200V for 4 hr at 4°C. The gel was 
covered with plastic wrap and placed on TLC paper with fluorescent indicator 
(UV245) (Section 2.1.2). The bands were identified by exposure to 245 nm UV light, 
excised from the gel and eluted overnight in TNE buffer (Section 2.2.2) on a gyro-
rocker at 4°C. The DNA concentration was measured as described in Section 2.8.2. 
 
2.11.3 5’-32P-end labelling of oligonucleotides and substrate preparation  
Reactions contained 100 ng of oligonucleotide, approximately 10 pmol of 32P-γATP 
and 10 U of T4 PNK in 1x NEB T4 PNK buffer (Section 2.1.1). Mixtures were 
incubated at 37°C for 45 min and reactions were stopped by the addition of EDTA 
to 50 mM. Unincorporated label was removed using IllustraTM MicroSpin® G-25 
columns (GE Healthcare) according to the manufacturer’s instructions. 
Radiolabelled oligonucleotides were mixed with 300 ng of combinations of 
unlabelled oligonucleotides in order to obtain the DNA substrates illustrated in 
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Table 2.4 Oligonucleotides sequences of synthetic DNA substrates 
Identical colours indicate complementary strands. Note that 3’-flap, 5’-flap, 
replication fork, splayed-arm, static HJ, nicked HJ and mobile HJ have 
oligonucleotides X01 and X04 in common 
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Table 2.4. Mixtures were boiled for 2 min and annealed overnight at RT. Annealed 
substrates were mixed with 1x DNA loading buffer (Section 2.2.2) and 
electrophoresed through a native 12% polyacrylamide gel (Bio-Rad Protean® II xi 
system) in TBE at 200 V for 4 hr at 4°C. The gel was covered with plastic wrap, 
exposed to Biomax MR film for 2 min and the DNAs were excised from the gel and 
eluted overnight in TN buffer (Section 2.2.2) on a gyro-rocker at 4°C. 
 
2.11.4 Preparation of 5’-32P-end-labeled length marker oligonucleotides 
Length marker oligonucleotides (10 µM) listed in Table 2.5 were mixed in equimolar 
amounts. Reactions contained the mixture of marker oligonucleotides (0.5 µM), 
approximately 3 pmol of 32P-γATP and 10 U of T4 PNK in 1x NEB T4 PNK buffer 
(Section 2.1.1). Mixtures were incubated at 37°C for 45 min and reactions were 
stopped by the addition of EDTA to 50 mM. Unincorporated label was removed 
using IllustraTM MicroSpin® G-25 columns (GE Healthcare) according to the 
manufacturer’s instructions. Formamide loading buffer (two to four volumes) was 
added to the labelled marker oligonucleotides and the mixture was boiled for 5 min 
before loading on a denaturing PAGE (Section 2.7.4). 
 
Table 2.5 Sequences of the length marker oligonucleotides 
OLIGONUCLEOTIDE SEQUENCE (5’-3’) 
X01.35 ACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACA 
X01.30 ACGCTGCCGAATTCTACCAGTGCCTTGCTA 
X01.25 ACGCTGCCGAATTCTACCAGTGCCT 
X02.35 GGGTGAACCTGCAGGTGGGCAAAGATGTCCATCTG 
X02.30 GGGTGAACCTGCAGGTGGGCAAAGATGTCC 
X02.25 GGGTGAACCTGCAGGTGGGCAAAGA 
X03.35 ACGGCATAAAGCTTGACGATTACAACAGATCATGG 
X03.30 ACGGCATAAAGCTTGACGATTACAACAGAT 
X03.25 ACGGCATAAAGCTTGACGATTACAA 
X04.35 CGATAGTCGGATCCTCTAGACAGCTCCATGTAGCA 
X04.30 CGATAGTCGGATCCTCTAGACAGCTCCATG 
X04.25 CGATAGTCGGATCCTCTAGACAGCT 
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DL-0.57 
CGTTGGACGCTGCCGAATTCTACCACTGCGTGCCTTGCTAGG
ACATCTTTGCCCA 
DL-0.52 
CGTTGGACGCTGCCGAATTCTACCACTGCGTGCCTTGCTAGG
ACATCTTT 
DL-0.47 
CGTTGGACGCTGCCGAATTCTACCACTGCGTGCCTTGCTAGG
ACA 
DL-0.32 CGTTGGACGCTGCCGAATTCTACCACTGCG 
DL-0.27 CGTTGGACGCTGCCGAATTCTACCA 
DL-0.22 CGTTGGACGCTGCCGAATTC 
DL-1.57 
GCGATGGGTGAACCTGCAGGTGGGCGGCTGCTCATCGTAGG
TTAGTGAATTGGTA 
DL-1.52 
GCGATGGGTGAACCTGCAGGTGGGCGGCTGCTCATCGTAGG
TTAGTGAAT 
DL-1.47 
GCGATGGGTGAACCTGCAGGTGGGCGGCTGCTCATCGTAGG
TTAG 
DL-1.32 GCGATGGGTGAACCTGCAGGTGGGCGGCTG 
DL-1.27 GCGATGGGTGAACCTGCAGGTGGGC 
DL-1.22 GCGATGGGTGAACCTGCAGG 
DL-2.32 GATCGTAAGAGCAAGATGTTCTATAAAAGA 
DL-2.27 GATCGTAAGAGCAAGATGTTCTATA 
DL-2.22 GATCGTAAGAGCAAGATGTT 
DL-3.22 TATAGAACATCTTGCTCTTA 
 
2.11.5 Endonucleolytic cleavage assay 
Reactions (10 µl) contained 100 µM of non-radiolabelled DNA (Section 2.11.2), 1 µl 
of 5’-32P-labelled DNA (Section 2.11.3) and cleavage buffer (Section 2.2.3), unless 
otherwise specified. Various concentrations of MUS81-SFEME1, MUS81-SFEME2A, 
MUS81-SFEME2B and MUS81D307A-SFEME2A complexes (Section 2.10.1) diluted in 
protein dilution buffer (Section 2.2.1) were added to the reaction mixtures. 
Reactions were initiated by incubation at 37°C, allowed to proceed for 30 min and 
then terminated by addition of stop buffer (5x) (Section 2.2.3). Labelled DNA 
products were analysed by neutral PAGE (Section 2.7.3) or by denaturing PAGE 
(Section 2.7.4) followed by autoradiography (Section 2.7.7) or phosphorimaging 
(Section 2.7.8). 
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2.12  Preparation of metaphase spreads and stainings 
2.12.1 Metaphase spreads 
To enrich for the mitotic cell population, cells were treated for 1.5 hr with 0.2 µg/ml 
of colcemid, a drug that depolymerises microtubules and arrests cells in metaphase 
(Section 2.1.2). Cells were collected by mitotic shake-off, washed in PBS and 
swollen in 5 ml of 750 mM KCl for 30 min at 37°C. Ice-cold methanol/acetic acid 
(3:1, 5 ml) was added on top of the swelling buffer and cells were centrifuged for 5 
min at 1200 rpm at RT. The two-layered solution was removed from the bottom to 
the top and cells were resuspended in an additional 5 ml of ice-cold 
methanol/acetic acid (3:1). Fixation was performed for 15 min on ice. Metaphase 
cells were then spread on Superfrost® Microscope slides (Thermo Scientific) and 
air-dried overnight at RT. 
 
2.12.2 Sister Chromatid Exchanges (SCEs) 
Reciprocal exchanges of DNA between the sister chromatids was detected by the 
SCEs assay essentially as described (Bayani and Squire, 2005). One day before 
siRNA transfection, GM08505 (7 x 105) cells were seeded on 10 cm plates. On the 
following day, cells were transfected with siRNA as described in Section 2.6.1. 
After 48 hr, cells were incubated with 100 µM BrdU for 72 hr. Colcemid (0.2 µg/ml) 
was added for the last 1.5 hr of BrdU incubation. Metaphase spreads were 
performed as described in Section 2.12.1. Slides were air-dried overnight and then 
stained for 30 min in 50 ml Soerensen buffer (pH 6.8) (Section 2.2.4) containing 
100 µg/ml Hoechst 33258. After washing with an additional 50 ml Soerensen buffer 
(pH 6.8), slides were placed in a shallow container, covered with Soerensen buffer 
(pH 6.8) and exposed to 254 nm UV light (Stratalinker 2400) for 45 min. Slides 
were then covered with 2x SSC buffer (Section 2.2.4), incubated at 60°C for 1 hr 
and stained in 50 ml 7% (v/v) GIEMSA solution (Section 2.1.2) at RT for 7 min. 
After washing three to four times with 50 ml water, coverslips were mounted on the 
slides using 80 µl DPX mounting medium (Section 2.1.2). Images were acquired 
with a Zeiss Axio Imager M1 microscope using a Plan-Neofluar x60, 0.4 numerical 
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aperture oil objective lens, and captured using an ORCA-ER camera (Hamamatsu) 
controlled by Volocity 6.0.1 software (Improvision). 
 
2.12.3 Telomeric quantitative-FISH (Q-FISH) on metaphase chromosomes 
Metaphase spreads were prepared as described in Section 2.12.1. Q-FISH was 
performed essentially as described (Blasco et al., 1997; Zijlmans et al., 1997). 
Briefly, slides were re-hydrated in 50 ml PBS for 5 min, fixed with 100 µl of 4% (v/v) 
paraformaldehyde for 2 min and treated with 100 µl of 1 mg/ml pepsin for 10 min at 
37°C. Slides were washed in 50 ml PBS, fixed again with 100 µl of 4% (v/v) 
paraformaldehyde and dehydrated using a series of ethanol washes (5 min in 70% 
(v/v), 5 min in 95% (v/v) and 5 min in 100%). Hybridisation solution (80 µl) (Section 
2.2.4) containing 110 nM FISH-TelC probes (Section 2.1.2) was added to the slides 
and denaturation was performed on a 70°C hot plate for 7 min. Slides were 
incubated in a humid chamber for 2 hr at RT or overnight at 4°C, washed 2x with 
50 ml of hybridisation wash #1 (Section 2.2.4) for 15 min and 3x with 50 ml of 
hybridisation wash #2 (Section 2.2.4) for 5 min (160 ng/ml DAPI was added to the 
second wash) in Coplin jars. Slides were dehydrated using a series of ethanol 
washes (5 min in 70% (v/v), 5 min in 95% (v/v) and 5 min in 100%), air-dried and 
mounted using ProLong® Gold Antifade Reagent (Section 2.1.2). Images were 
acquired with a Zeiss Axio Imager M1 microscope using a Plan-Neofluar x60, 0.4 
numerical aperture oil objective lens, and captured using an ORCA-ER camera 
(Hamamatsu) controlled by Volocity 6.0.1 software (Improvision). 
 
2.12.4 Telomeric chromosome orientation-FISH (CO-FISH)  
One day before siRNA transfection, U2OS cells (7 x 105 cells) were seeded on 10 
cm plates. Cells were transfected with siRNA as described in Session 2.6.1. 
Twenty hours before harvesting, 10 µM BrdU was added to the cells and 
metaphase spreads were prepared as described in Section 2.12.1. CO-FISH was 
performed as described (Bailey et al., 2004; Bechter et al., 2004; Londono-Vallejo 
et al., 2004). Briefly, slides were re-hydrated for 5 min in PBS, treated with 0.5 
mg/ml RNase A for 10 min at 37°C and stained with 0.5 µg/ml Hoechst 33258 in 2x 
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SSC (Section 2.2.4) for 15 min at RT. Slides were placed in a shallow container, 
covered with 2x SSC buffer and exposed to 365 nm UV light (Stratalinker 1800) at 
RT for 30 min. The BrdU-substituted DNA strands were digested by treatment with 
80 µl of 10 U/ml of Exonuclease III (Section 2.1.1) at RT for 10 min. Slides were 
washed with 50 ml of PBS, dehydrated using a series of ethanol washes (5 min in 
70% (v/v), 5 min in 95% (v/v) and 5 min in 100%) and air-dried at RT. The first 
hybridisation was performed by adding 80 µl of hybridising solution (Section 2.2.4) 
containing 10 nM TelG-TMR probe onto the slides and incubating for 2 hr at RT in 
a humidified chamber. Slides were rinsed in hybridisation wash #1 (Section 2.2.4) 
for 5 s. The second hybridisation was performed by adding 80 µl of hybridisation 
solution containing 110 nM FITC TelC probe onto the slides and incubating for 2 hr 
at RT in a humidified chamber. Slides were washed 2x with 50 ml of hybridisation 
buffer #1 for 30 min each, 3x with 50 ml of hybridisation buffer #2 (Section 2.2.4) 
for 5 min (160 ng/ml DAPI was added to the second wash) in Coplin jars, 
dehydrated using a series of ethanol washes (5 min in 70% (v/v), 5 min in 95% 
(v/v) and 5 min in 100%) and air-dried at RT. Coverslips were mounted onto the 
slides using ProLong® Gold Antifade Reagent (Section 2.1.2). Images were 
acquired with a Zeiss Axio Imager M1 microscope using a Plan-Neofluar x60, 0.4 
numerical aperture oil objective lens, and captured using an ORCA-ER camera 
(Hamamatsu) controlled by Volocity 6.0.1 software (Improvision). 
 
2.12.5 Immunofluorescence  
Immunofluorescence was performed as described (Perez-Burgos et al., 2004) with 
some variations. Briefly, cells were seeded in 6 cm plates containing two 22 mm x 
22 mm coverslips. On the day of the experiment, coverslips were transferred into 6-
well plates, washed with 2 ml PBS and incubated with 2 ml pre-extraction buffer 
(Section 2.2.4) for 4 min at RT. Cells were fixed with 2 ml of 4% (v/v) 
paraformaldehyde for 10 min, washed 2x in PBS and permeabilised in 2 ml of 
permeabilisation buffer (Section 2.2.4) for 5 min at RT. Coverslips were washed 2x 
with PBS (2 ml, 5 min each) and then 2x in IF washing solution (Section 2.2.4, 2ml, 
5 min each) before incubating with 2 ml of IF blocking solution (Section 2.2.4) for 
30 min at RT. Primary antibodies (Section 2.1.3.1) were diluted in IF blocking 
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solution and 40 µl drops were placed on parafilm. Coverslips were positioned on 
the primary antibody solution drops and incubated in a humid chamber for 2 hr at 
RT or overnight at 4°C. After washing the coverslips 3x with 2 ml of IF washing 
solution (10 min each), secondary antibodies (Section 2.1.3.2) were diluted in IF 
blocking buffer and applied to the coverslips as described above. Excess 
secondary antibody was washed out with 2 ml of IF washing solution (three washes, 
10 min each, RT). Coverslips were air-dried and mounted using ProLong® Gold 
Antifade Reagent with DAPI (Section 2.1.2). 
 
2.12.6 Immunofluorescence-FISH 
Cells were grown on 22 mm x 22 mm coverslips and IF was performed as 
described in Section 2.12.5. After incubation with the secondary antibody, cells 
were washed with 3x with 2 ml PBS (5 min each) and fixed for 2 min with 2 ml of 
4% (v/v) paraformaldehyde. Coverslips were washed with 2 ml of PBS, dehydrated 
using a series of ethanol washes (5 min in 70% (v/v), 5 min in 95% (v/v) and 5 min 
in 100%) and air-dried for 30 min at RT. FISH was performed as described in 
Section 2.12.3. 
 
2.13   Fluorescence-activated cell sorting (FACS) analysis 
2.13.1 Propidium Iodide (PI) staining 
Cells were washed with PBS, treated with trypsin and harvested in their own media. 
Pellets were washed with PBS and fixed with 70% (v/v) ethanol for at least 30 min 
on ice. Ethanol was removed by washing the cell pellets 2x with 5 ml of PBS. Cells 
were treated with 50 µl of 100 µg/ml RNase A (Section 2.1.2) and stained with 200 
µl of 50 µg/ml PI (Section 2.1.2). DNA content was analysed on a FACSCaliburTM 
flow cytometer (BD Biosciences) and FACS data were analysed using FlowJo 10.1 
software. 
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2.13.2 BrdU staining 
BrdU staining was performed as described (Sasaki et al., 1989). Briefly, cells were 
treated for 30 min with 10 µM BrdU, washed with PBS, treated with trypsin and 
harvested in their own media.  Pellets were washed with 5 ml of PBS and fixed with 
70% (v/v) ethanol for at least 30 min on ice. Ethanol was removed by washing the 
cell pellets 2x with 5 ml of PBS. Cells were treated with 5 ml of 2 M HCl for 30 min 
at RT, washed 2x with 5 ml of PBS and once with 5 ml of PBS supplemented with 
0.5% (v/v) Tween-20. FITC anti-BrdU antibody (2µl, Section 2.1.3.1) was added 
directly to the cell pellet and incubated in the dark for 20 min. Cells were washed 
with 5 ml of PBS and stained with PI as described in Section 2.13.1. 
 
2.13.3 Phospho histone H3 staining 
Cells were washed with PBS, treated with trypsin and in their own media. Pellets 
were washed with 5 ml of PBS and fixed with 70% (v/v) ethanol for at least 30 min 
on ice. Ethanol was removed by washing the cell pellets 2x with 5 ml of PBS. Cells 
were incubated with 2% (v/v) FBS in PBS containing mouse anti-phospho histone 
H3 antibody (1:500 dilution, Section 2.1.3.1) for 2 hr at RT and then washed once 
with 5 ml of 2% (v/v) FBS in PBS. Alexa Fluor® 488 goat anti-mouse IgG (H+L) 
secondary antibody (1:500 dilution, Section 2.1.3.2) was diluted in 2% (v/v) FBS in 
PBS and added to the cell pellet. After 1 hr, cells were washed once with 5 ml of 
2% (v/v) FBS in PBS and stained with PI as described in Section 2.13.1. 
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CHAPTER 3 
Biochemical characterisation of 
MUS81-EME1 and MUS81-EME2 complexes 
 
3.1 Two isoforms of EME2 are expressed in human cells 
Human EME2 was first identified using a PSI-BLAST (Position Specific Iterated – 
Basic Local Alignment Search Tool) search for the human ortholog of the S. pombe 
Eme1 and corresponds to a 245 amino acid protein with a molecular mass of 26 
kDa (NCBI # XM_113869) (Ciccia et al., 2003). However, this sequence for EME2 
was removed from the National Centre for Biotechnology Information (NCBI) 
database due to insufficient evidence for the existence of the transcript. Later, the 
database entry was replaced by a sequence predicted to encode a 444 amino acid 
protein (NM_001010865), but this sequence has also recently been revised to one 
that now encodes a 379 amino acid protein (NM_001257370.1). In addition to the 
sequence deletion, there are two amino acid changes compared with the earlier 
version. 
 
To verify whether which, if any, transcript variants are expressed in human cells, 
the EME2 sequence was amplified from human cDNA. First, mRNA was extracted 
from MCF-7 cells and cDNA was prepared (Section 2.8.1). Second, primers 19 and 
20 (Section 2.4), corresponding to the 5’- and 3’-ends of the longest gene transcript 
(NM_001010865), were used to PCR-amplify the EME2 sequence from MCF-7 
cDNA (Section 2.8.1). PCR amplification resulted in two products of around 1100 
and 1300 base pairs (bp), with the 1100bp product being more abundant (Figure 
3.1A). Sequencing of the product DNA led to the identification of two splice variants 
of EME2: the smaller and more abundant transcript variant results from the 
alternative splicing of exons 4, 5 and 6, and encodes for a 379 amino acid protein, 
hereafter referred to as EME2A, that is identical to that in the NCBI database 
(NM_001257370.1); the second, less abundant splice variant represents the  
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Figure 3.1 Identification of two isoforms of EME2 
A. Agarose gel (Section 2.7.2) stained with SafeView showing the products of the 
PCR amplification of the EME2 sequence from MCF-7 cDNA (Section 2.8.1). B. 
Schematic representation of the two isoforms of EME2, EME2A and EME2B. C. 
Sequence alignment of the EME2A and EME2B proteins. Blue = non-conserved 
residues, yellow = highly conserved residues. Sequence alignments were 
performed using ClustalW and analysed in Jalview. 
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longest gene transcript, equivalent to NM_001010865, which encodes for a 444 
amino acid protein hereafter referred to as EME2B (Figure 3.1B). Sequence 
alignment of the two proteins showed that EME2A and EME2B share 85.36% of 
identity (Figure 3.1C). Human MUS81, EME1 and EME2 have a conserved C-
terminal domain, through which they are believed to interact to form active 
endonuclease heterodimers (Ciccia et al., 2003). Sequence alignment of MUS81, 
EME1, EME2A and EME2B showed that the newly identified EME2 isoforms align 
mainly with the C-terminal region of MUS81 and EME1 (Figure 3.2A). In addition, 
sequence comparisons revealed that EME1 shares 37% identity and 61.2% 
similarity with EME2A and 33.1% identity and 56.9% similarity with EME2B (Figure 
3.2A).  
 
In order to determine the domain architecture of EME2A and EME2B, the protein 
sequences were analysed by the Simple Modular Architecture Research Tool 
(SMART) server, which allows the identification of evolutionary conserved domains. 
Both isoforms were found to have an ERCC4 nuclease domain (Figure 3.2A-B, 
amino acids 77-326 in EME2A and amino acids 77-391 in EME2B) but, as already 
observed for EME1, the amino acid sequence of the ERKXXXD catalytic motif has 
diverged (Figure 3.2A, compare amino acids 333-339 of MUS81 with the 
corresponding amino acids of EME1, EME2A and EME2B) (Ciccia et al., 2003). 
Also, like MUS81 and EME1, EME2A and EME2B harbour a C-terminal (HhH)2 
domain (Figure 3.2A-B) (Ciccia et al., 2008). 
 
3.2 EME2A and EME2B associate with MUS81 in vivo 
To determine whether EME2A and EME2B interact with MUS81, we performed 
FLAG pull-downs from HEK293-TRExTM cells carrying Strep-FLAG-tagged versions 
of either EME2A or EME2B (SFEME2A or SFEME2B) (Section 2.10.3). Both 
SFEME2A and SFEME2B immunoprecipitated endogenous MUS81 efficiently, as 
determined by SDS-PAGE and western blotting (Sections 2.7.1 and 2.8.7) (Figure 
3.3). Interestingly, we did not detect EME1 in SFEME2A or SFEME2B 
immunoprecipitates, although it formed a stable complex with MUS81 under the 
same conditions (data not shown). These results suggest that human MUS81 can 
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Figure 3.2 Sequence alignment between EME2A, EME2B, EME1 and MUS81 
A. Conservation of the residues is indicated using the following colour ramp: blue = 
non-conserved, yellow = highly conserved. The ERKXXXD domain of MUS81 is 
indicated in the red box. The dark green box indicates the ERCC4 domain of 
EME1, EME2A and EME2B. The orange line indicates the ERCC4 domain of 
MUS81. Black boxes indicate important hydrophobic residues for the formation of 
the HhH domain. Sequence alignments were performed using ClustalW and 
analysed in Jalview. B. Schematic representation of MUS81, EME1, EME2A and 
EME2B. HhH and ERCC4 nuclease domains are indicated in black. The active 
ERCC4 domain of MUS81 is indicated in red. Inactive ERCC4 domains are 
indicated in white. 
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Figure 3.3 SFEME2A and SFEME2B interact with endogenous MUS81 
Expression of SFEME2A and SFEME2B was induced in HEK293-TRExTM cell lines 
(Section 2.6.2) with 1 µg/ml tetracycline for 72 hr. FLAG pull-down was performed 
as described in Section 2.10.3. 
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form three distinct heterodimeric complexes: MUS81-EME1, MUS81-EME2A and 
MUS81-EME2B. 
 
3.3 Purification of the MUS81 complexes 
To determine whether MUS81-EME2A and MUS81-EME2B form active 
endonucleases and to compare their in vitro endonucleolytic activities with those of 
MUS81-EME1, all three MUS81 complexes were purified to near homogeneity. Co-
expression of MUS81 with EME1, EME2A or EME2B in E. coli produced mostly 
insoluble proteins and attempts to purify the soluble complexes were unsuccessful. 
Therefore, MUS81-EME1, MUS81-EME2A and MUS81-EME2B were expressed in 
insect cells using the baculovirus protein expression system, which allows the 
production of post-translationally-modified multi-protein complexes. Furthermore, 
tandem affinity purification strategies were used to purify proteins quickly away 
from contaminants. For this purpose, we inserted a 2xStrepII-FLAG (SF) tag at the 
N-terminus of EME1, EME2A and EME2B. It has been reported that the 
combinations of Strep-tag II and a FLAG tag results in the best protein purity and 
recovery rates when compared to combinations of other protein tags (Gloeckner et 
al., 2007). In addition, the SF tag is small (4.6 kDa) and contains terminal 
hydrophilic residues that prevent its folding into the protein structure, thus 
minimising the potential interference of the tag with protein function.  
 
MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B were cloned into the 
pFL bicistronic vectors for baculovirus protein expression and the bacmid DNA was 
obtained as described in Section 2.9.1 and illustrated in Figure 3.4. Baculoviruses 
expressing MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B were then 
generated (Section 2.9.2) and used to infect Hi5 insect cells. Hi5 whole cell extracts 
were cleared by high-speed centrifugation and loaded onto a Strep-Tactin® affinity 
column (Figure 3.5A). The MUS81 complexes were eluted by ligand competition 
using desthiobiotin (Figure 3.5B, lanes a), and peak fractions were collected and 
loaded onto an anti-FLAG-M2 column (Figure 3.5A). After elution with 3xFLAG 
peptides (Figure 3.5B, lanes b), fractions containing MUS81 complexes were 
applied to a heparin column and eluted with a 0.15 - 1 M NaCl gradient (Figure  
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Figure 3.4 Construction of baculovirus expression vectors for production 
of bacmid DNA and protein expression in insect cells 
Human MUS81 and STREP/FLAG (SF)-tagged EME1, EME2A and EME2B were 
cloned into the pFL vector with In-Fusion® cloning system. DNA fragments 
containing MUS81-SFEME1, MUS81-SFEME2A or MUS81-SFEME2B were inserted 
into the bacmid DNA by Tn7 transposition. Isolated recombinant bacmid DNA was 
used to express the tagged protein complexes in insect cells (Section 2.9).  
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Figure 3.5 Affinity purification of MUS81-SFEME1, MUS81-SFEME2A and 
MUS81-SFEME2B 
A. Hi5 cells expressing MUS81-SFEME1, MUS81-SFEME2A or MUS81-SFEME2B 
were lysed in high salt lysis buffer and the proteins were purified by affinity 
chromatography (Section 2.10.1). B. SYPRO® Ruby-stained SDS gel (Section 
2.7.6) showing the level of purity of the proteins after elution from each column C. 
InstantBlueTM-stained SDS gel (Section 2.7.5) showing purified MUS81-SFEME1, 
MUS81-SFEME2A and MUS81-SFEME2B. 
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3.5B, lanes c). MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B were 
purified to near homogeneity, as shown in Figure 3.5C. 
 
3.3.1 Determination of the cofactor requirements for optimal activity of the 
three purified MUS81 complexes 
Most enzymes that catalyse the hydrolysis of DNA phosphodiester bonds require 
Mg2+ as a cofactor (Yang et al., 2006). Affinity purified Mus81-Mms4 endonuclease, 
the S. cerevisiae ortholog of human MUS81-EME1, shows optimal nuclease activity 
at a concentration of approximately 3 mM Mg2+ (Ehmsen and Heyer, 2008). To 
determine the optimal Mg2+ concentration for the three purified MUS81 complexes, 
MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B were incubated with a 
5’-32P-end-labelled 3’-flap synthetic substrate (Section 2.11) in the presence of 
increasing amounts of MgCl2. The DNA was prepared by annealing partially 
complementary oligonucleotides, only one of which was 32P-labelled at the 5’-end. 
Nuclease activities were analysed by neutral PAGE (Section 2.7.3) and the 
appearance of faster migrating bands indicated the generation of cleaved DNA 
products (Figure 3.6A). The intensity of the bands corresponding to the cleavage 
products was quantified by phosphorimaging analysis and product formation was 
plotted as a percentage of the total radiolabeled DNA (Figure 3.6B, Section 2.7.8). 
All heterodimers cleaved the 3’-flap substrate efficiently, indicating that, like EME1, 
EME2A and EME2B form catalytically active complexes with MUS81 in vitro. As 
observed with Mus81-Mms4 (Ehmsen and Heyer, 2008), optimum nuclease activity 
for MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B was observed at 2.5 
mM MgCl2. Importantly, we did not observe loss of label or fragmentation of the 
substrate due to the activities of contaminating phosphatases or exonucleases 
(Figure 3.6 and data not shown). This indicated that the protein preparations did 
not contain any contaminating activities able to modify the substrate during the 
incubation time of the cleavage assays. 
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Figure 3.6 Determination of the optimal Mg2+ concentration for 
MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B nuclease activity on a 
3’-flap 
A. The 3’-flap synthetic substrate (100 nM) was incubated with purified 
MUS81-SFEME1 (5 nM), MUS81-SFEME2A (0.5 nM) or MUS81-SFEME2B (5 nM) for 
30 min at 37°C (Section 2.11.4). Reactions contained the indicated concentrations 
of MgCl2 and the products were analysed by neutral PAGE (Section 2.7.3). Red 
asterisks indicate the 32P-labelled oligonucleotide. B. Quantification of the data 
showed in A was performed by phosphorimaging analysis (Section 2.7.8). Product 
formation is expressed as a percentage of total radiolabeled DNA. Data are 
presented as the mean of three experiments (±SEM). 
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3.4 Substrate specificities of MUS81-SFEME1, MUS81-SFEME2A 
and MUS81-SFEME2B 
Previous studies showed that recombinant S. cerevisiae Mus81-Mms4, S. pombe 
Mus81-Eme1 and human MUS81-EME1 preferentially cleave three-way branched 
structures like 3’-flaps, RFs and nicked HJs (Bastin-Shanower et al., 2003; Ciccia 
et al., 2003; Gaillard et al., 2003). Also, as shown previously, the activity of 
MUS81-EME2 (XM_113869) was reported to be 10-fold greater than that of 
MUS81-EME1 on 3’-flap and splayed-arm substrates (Ciccia et al., 2007). However, 
in view of the identification of two novel MUS81 complexes, a comparative analysis 
of the biochemical properties of MUS81-EME1, MUS81-EME2A and MUS81-
EME2B was necessary. 
 
To study the substrate specificities of the three endonucleases, a series of model 
branched DNA substrates were generated by annealing partially complementary 
oligonucleotides (Section 2.11). These included splayed-arm, 3’-flap, 5’-flap, 
replication fork and Holliday junction (HJ) structures, all containing a common 
5’-32P-end-labelled oligonucleotide (X0.1) (Figure 3.7). Specifically, the HJs used in 
this analysis have a mobile homologous core (mobile HJ), an immobile non-
homologous core (static HJ) or a nick adjacent to the branch point (nicked HJ). 
Reactions were performed with a fixed amount of non-radiolabeled substrate and 
‘spiked’ with a negligible concentration of 5’-32P-end-labelled DNA. Increasing 
amounts of MUS81-SFEME1, MUS81-SFEME2A or MUS81-SFEME2B were mixed 
with the DNA substrates and the cleavage activities were analysed by neutral 
PAGE (Section 2.7.3).  
 
MUS81-SFEME1 preferentially cleaved the 3’-flap, replication fork and nicked HJ 
substrates, as previously described (Ciccia et al., 2003). Interestingly, the activity of 
MUS81-SFEME2A was higher than that of MUS81-SFEME1 on each of the 
substrates analysed (Figure 3.7). Also, cleavage of the 3’-flap and replication fork 
resulted in the formation of two products. Reactions performed with limiting 
amounts of substrate resulted in the complete conversion of one product into the 
other (data not shown), suggesting that MUS81-SFEME2A processes 3’-flaps and 
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replication forks in a two-step reaction. The cleavage mechanism of 3’-flaps by 
MUS81-SFEME2A will be described in more detail in Section 3.6. In contrast to 
MUS81-SFEME1, MUS81-SFEME2A was also able to cleave the 5’-flap substrate. 
 
Interestingly, the activity profile of MUS81-SFEME2B was closer to that of MUS81-
SFEME1 than to that of MUS81-SFEME2A. MUS81-SFEME2B cleaved the 3’-flap 
DNA with an efficiency that was comparable to that of MUS81-SFEME1, but showed 
moderate activity towards replication fork and nicked HJ substrates. In contrast to 
MUS81-SFEME2A, few cleavage products were detected when MUS81-SFEME2B 
was incubated with splayed-arm, 5’-flap, mobile and static HJs. Finally, 
quantification of the reaction products by phosphorimaging revealed that, 
consistent with results obtained with Mus81-Mms4 from S. cerevisiae and Mus81-
Eme1 from S. pombe (Chang et al., 2008; Fricke et al., 2005; Gaillard et al., 2003; 
Osman et al., 2003; Whitby et al., 2003), the nicked HJ is the preferred substrate of 
MUS81-SFEME1 whereas MUS81-SFEME2A preferentially cleaves 3’-flaps and 
replication forks (Figure 3.8). 
 
3.5 Purification of the catalytically inactive MUS81D307A-EME2A 
To determine whether all the activities described in the previous section were 
intrinsic to MUS81-SFEME2A, catalytically inactive MUS81D307A-SFEME2A complex 
was purified using a similar scheme to the wild-type protein. Inactive MUS81 was 
obtained by alanine mutagenesis of the residue D307 (D307A), as previously 
reported (Taylor and McGowan, 2008). Indeed, on the basis of structural studies 
performed on the related nucleases Pyrococcus furiosus Hef and Aeropyrum pernix 
XPF (Newman et al., 2005; Nishino et al., 2003), aspartic acid D307 of human 
MUS81 was predicted to be critical for catalysis. MUS81D307A and SFEME2A were 
cloned in the pFL bicistronic expression vector and the bacmid DNA was generated 
as described in Section 2.9. Baculovirus expression and purification of 
MUS81D307A-SFEME2A were performed as previously described for 
MUS81-SFEME2A. The complex was purified to homogeneity and its purity was 
similar to that of MUS81-SFEME2A (Figure 3.9A). The activities of 
MUS81-SFEME2A and MUS81D307A-SFEME2A were compared on 3’-flap and 5’-flap 
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substrates under the same reaction conditions. As expected, MUS81-SFEME2A 
efficiently cleaved the two DNA structures, whereas no cleavage was detected 
when the DNA was incubated with catalytically inactive MUS81D307A-SFEME2A 
(Figure 3.9B). These results indicate that all the activities observed with 
MUS81-SFEME2A are strictly dependent on its catalytic site. 
 
3.6  MUS81-EME1 and MUS81-EME2A exhibit distinct DNA 
cleavage mechanisms 
In the previous section it was shown that the activity of MUS81-EME2B was 
comparable to that of MUS81-EME1. On the basis of this, and other, results we 
hypothesised that the nuclease activity of MUS81-EME2B might not be 
physiologically relevant (details will be provided in Chapter 4). Conversely, 
significant differences were observed in the cleavage efficiency and substrate 
specificities of MUS81-EME2A and MUS81-EME1. Therefore, to investigate the 
basis of these differences, the DNA cleavage mechanism of MUS81-EME1 and 
MUS81-EME2A was determined by comparing their pattern of cleavage with 3’-flap, 
5’-flap, immobile HJ and D-loop substrates.  
 
Recombinant affinity purified S. cerevisiae Mus81-Mms4 processes a 3’-flap 
substrate by recognising the 5’-end of the DNA strand located downstream of the 
flap and by cleaving the duplex DNA 3-7 nucleotides on the 5’-side of the branch 
point (Bastin-Shanower et al., 2003). To test whether MUS81-EME1 and MUS81-
EME2A share the same pattern of cleavage, purified MUS81-SFEME1 or MUS81-
SFEME2A complex were incubated with 3’-flap substrates, 5’-32P-end-labelled on 
strand 1, 2 or 3, as indicated in Figure 3.10B. Reaction products were analysed by 
denaturing PAGE (Figure 3.10A, Section 2.7.4) and 32P-labelled marker 
oligonucleotides were used to determine the position of the incisions (data not 
shown). Both MUS81-SFEME1 and MUS81-SFEME2A showed the same incision 
sites (5’-T↓G↓C↓C↓T↓T↓G↓C-3’), with three major consecutive cuts (5’-C↓T↓T↓G-
3’) (Figure 3.9A-B). All the incisions were positioned 3 to 7 nucleotides on the 
5’-side of the branch point; therefore, the cleavage pattern observed on
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Figure 3.7 Substrate specificities of MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B 
The indicated DNA substrates (100 nM) were incubated with the indicated concentrations of purified MUS81-SFEME1, 
MUS81-SFEME2A and MUS81-SFEME2B for 30 min at 37°C (Section 2.11.5). Reactions were analysed by neutral PAGE (Section 
2.7.3). Red asterisks indicate 32P-labelled oligonucleotides. 
 
 
Figure 3.8 Quantification of the nuclease activities of MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B 
Quantification of the data shown in Figure 4.1 was performed by phosphorimaging analysis (Section 2.7.6). Product formation is 
expressed as a percentage of total radiolabeled DNA. Data are presented as the mean of three experiments (±SEM). 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 - Results 
 
 122 
 
CHAPTER 3 - Results 
 
 123 
 
CHAPTER 3 - Results 
 
 124 
 
 
Figure 3.9 Affinity purification of the catalytically inactive 
MUS81D307A-SFEME2A 
A. InstantBlueTM-stained SDS gel (Section 2.7.5) showing purified 
MUS81-SFEME2A and MUS81D307A-SFEME2A. B. The 3’-flap and 5’-flap synthetic 
substrates (100 nM) were incubated with purified MUS81-SFEME2A (2 nM) or 
catalytically inactive MUS81D307A-SFEME2A (2 nM) for 30 min at 37°C (Section 
2.11.4). Reaction products were analysed by neutral PAGE (Section 2.7.3). Red 
asterisks indicate 32P-labeled oligonucleotides. 
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a 3’-flap structure with MUS81-SFEME1 and MUS81-SFEME2A was consistent with 
the incisions performed by yeast Mus81-Mms4. However, we observed that, unlike 
MUS81-SFEME1, MUS81-SFEME2 performed a minor incision on the strand 
opposite to that containing the flap at the site (5’-CT↓CC-3’) (Figure 3.10B). 
 
As shown in Section 3.4, in contrast to MUS81-SFEME1, MUS81-SFEME2A was 
found to process 5’-flap substrates. To gain further insights into its cleavage 
mechanism, MUS81-SFEME2A was incubated with 5’-flap structures, 5’-32P-end-
labelled on strand 1, 2 or 3 (Figure 3.11C). Reactions were analysed by neutral 
PAGE (Figure 3.11A, Section 2.7.3) and 32P-labelled marker oligonucleotides were 
used to map the cleavage sites using denaturing PAGE (Figure 3.11B and data not 
shown, Section 2.7.4). As a control, MUS81-SFEME1 was incubated with the 
5’-flaps but no DNA cleavage was observed (Section 3.4, Figure 3.11A-B). As a 
positive control, the cleavage mechanism of MUS81-SFEME2A was compared to 
that of the purified HJ resolvase GEN11-527, which removes the flap strand by 
cleaving at one of three main sites: 5’-GC↓TCCA↓T↓GT-3’ (Figure 3.11) (Rass et 
al., 2010). Surprisingly, the pattern of cleavage of MUS81-SFEME2A was very 
different from that of GEN11-527 as MUS81-SFEME2A performed multiple incisions 
on the duplex DNA 3-11 nucleotides on the 5’-side of the branch point 
(5’-G↓C↓AA↓A↓GA↓T↓G↓T-3’) and on the strand opposite to the flap 
(5’-T↓C↓G↓TT↓C↓CGTGA↓C-3’) (Figure 3.11B-C). Hence, although 
MUS81-SFEME1 and MUS81-SFEME2 are able to process a 3’-flap structure in the 
same conserved way, MUS81-SFEME2A has the remarkable ability to cleave a 
5’-flap substrate by incising the strand complementary to that containing the flap.  
 
Next, we considered the possibility that the higher cleavage efficiency displayed by 
MUS81-SFEME2A when compared to MUS81-SFEME1 and MUS81-SFEME2B could 
account for its ability to cleave a 5’-flap substrate. To test this hypothesis, the 
activities of MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B were first 
normalised on a 3’-flap and nicked HJ substrates and then compared on a 5’-flap, 
using a time course experiment (Figure 3.12A). In conditions in which the three 
MUS81 complexes exhibited the same level of activity on the 3’-flap and nicked HJ, 
MUS81-SFEME2A was still able to cut the 5’-flap structure, whereas little or no 
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cleavage was observed with MUS81-SFEME1 and MUS81-SFEME2B (Figure 3.12B). 
In addition, we wanted to determine whether MUS81-SFEME1 was able to process 
5’-flaps in the presence of Mn2+, a cofactor that decreases the stringency of the 
endonucleolytic reaction (Loeb and Kunkel, 1982; Vermote and Halford, 1992). 
MUS81-SFEME1 and MUS81-SFEME2A were mixed with the DNA in the presence 
of increasing amounts of MnCl2 (Figure 3.13). Reaction products were analysed by 
neutral PAGE (Section 2.7.3) and quantified by phosphorimaging (Section 2.7.8). 
As observed with Mg2+, the 5’-flap substrate was cleaved efficiently by 
MUS81-SFEME2A but not by MUS81-SFEME1, indicating that the efficiency of the 
reaction is independent of the divalent metal ion used as cofactor. 
 
Given that, like the HJ resolvase GEN1, MUS81-SFEME2A was able to process 
5’-flaps, we investigated in more detail the mechanistic differences between 
MUS81-SFEME1 and MUS81-SFEME2A with a HJ substrate. MUS81-SFEME2A 
cleaved the HJs more efficiently than MUS81-SFEME1, as shown in Figures 3.7 and 
3.8. In order to be able to determine and compare their patterns of cleavage, 
MUS81-SFEME1 and MUS81-SFEME2A were incubated with immobile HJs, 
5’-32P-end-labelled on strand 1, 2, 3 or 4, as illustrated in Figure 3.14B. Reaction 
products were analysed by denaturing PAGE (Section 2.7.4) and 32P-labelled 
marker oligonucleotides were used to determine the positions of the cuts (Figure 
3.14A). In contrast to GEN1, which cuts symmetrically across the junction (Ip et al., 
2008), both MUS81 complexes introduced multiple incisions in all four strands of 
the immobile HJ (Figure 3.14A-B). Specifically, the major cleavage sites by 
MUS81-SFEME1 were closer to the branch point compared to those of 
MUS81-SFEME2A and both enzymes cleaved the junction 6 nucleotides to the 
5’-side of the branch point of strand 3 (5’-CA↓AC-3’) and 5 nucleotides on the 
5’-side of the branch point of strand 4 (5’-CC↓TC-3’), as illustrated in Figure 3.14B. 
 
D-loops are intermediate structures of HR-mediated repair of both one- and two-
ended DSBs (Section 1.2.2) as they are generated by RAD51-mediated 3’-ended 
strand invasion. The formation of D-loop structures is also very important in the 
context of telomere maintenance: at telomeres, D-loops are generated when the 
3’-G-rich single-stranded overhangs invade duplex telomeric DNA to form a lariat-
like structure referred to as T-loop, which protects chromosome ends from being
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Figure 3.10 Cleavage of a 3’-flap substrate by MUS81-SFEME1 and 
MUS81-SFEME2A  
A. The 3’-flap substrate (100 nM) was incubated with purified MUS81-SFEME1 (5 
nM) or MUS81-SFEME2A (2 nM) for 15 min at 37°C (Section 2.11.5). Reaction 
products were analysed by denaturing PAGE (Section 2.7.4). Numbers with red 
asterisks indicate the 32P-labelled strands. The size of the intact and cleaved 
oligonucleotides is indicated. B. Schematic representation of the 3’-flap synthetic 
substrate. Red arrows indicate the sites of cleavage by MUS81-SFEME1 and 
MUS81-SFEME2A. Arrow size is proportional to the relative efficiency of the 
cleavage.  
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Figure 3.11 MUS81-SFEME2A cleaves a 5’-flap substrate 
A-B. The 5’-flap substrate (3 nM) was incubated with purified MUS81-SFEME1 (1 
nM) and MUS81-SFEME2A (1 nM) for 30 min at 37°C (Section 2.11.5). Purified 
GEN11-527 (0.5 nM) was used as a positive control (10 min incubation at 37°C). 
Samples were divided in half and analysed by neutral PAGE (A, Section 2.7.3) and 
denaturing PAGE (B, Section 2.7.4). Red asterisks indicate 32P-labelled 
oligonucleotides. In B, the sizes of intact and cleaved oligonucleotides are 
indicated. C. Schematic representation of the 5’-flap synthetic substrate showing 
the sites of cleavage introduced by MUS81-SFEME2A (red arrows). Green arrows 
indicate the sites of cleavage by GEN11-527. Arrow size is proportional to the relative 
cleavage efficiency. 
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Figure 3.12 Comparison of the activities of purified MUS81-SFEME1, MUS81-SFEME2A and MUS81-SFEME2B on a 3’-flap, nicked 
HJ and 5’-flap 
A. The indicated substrates (100 nM) were incubated with purified MUS81-SFEME1 (5 nM), MUS81-SFEME2A (1 nM) or 
MUS81-SFEME2B (5 nM) at 37°C for the indicated times (Section 2.11.5). Reaction products were analysed by neutral PAGE (Section 
2.7.3). Red asterisks indicate 32P-labelled oligonucleotides. B. Quantification of the data shown in A was performed by phosphorimager 
analysis (Section 2.7.8). Product formation is expressed as a percentage of total radiolabeled DNA. Data are presented as the mean of 
three experiments (±SEM). 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 - Results 
 
 131 
 
CHAPTER 3 - Results 
 
 132 
 
 
 
 
 
 
 
 
 
Figure 3.13 Comparison of the activities of MUS81-SFEME1 and MUS81-
SFEME2A on a 5’-flap using MnCl2 as a cofactor 
The 5’-flap substrate (100 nM) was incubated with purified MUS81-SFEME1 (4 nM) 
or MUS81-SFEME2A (1 nM) for 30 min at 37°C  (Section 2.11.5). Reactions 
contained the indicated concentrations of MnCl2 and were analysed by neutral 
PAGE (Section 2.7.3). Red asterisks indicate 32P-labelled oligonucleotides. 
Quantification was performed by phosphorimager analysis (Section 2.7.8). Product 
formation is expressed as a percentage of total radiolabeled DNA. 
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Figure 3.14 Comparison of the activities of MUS81-SFEME1 and MUS81-
SFEME2A on an immobile HJ 
A. The immobile HJ (approximately 3 nM), 5’-32P-end-labeled on strands 1, 2, 3 or 
4, was incubated with purified MUS81-SFEME1 (5 nM) or MUS81-SFEME2A (1 nM) 
for 30 min at 37°C (Section 2.11.5). Reaction products were analysed by 
denaturing PAGE (Section 2.7.4). Red asterisks indicate 32P-labelled 
oligonucleotides. The sizes of intact and cleaved oligonucleotides is indicated. M = 
5’-32P-end-labeled marker oligonucleotides (Section 2.11.4). All the reactions 
shown were analysed in the same gel. B. Schematic representation of the static HJ. 
Red arrows indicate the sites of cleavage by MUS81-SFEME1 or MUS81-SFEME2A. 
Arrow size is proportional to the relative efficiency of the cleavage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 - Results 
 
 134 
 
CHAPTER 3 - Results 
 
 135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Comparison of the activities of MUS81-SFEME1 and 
MUS81-SFEME2A on a D-loop structure 
A. Schematic representation of the D-loop structure, indicating the strands and 
oligo lengths. B-C. The D-loop structure (100 nM), 5’-32P-end-labeled on strands 
DL-0, DL-1 or DL-2, was incubated with purified MUS81-SFEME1 (5 nM) or MUS81-
SFEME2A (5 nM) for 30 min at 37°C (Section 2.11.5). Samples were divided in half 
and analysed by neutral PAGE (B, Section 2.7.3) and by denaturing PAGE (C, 
Section 2.7.4). Red asterisks indicate 32P-labelled oligonucleotides. In C, the size of 
the intact and cleaved oligonucleotides is indicated. M = 5’-32P-end-labeled marker 
oligonucleotides (Section 2.11.4).  
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Figure 3.16 Analysis of the activities of MUS81-SFEME1 and MUS81-SFEME2A 
on a D-loop structure 
A. The D-loop structure (100 nM), 5’-32P-end-labeled on strands DL-0, DL-1 or 
DL-2, was incubated with MUS81-SFEME2A (5 nM) at 37°C for the indicated times 
(Section 2.11.5). Reactions were analysed by neutral PAGE (Section 2.7.3). Red 
asterisks indicate 32P-labelled oligonucleotides. B. Schematic representation of the 
D-loop substrate. Red arrows indicate the sites of cleavage by MUS81-SFEME1 or 
MUS81-SFEME2A. Arrow size is proportional to the relative efficiency of the 
cleavage. 
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recognised as DSBs by the cellular DNA damage response machinery (Section 
1.4) (Griffith et al., 1999). 
 
To determine whether MUS81-SFEME1 and MUS81-SFEME2A differ in their ability 
to cleave D-loop structures, equal amounts of the purified proteins were incubated 
with D-loops, 5’-32P-end-labelled on strands DL-0, DL-1 or DL-2 (Figure 3.15A). 
Analysis of the reaction products by neutral PAGE (Section 2.7.3) showed that, as 
observed for the other model substrates analysed, MUS81-SFEME2A was about ten 
times more efficient than MUS81-SFEME1 in promoting cleavage (Figure 3.15B). To 
map the cleavage sites, reaction products were also analysed using denaturing 
PAGE (Section 2.7.4) (Figure 3.15C). MUS81-SFEME1 performed only one incision 
on the strand complementary to the invading single-stranded 3’-overhang, 4 
nucleotides to the 5’-side of the invasion point (Figure 3.15C and 3.16B). 
MUS81-SFEME2A cleaved the D-loop on the same strand as MUS81-SFEME1 but 
performed multiple incisions 2-9 and 27 nucleotides to the 5’-side of the invading 
site, with the major cuts being at sites 5’-G↓GAC↓A-3’. In contrast to 
MUS81-SFEME1, MUS81-SFEME2A was able to disengage the D-loop structure by 
cleaving the 3’-invading overhang off from the duplex DNA. The incisions occurred 
2 and 4 nucleotides to the 5’-side of the invading point at the site 5’-T↓AT↓C-3’ 
(Figure 3.15C and 3.16B). Finally, to determine whether MUS81-SFEME2A 
processes D-loops by a one-step or multi-step mechanism, the activity of the 
purified complex was analysed in a time course experiment (Figure 3.16A). All the 
products observed by neutral PAGE (Section 2.7.3) were generated simultaneously, 
even after short incubations, suggesting that MUS81-SFEME2A processes a D-loop 
in a one-step reaction. 
 
3.7 Conclusions 
In summary, these results indicate that human cells express two isoforms of EME2, 
referred to as EME2A and EME2B, which can form heterodimeric complexes with 
MUS81 in vivo. Comparative biochemical analysis of affinity-purified MUS81-EME1, 
MUS81-EME2A and MUS81-EME2B shows that the three heterodimers differ in 
nucleolytic cleavage efficiency and substrate specificities. Specifically, 
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MUS81-EME2A appears to be the most active of the complexes, exhibiting 
approximately a 10-fold greater activity compared to MUS81-EME1 and 
MUS81-EME2B on the substrates analysed. Furthermore, in contrast to 
MUS81-EME1, which preferentially cleaves nicked HJs, MUS81-EME2A cleaves 
3’-flaps and RFs more efficiently than nicked HJs. MUS81-EME2A was also able to 
cleave 5’-flaps by inserting nicks on the strand complementary to that containing 
the flap, indicating that MUS81-EME1 and MUS81-EME2A have different 
enzymatic properties. Conversely, we did not observe any remarkable difference 
between the substrate specificities of MUS81-EME1 and MUS81-EME2B, 
indicating that the activity of MUS81-EME2B might not be physiologically important. 
Further details regarding the expression and function of MUS81-EME2B in vivo will 
be provided in the next chapter. 
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CHAPTER 4 
Functional analysis of MUS81-EME1 and 
MUS81-EME2 complexes in DNA repair 
 
4.1 Generation and validation of an anti-EME2 antibody 
To determine the level of expression of EME2A and EME2B in human cells, we 
raised a rabbit polyclonal antibody (APEP13) using synthetic peptides common to 
both EME2 isoforms (Section 2.8.6). The antibody was purified using Protein-A 
agarose and tested for western blotting (Section 2.8.7) using WCEs (Section 2.8.4) 
of human cells transfected with control luciferase siRNA or with EME2 #1 siRNA 
(Section 2.6.1). A band at the predicted size of EME2A (~42kDa) was detected in 
the WCE of control-treated cells but not in the EME2 siRNA-transfected sample, 
confirming the specificity of the antibody (Figure 4.1A, compare lane a and c). No 
band corresponding to EME2B (~49kDa) was observed. Therefore, despite the 
synthesis of its transcript, it is unclear whether the EME2B protein is expressed in 
human cells or whether its expression is tissue-specific.  
 
In all subsequent studies, RNA interference (RNAi) was used to investigate the 
cellular roles of EME2. Although we favour the hypothesis that EME2A is the only 
isoform expressed by human cells, all experiments were performed with siRNAs 
targeting both EME2A and EME2B (Figure 4.1B, Section 2.6.1). Hence, for 
simplicity, EME2A and EME2B will be hereafter referred to as EME2. Two non-
overlapping siRNAs were designed using Sfold (Section 2.6.1) and were 
designated siEME2#1 and siEME2#2 (Figure 4.1B). The studies described in this 
chapter were performed using siEME2#1, whereas siEME2#2 was used in the 
experiments described in Chapter 5. 
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4.2 Analysis of the interdependence between MUS81 and its 
non-catalytic partners EME1 and EME2 
Previous studies showed that depletion of MUS81 or EME1 affects the stability of 
the MUS81-EME1 heterodimeric complex (Forment et al., 2011). In order to 
evaluate the interdependence between MUS81 and its interacting partners EME1 
and EME2, we assessed the stability of these proteins in control, MUS81, EME1 
and EME2 siRNA-transfected cells (Section 2.6.1) by western blotting (Section 
2.8.7). As previously described, depletion of EME1 significantly affected the cellular 
level of MUS81 (Figure 4.1A, lane b). The knockdown of EME2 resulted in a 
moderate reduction of MUS81 (Figure 4.1A, lane c). Finally, the knockdown of 
MUS81 resulted in a decrease in the level of EME2, indicating that the stability of 
EME2 depends on the formation of the MUS81-EME2 heterodimer (Figure 4.1A, 
lane d). Hence, depletion of EME1 or EME2 causes the destabilisation of the 
MUS81-EME1 or MUS81-EME2 complex, respectively. To determine the relative 
ratio between the MUS81-EME1 and MUS81-EME2 complex, we quantified the 
effect of EME1 or EME2 depletion on the cellular level of MUS81. We found that 
the stability of MUS81 was decreased by approximately 30% in EME2-depleted 
cells and by approximately 70% in EME1-depleted cells (Figure 4.1A), indicating 
that approximately 30% of the total MUS81 expressed in human cells interacts with 
EME2 whereas the remaining 70% forms a complex with EME1.  
 
4.3 The MUS81-EME2 complex is required for the processing 
of stalled replication forks 
Treatment of cells with agents that affect RF progression results in the production 
of S-phase specific DSBs (Arnaudeau et al., 2000; Saintigny et al., 2001). 
Interestingly, several studies showed that depletion of MUS81 results in a 
significant decrease in the production of DSBs, indicating a role for MUS81 in the 
collapse of stalled RFs (Fugger et al., 2013; Hanada et al., 2007). Unlike human 
cells, where the activity of MUS81 appears to be only required for the repair of 
stalled RFs, mouse cells rely on RF cleavage by Mus81 to restart RF progression 
(Petermann et al., 2010).  
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Figure 4.1 Design of siRNAs targeting EME2 
A. U2OS cells were transfected with the indicated siRNAs for 72 hr (Section 2.6.1). 
WCEs (Section 2.8.4) were analysed on NuPAGE® 10% Bis-Tris gel and efficiency 
of the depletion was determined by western blotting (Section 2.8.7). Percentages 
refer to the level of MUS81 in the WCEs. B. Alignment of EME2A and EME2B 
cDNAs. The red boxes indicate the sequences targeted by EME2 #1 and EME2 #2 
siRNAs (Section 2.6.1). 
CHAPTER 4 - Results 
 
 144 
The role of EME1 in RF repair, however, has not been investigated and the 
function of MUS81 has always been related, without any supporting experimental 
evidence, to the MUS81-EME1 complex. Therefore, to determine whether the 
activity of human MUS81 at stalled RFs is dependent on MUS81-EME1 or 
MUS81-EME2, we analysed the contribution of MUS81, EME1 or EME2 to HU-
induced DSB formation by pulse-field gel electrophoresis (PFGE). PFGE allows the 
separation of large DNA molecules from DNA fragments and was performed as 
described in Section 2.7.9. As opposed to intact DNA, broken DNA migrates into 
the gel and DSB formation can be quantified as the ratio of broken to intact DNA. 
HeLa cells were transfected with control, MUS81, EME1 or EME2 siRNAs (Section 
2.6.1). The three proteins were efficiently depleted, as determined by western 
blotting (Figure 4.2A, Section 2.8.7). Forty-eight hours after transfection, cells were 
treated with increasing concentrations of HU for 24 hr. As expected, treatment with 
HU caused a delay during S-phase of the cell cycle, as indicated by the 
accumulation of cells incorporating BrdU (Figure 4.2B, Section 2.13.2). Consistent 
with previous observations (Fugger et al., 2013; Hanada et al., 2007), depletion of 
MUS81 resulted in a significant decrease in DSB formation following treatment with 
HU (Figure 4.3 A-B). Surprisingly, the amount of DSBs observed in EME1-depleted 
cells was comparable to that of control siRNA-transfected cells, whereas depletion 
of EME2 caused a decrease in DSB formation that was comparable to that 
obtained after loss of MUS81 (Figure 4.3A-B, the quantification of DSBs in Figure 
4.3B represents the mean of four experiments). 
 
Similar results were observed after treatment with the ICL agent cisplatin. 
Forty-eight hours after transfection with control, MUS81, EME1 or EME2 siRNAs 
(Section 2.6.1), cells were exposed to increasing concentrations of cisplatin for 24 
hr. Treatment with cisplatin causes a delay during S-phase of the cell cycle, as 
indicated by the accumulation of cells incorporating BrdU (Figure 4.2C, Section 
2.13.2). As already observed with HU-treated cells, MUS81 and EME2 depletion 
significantly affected the production of ICL-dependent DSBs (Figure 4.4 A-B). 
Conversely, cells transfected with control or EME1 siRNA displayed comparable 
levels of DSB formation (Figure 4.4 A-B, the quantification of DSBs in Figure 4.4B 
represents the mean of two experiments). Taken together, these results indicate 
that, in contrast to what was previously assumed, but not tested, MUS81-EME2, 
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rather than MUS81-EME1, is required for the collapse and repair of stalled RFs 
after prolonged HU or cisplatin treatments. 
 
4.4 MUS81 interacts with EME2 during the S-phase of the cell 
cycle 
Results from our laboratory have established that MUS81 and EME1 form a stable 
complex throughout the cell cycle and that at the G2/M transition, MUS81-EME1 
cooperates with SLX1-SLX4 to efficiently resolve HJs that have escaped BTR- 
mediated dissolution (Section 1.3.1) (Wyatt et al., 2013). In view of the function of 
the MUS81-EME2 complex in the repair of stalled RFs, we decided to investigate 
whether MUS81 might also interact with EME2 in a cell cycle-dependent manner. 
To do this, we generated a HeLa Kyoto cell line expressing BAC-MUS81FLAP 
(Section 2.6.3) (Figure 4.5A). BAC-MUS81FLAP HeLa Kyoto cells were synchronised 
at G1/S by double thymidine block (Section 2.6.4) and released into fresh media. 
Samples were collected at intervals of 3 hr and nocodazole, a drug that interferes 
with the polymerization of microtubules, was added 6 hr after the thymidine release. 
FACS analysis of the cellular DNA content (propidium iodide staining, Section 
2.13.1) showed that the majority of the cells were efficiently synchronised at G1/S 
(Figure 4.5C). Between 3 and 6 hr after thymidine release, cells were undergoing 
DNA replication and, upon addition of nocodazole, began to accumulate in 
prometaphase with a 4n DNA content. GFP affinity purification was performed from 
samples collected at the time points indicated in Figure 4.5 B and C (Section 
2.10.2). Western blotting analysis was used to assess the efficiency of the 
MUS81FLAP pull-down and the presence of EME1, EME2 and SLX4 in the 
immunoprecipitates (Figure 4.5B, Section 2.8.7). As previously shown, EME1 
interacted with MUS81 throughout the cell cycle and its phosphorylation status 
appeared to change according to the cell cycle stage (Figure 4.5B, lane e) (Wyatt 
et al., 2013). MUS81 was found to preferentially associate with SLX4 during the 
G2/M phase of the cell cycle (Figure 4.5B, lanes d and e) (Wyatt et al., 2013). 
Surprisingly, the interaction between MUS81 and EME2 also appeared to be cell 
cycle stage-dependent. 
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Figure 4.2 Cell cycle profiles of control and EME2 siRNA-transfected cells 
after treatment with HU or cisplatin 
HeLa cells were transfected with the indicated siRNAs for 48 hr and then treated 
with 1 mM HU (A) or 10 µM cisplatin (B) for 24 hr. BrdU staining was performed as 
described in Section 2.13.2. Data were analysed using the analysis software 
FlowJo 10.1. C. The efficiency of MUS81, EME1 and EME2 siRNA-mediated 
depletion was determined by western blotting (Section 2.8.7) on HeLa WCEs 
(Section 2.8.4).  
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Figure 4.3 The MUS81-EME2 complex contributes to the formation of DSBs 
in response to treatment with HU 
A. PFGE gels showing the formation of DNA DSBs after treatment with the 
indicated concentration of HU for 24 hr. HeLa cells were transfected with the 
indicated siRNAs for 48 hr before the addition of the drug. B. The formation of HU-
induced DSBs is expressed as the ratio of broken to intact DNA. Data are 
presented as a mean of three experiments (±SEM). 
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Figure 4.4 The MUS81-EME2 complex contributes to the conversion of 
ICLs into DNA DSBs 
A. PFGE gels showing the formation of DNA DSBs after treatment with the 
indicated concentration of cisplatin for 24 hr. HeLa cells were transfected with the 
indicated siRNAs for 48 hr before the addition of the drug. B. The formation of 
cisplatin-induced DSBs is expressed as the ratio of broken to intact DNA. Data are 
presented as a mean of two experiments (±SEM). 
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Specifically, EME2 was enriched in MUS81 immunoprecipitates during S-phase, i.e. 
3 to 6 hr after thymidine release (Figure 4.5B, lanes b and c). Some EME2 was 
also detected in the pull-down from cells arrested in G1/S (Figure 4.5B, lane a), 
suggesting that the MUS81-EME2 complex might start to form prior the initiation of 
DNA replication. Hence, in agreement with the concept that MUS81-EME2 may 
play a role in the repair of stalled RFs, these results show that MUS81 and EME2 
interact preferentially during G1- and S-phase. 
 
4.5 MUS81-EME2 is required for genomic stability after HU 
treatment 
Defects in the repair of damaged RFs often lead to the accumulation of 
chromosomal aberrations and genomic instability. For example, Fanconi Anaemia 
(FA) cells, which are defective in the repair of RFs stalled at ICLs, show an 
elevated level of chromosomal aberrations, which include radial chromosomes and 
chromosome breaks (Shahid et al., 1972). Given the role of MUS81-EME2 in the 
repair of stalled RFs, we analysed the formation of aberrant chromosomes in 
untreated or HU-treated MUS81-, EME1- and EME2-depleted cells (Figure 4.6A). 
To do so, untransformed RPE-1 cells, immortalised by overexpression of the 
telomerase subunit hTERT, were transfected with luciferase, EME1, EME2 and 
MUS81 siRNAs (Section 2.6.1). All proteins were efficiently depleted, as 
determined by western blotting (Figure 4.6C, Section 2.8.7). Cells were treated with 
HU for 24 hr and then incubated in fresh medium for further 24 hr. Metaphase 
spreads were prepared as described in Section 2.12.1 and stained with GIEMSA. 
RPE-1 hTERT cells transfected with EME1, EME2 and MUS81 siRNAs showed a 
mild increase in chromosomal aberrations compared to luciferase-transfected cells 
(Figure 4.6B and Table 4.1). The treatment with HU promoted the formation of 
chromosome aberrations in all the samples analysed. However, cells depleted of 
MUS81 or EME2 showed a two-fold increase in the number of aberrant 
chromosomes compared to control or EME1-depleted cells (Figure 4.6B and Table 
4.1). In line with the observations made so far in this study, this suggests that 
MUS81-EME2 is important for the maintenance of genomic stability of human cells 
after treatment with HU.  
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Figure 4.5 EME2 preferentially binds to MUS81FLAP during the S-phase of 
the cell cycle 
A. Schematic representation of BAC-MUS81FLAP. B. HeLa Kyoto BAC-MUS81FLAP 
cells were synchronised in the G1/S-phase of the cell cycle by double thymidine 
block (Section 2.6.4). Samples were collected after 0, 3, 6, 9 and 12 hr after 
thymidine release and nocodazole was added after 6 hr. GFP-pull-down of BAC-
MUS81FLAP was performed as described in Section 2.10.2. C. Propidium iodide 
staining (Section 2.13.1) of synchronised cells described in A. Data were analysed 
using the analysis software FlowJo 10.1. 
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We also observed that EME2-depleted cells displayed a high level of 
endoreduplication, a phenomenon characterised by the pairing of re-replicated 
chromosomes into ‘butterfly-like’ structures called diplochromosomes (Figure 4.7A). 
A previous study showed that also Mus81-depleted mouse cells displayed 
endoreduplication but with a much lesser frequency compared to that of the 
EME2-depleted cells analysed in this study (Hiyama et al., 2006). Importantly, the 
frequency of endoreduplication in RPE-1 hTERT cells transfected with MUS81 or 
EME1 siRNA was considerably lower compared to EME2 depleted cells (Figure 
4.7B). Therefore, we asked whether co-depletion of MUS81 and EME2 would 
phenocopy MUS81- or EME2-depleted cells. Surprisingly, when MUS81 was 
co-depleted with EME2, the number of cells showing endoreduplication was 
reduced to a level similar to that of the single MUS81 depletion, indicating that in 
the absence of MUS81-EME2, MUS81-EME1 promotes endoreduplication. 
 
4.6  MUS81-EME2 interacts with SLX1-SLX4 and XPF-ERCC1 
MUS81-EME1 forms a multi-nuclease complex with SLX1-SLX4 and the NER 
enzyme XPF-ERCC1 (Fekairi et al., 2009; Munoz et al., 2009; Svendsen et al., 
2009; Wyatt et al., 2013). To determine whether MUS81-EME2 can also form a 
complex with SLX1-SLX4 and XPF-ERCC1, we performed a FLAG 
immunoprecipitation (Section 2.10.3) from HEK293-TRExTM expressing SFEME2A 
(Figure 4.8, Section 2.6.2). FLAG pull-down from HEK293-TRExTM expressing 
SFEME1 was used as a positive control (Section 2.6.2). Western blotting analysis 
(Section 2.8.7) of SFEME1 and SFEME2 eluates showed that, like SFEME1, SFEME2 
interacted with MUS81, SLX1, SLX4, XPF and ERCC1 (Figure 4.8). This result 
indicates that in human cells SLX4 functions as a scaffold for the formation of two 
multi-nuclease complexes that differ in the non-catalytic subunit of the MUS81 
endonuclease.  
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Figure 4.6 MUS81-EME2 complex is required for maintaining genomic 
stability after HU treatment 
A. Representative images of metaphase spreads of RPE-1 hTERT cells showing 
the indicated chromosomal aberrations. Cells were transfected with MUS81, EME1, 
EME2 siRNAs or with control Luciferase siRNA (Section 2.6.1). After 48 hr, cells 
were treated with 1 mM HU for 24 hr and incubated in fresh media for further 24 hr. 
B. Quantification of the frequency of chromosomal breaks and fragments in siRNA-
transfected cells, untreated or treated with 1 mM HU for 24 hr. Data are presented 
as the mean of three different experiments (±SD). C. RPE-1 hTERT cells were 
transfected with the indicated siRNAs for 72 hr (Section 2.6.1). WCEs (Section 
2.8.4) were analysed on a NuPAGE® 10% Bis-Tris gel. Efficiency of the depletion 
was determined by western blotting (Section 2.8.7). 
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siRNA 
 
Treatment 
Number of 
metaphases 
analysed 
 
Acentric 
fragments 
 
Chromosome 
breaks 
 
Chromatid 
breaks 
 
Radials 
 
Dicentrics 
 
Rings 
Luciferase Mock 30 0.03 0 0 0 0 0 
EME1 Mock 30 0.06 0.03 0.1 0 0 0 
EME2 Mock 30 0.1 0.06 0.03 0.03 0.03 0.03 
MUS81 Mock 30 0.03 0.06 0.1 0 0 0 
         
Luciferase Hydroxyurea 30 0.03 0 0.2 0.26 0 0 
EME1 Hydroxyurea 30 0.1 0 0.2 0.13 0 0 
EME2 Hydroxyurea 30 0.3 0.16 0.2 0 0.03 0.1 
MUS81 Hydroxyurea 30 0.26 0.06 0.2 0.13 0 0.03 
 
Table 4.1 Frequency of chromosomal aberrations in control, EME1-, 
EME2- and MUS81-depleted cells, before and after treatment with HU 
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Figure 4.7 Depletion of EME2 increases the frequency of endoreduplication 
in RPE-1 hTERT cells 
A. Representative image of a metaphase spread of EME2-depleted RPE-1 hTERT 
cells showing diplochromosomes as an indication of endoreduplication. B. 
Quantification of the frequency of endoreduplication in RPE-1 hTERT cells 
transfected with the indicated siRNAs (Section 2.6.1). Data are presented as the 
mean of three different experiments (±SD).  
CHAPTER 4 - Results 
 
 155 
4.7 MUS81-EME2 does not significantly contribute to SCE 
formation 
Bloom’s syndrome cells are defective in the BTR-mediated dissolution of dHJs and 
show a high level of SCEs (Chaganti et al., 1974), which are largely 
MUS81-dependent (Wechsler et al., 2011; Wyatt et al., 2013). However, the 
contribution of EME1 and EME2 to SCE formation in BS cells has not been 
investigated and, without any supporting experimental evidence, the activity of 
MUS81 has always been related to that of the MUS81-EME1 complex. Therefore, 
to determine whether SCE formation depends on MUS81-EME1 or MUS81-EME2, 
we analysed SCE frequency in BS cells depleted for MUS81, EME1 or EME2 
(Figure 4.9A). BS cells were transfected with siRNAs targeting EME1, EME2 or 
MUS81 (Section 2.6.1) and all proteins were efficiently depleted (data not shown). 
The SCE assay was performed as described in Section 2.12.2. Depletion of 
MUS81 significantly reduced the number of SCEs compared to cells transfected 
with control luciferase siRNA, as previously described (Figure 4.9B) (Wechsler et 
al., 2011; Wyatt et al., 2013). EME1-depleted cells showed a similar level of SCE 
frequencies compared to that of MUS81-depleted cells, suggesting that the 
MUS81-EME1 complex is responsible for SCE formation in BS cells. Conversely, 
depletion of EME2 did not result in a significant decrease in the number of SCEs. 
SLX1 and SLX4 were also implicated in the formation of SCEs in BS cells and were 
shown to function in the same pathway of HJ resolution as MUS81 (Wechsler et al., 
2011; Wyatt et al., 2013). These results further support a model in which SLX1-
SLX4 and MUS81-EME1 interact to promote efficient HJ resolution (Fekairi et al., 
2009; Munoz et al., 2009; Svendsen et al., 2009; Wyatt et al., 2013). Conversely, 
MUS81-EME2 does not appear to play an important role in SCEs formation, in 
further agreement with its function in the repair of stalled replication forks. 
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Figure 4.8 SFEME2 interacts with SLX1-SLX4 and XPF-ERCC1 
The expression of SFEME2 and SFEME1 was induced in HEK293-TRExTM cell lines 
(Section 2.6.2) with 1 µg/ml tetracycline for 72 hr. As a control, the same 
concentration of tetracycline was added to the HEK293-TRExTM cell line. FLAG 
pull-downs were performed as described in Section 2.10.3. 
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Figure 4.9 The MUS81-EME2 complex does not significantly contribute to 
SCE formation in BS cells 
A. Representative images of metaphase spreads prepared from BLM-deficient cells 
(GM08505) transfected with the indicated siRNAs (Section 2.12.2). B. 
Quantification of SCE formation after siRNA transfection. Each data point 
represents the number of SCEs per 100 chromosomes per metaphase spread (for 
each condition 32 metaphases were analysed). P values were determined using 
two-tailed unpaired t-test with Welch correction. 
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4.8 Conclusions 
In summary, these studies indicate that MUS81 forms two mutually exclusive 
heterodimers in vivo: MUS81-EME1 and MUS81-EME2. MUS81 interacts with 
EME2 preferentially during the S-phase of the cell cycle, during which it appears to 
be required for the restart of stalled RFs. In support of this, analysis of 
chromosomal aberrations reveals that MUS81-EME2 is required for the 
maintenance of genomic stability following treatment with HU. Furthermore, in 
contrast to MUS81-EME1, MUS81-EME2 is not required for SCE formation in BS 
cells, providing further evidence for distinct cellular functions of the two MUS81 
heterodimers. Interestingly, as already observed for MUS81-EME1 (Fekairi et al., 
2009; Munoz et al., 2009; Svendsen et al., 2009), MUS81-EME2 interacts with 
SLX1-SLX4 and XPF-ERCC1. The biological relevance of this interaction will be 
investigated in further studies. 
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CHAPTER 5 
MUS81-EME2 is required for telomere 
maintenance of ALT cells 
 
5.1 Depletion of EME2 affects the cell cycle progression of 
ALT-cells 
Previously, it was shown that MUS81-/- cells displayed a spontaneous mild delay in 
the S/G2-phase of the cell cycle when compared to wild-type cells (Hiyama et al., 
2006). Therefore, we determined the effect of EME2 depletion on the cell cycle 
progression of U2OS and HeLa cells by FACS analysis (Section 2.13.1). We 
observed that depletion of EME2 did not affect the cell cycle profile of HeLa cells, 
whereas EME2-depleted U2OS cells accumulated with a 4n DNA content. We 
hypothesised that this difference in cell cycle progression could be related to the 
different telomere maintenance mechanisms employed by the two cell lines, with 
U2OS being ALT-positive and HeLa being telomerase-positive cells. To confirm 
this hypothesis, we analysed the effect of EME2 depletion on the cell cycle profile 
of additional ALT (GM847) and telomerase-positive (HT1080) cell lines (Figure 5.1). 
As observed for U2OS and HeLa cells, loss of EME2 caused a cell cycle delay in 
ALT cells but not in the telomerase-positive cells (Figure 5.1). Specifically, FACS 
analysis of BrdU incorporation and histone H3 phosphorylation performed on U2OS 
cells (Sections 2.13.1 and 2.13.2) showed that EME2 depletion caused a delay in 
the late S/G2-phase of the cell cycle, but not in mitosis, as indicated by the 
decreased frequency of phospho-histone H3-positive cells (Figure 5.2). Importantly, 
the same results were obtained with two, non-overlapping EME2 siRNAs (Figure 
5.1, 5.2 and 5.3C, Section 2.6.1), excluding the contribution of siRNA-mediated 
off-target effects. Proteins were efficiently depleted in all cell lines analysed, as 
determined by western blotting (Figure 5.3A-B, Section 2.8.7). When the cell cycle 
distribution of EME2-depleted cells was compared to that of control, EME1 and 
MUS81 siRNA-transfected cells, we observed that both 
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Figure 5.1 EME2 depletion causes a delay in the G2/M phase of the cell cycle of ALT-positive cells 
Cells were transfected with the indicated siRNAs for 72 hr as described in Section 2.6.1. PI staining was performed as described in 
Section 2.13.1. Data were analysed using the analysis software FlowJo 10.1. 
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Figure 5.2 BrdU and phospho histone H3 staining of U2OS cells 
transfected with two EME2 siRNAs 
Cells were transfected with the indicated siRNAs for 72 hr as described in Section 
2.6.1. BrdU and phospho-histone H3 stainings were performed as described in 
Section 2.13.2 and 2.13.3, respectively. Data were analysed using the analysis 
software FlowJo 10.1. 
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Figure 5.3 
A-B-C. Western blot analysis of siRNA-mediated depletions  
HeLa, HT1080, GM847 and U2OS cells were transfected with the indicated siRNAs 
for 72 hr, as described in Section 2.6.1. WCEs (Section 2.8.4) were analysed on a 
NuPAGE® 10% Bis-Tris gel. The efficiency of depletion was determined by 
western blotting (Section 2.8.7)  
D. Depletion of MUS81 or EME1 rescues the G2/M delay of EME2-depleted 
U2OS cells 
Cells were transfected with the indicated siRNAs for 72 hr as described in Section 
2.6.1. PI staining was performed as described in Section 2.13.1. Data were 
analysed using the analysis software FlowJo 10.1. 
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ALT-positive and ALT-negative cells transfected with control, EME1 or MUS81 
siRNA showed similar cell cycle progression profiles (Figure 5.1). Taken together, 
these results indicate that the cell cycle delay caused by the loss of EME2 is 
specific to ALT-positive cells.  
 
Because we did not observe a defect in the cell cycle progression of MUS81- and 
EME1-depleted cells, we asked whether co-depletion of EME2 with MUS81 or 
EME1 would rescue the EME2-specific cell cycle defect. Indeed, when EME2 was 
co-depleted with MUS81 or EME1 in U2OS cells, the frequency of cells with 4n 
DNA content was significantly reduced (Figure 5.3D). As described in Section 4.2, 
loss of EME1 or EME2 causes the depletion of the MUS81-EME1 or MUS81-EME2 
complex, respectively. Given that MUS81 protein level was reduced in cells treated 
with EME1 and EME2 siRNA (Figure 5.3B), we concluded that depletion of both 
MUS81-EME1 and MUS81-EME2 complexes rescues the delay in cell cycle 
progression of EME2-depleted cells. 
 
5.2 SFEME1 and SFEME2 localise to ALT-associated PML bodies  
ALT-associated PML bodies (APBs) accumulate in ALT-positive cells during the 
G2-phase of the cell cycle and are believed to be sites of telomere elongation 
(Bryan et al., 1995; Yeager et al., 1999). These bodies are identified by the co-
localisation of telomeric DNA with the shelterin proteins TRF1 and TRF2 at nuclear 
foci that are larger than those formed at individual telomeres (Jiang et al., 2007; 
Yeager et al., 1999). As discussed in Section 1.4.2, many proteins involved in 
telomere maintenance and DNA repair have been visualised at APBs, including 
MUS81 (Zeng et al., 2009).  
 
To determine whether the non-catalytic partners of MUS81 localise to APBs, we 
examined the nuclear localisation of EME1 and EME2 by immunofluorescence (IF) 
(Section 2.12.5). Unfortunately, the anti-EME1 (Section 2.1.3.1) and anti-EME2 
(Section 2.8.8) antibodies were unable to specifically detect EME1 and EME2 in IF. 
For this reason, we analysed the localisation of ectopically expressed SFEME1 and 
SFEME2. The expression of SFEME1 or SFEME2 was induced in U2OS-TRExTM cells 
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Figure 5.4 SFEME2 localises to APBs 
The expression of SFEME2 was induced in U2OS-TRExTM-SFEME2 cells (Section 
2.6.2) with 1 µg/ml tetracycline for 48 hr. IF was performed as described in Section 
2.12.5. SFEME2 was detected using the rabbit anti-FLAG primary antibody (Section 
2.1.3.1). IF-FISH was performed as described in Section 2.12.6. 
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Figure 5.5 SFEME1 localises to APBs 
The expression of SFEME1 was induced in U2OS-TRExTM-SFEME1 cells (Section 
2.6.2) with 1 µg/ml tetracycline for 48 hr. IF was performed as described in Section 
2.12.5. SFEME1 was detected using the rabbit anti-FLAG primary antibody (Section 
2.1.3.1). IF-FISH was performed as described in Section 2.12.6. 
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(Section 2.6.2) for 48 hr and IF was performed using the anti-FLAG M2 antibody 
(Section 2.1.3.1), as described in Section 2.12.5. We observed that both SFEME1 
and SFEME2 formed large foci in cells showing a nuclear CENP-F staining, which is 
specific for the G2-phase of the cell cycle (Figure 5.4 and 5.5). These foci co-
localised with MUS81 and were decorated with TRF1 and TRF2, indicating that 
SFEME1 and SFEME2 are found at APBs (Figure 5.4 and 5.5). These results 
indicate that both MUS81-EME1 and MUS81-EME2 complexes are recruited to 
APBs and might have a role in telomere maintenance of ALT-positive cells. 
 
5.3 MUS81-EME2 is required for telomere maintenance of ALT-
positive cells 
Previously, it was shown that MUS81 is required for telomere maintenance of 
ALT-positive cells, as indicated by the increased loss of telomere signals in 
MUS81-depleted cells (Zeng et al., 2009). To determine whether the telomeric 
function of MUS81 depended on the activity of the MUS81-EME1 or MUS81-EME2 
complex, we performed Q-FISH analysis (Section 2.12.3), which allows the 
visualisation of telomere DNA through the hybridisation of telomeric fluorescent 
probes on metaphase chromosomes. ALT-positive U2OS cells were transfected 
with control, MUS81, EME1 or EME2 siRNA (Figure 5.6) and all proteins were 
efficiently depleted, as determined by western blotting (Figure 5.3B, Section 2.8.9). 
Loss of MUS81 resulted in an increased frequency of telomere-free chromosome 
ends, as already described (Zeng et al., 2009) (Figure 5.7A). However, when 
EME1- and EME2-depleted cells were compared, we observed that the rate of 
telomere signal loss in cells transfected with EME1 siRNA was comparable to that 
of control-treated cells, whereas depletion of EME2 using two, non-overlapping 
siRNAs resulted in a two-fold increase in telomere-free ends. To determine the 
requirement for the MUS81 endonucleases in ALT-negative cells, we performed 
Q-FISH analysis on metaphase spreads from HT1080 cells transfected with control, 
MUS81, EME1 or EME2 siRNA (Section 2.6.1), but no significant difference in the 
rate of telomere loss was observed between the samples (Figure 5.8A-B). Taken 
together, these results confirm that the role of MUS81 in telomere maintenance is 
restricted to ALT-positive cells (Zeng et al., 2009) and reveal that MUS81-EME2, 
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Figure 5.6 Depletion of EME2 or MUS81 causes telomere loss in 
ALT-positive cells 
Representative images of Q-FISH (Section 2.12.3) on metaphase spreads from 
U2OS cells transfected with the indicated siRNAs (Section 2.6.1). The arrows point 
to a normal chromosome (A) or to chromosomes with telomere-free ends (B and C). 
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Figure 5.7 Quantification of telomere loss and telomere intensity in siRNA-
transfected U2OS cells 
A. Quantification of the data shown in Figure 5.6. Data are presented as the mean 
of three different experiments (±SD). n = number of telomere ends analysed. P 
values were determined using Pearson’s chi-squared test.  
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Figure 5.8 Depletion of EME2 or MUS81 does not cause telomere loss in 
ALT-negative cells 
A.  Representative images of Q-FISH (Section 2.12.3) on metaphase spreads from 
HT1080 cells transfected with EME2 siRNA #1 (Section 2.6.1). B. Quantification of 
telomere-free ends from Q-FISH analysis of HT1080 cells transfected with the 
indicated siRNAs. Data are presented as the mean of three different experiments 
(±SD). n = number of telomere ends analysed. 
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and not MUS81-EME1, is required for this function. Preliminary data shows that the 
telomere fluorescence intensity of EME2- and MUS81-depleted cells is significantly 
lower compared to control or EME1-depleted cells, suggesting that the loss of 
MUS81 or EME2 results in a decrease in the overall telomere length (data not 
shown). Furthermore, we did not observe chromosome end-to-end fusion in 
MUS81- or EME2-depleted cells (data not shown), suggesting that MUS81-EME2 
might be required for telomere elongation but not for telomere end protection in 
ALT-positive cells.  
 
Given that ALT-positive cells are characterised by an elevated frequency of 
telomere SCEs (T-SCEs) and telomere recombination (Londono-Vallejo et al., 
2004), we asked whether loss of EME2 affected the rate of T-SCEs in ALT-cells. 
Previous studies have shown that depletion of MUS81 in GM847 cells causes a 
decrease in T-SCEs (Zeng et al., 2009), but it is unclear whether this phenotype 
resulted from the loss of the MUS81-EME1 or MUS81-EME2 complex. Therefore, 
to determine the role of the two MUS81 heterodimers in telomere recombination, 
we analysed the frequency of T-SCEs in U2OS cells depleted of MUS81, EME1 or 
EME2 (Section 2.6.1). To do so, we used CO-FISH analysis (Figure 5.9, Section 
2.12.4), which allows the monitoring of telomere recombination by hybridisation of a 
G-strand (red)- and a C-strand (green)-specific fluorescent probe: when 
recombination occurs, the red G-strand- and the green C-strand-specific signals 
overlap and produce a yellow double signal (T-SCE). We observed that depletion 
of MUS81 and EME2 caused a significant decrease in the frequency of T-SCEs, 
compared to control-transfected cells (Figure 5.10). Conversely, the rate of T-SCEs 
in EME1-depleted cells was comparable to that of cells treated with luciferase 
siRNA, implicating MUS81-EME2 but not MUS81-EME1 in the production of 
T-SCEs in ALT-positive cells. 
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Figure 5.9 Depletion of EME2 or MUS81 causes a significant decrease of 
T-SCEs in ALT-positive cells 
A. Representative images of CO-FISH (Section 2.12.4) on metaphase spreads 
from U2OS cells transfected with the indicated siRNAs (Section 2.6.1). T-SCEs 
were detected using a telomeric G-strand PNA probe (red) and a telomeric C-
strand PNA probe (green). The arrows point to a chromosome without T-SCEs (A) 
and to chromosomes with telomeric exchange signals (yellow, B and C).  
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Figure 5.10 Quantification of chromosome ends with T-SCEs 
Cells were transfected with the indicated siRNAs (Section 2.6.1). Data are 
presented as the mean of three different experiments (±SD). n = number of 
telomere ends analysed. P values were determined using Pearson’s chi-squared 
test. 
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5.4 Loss of EME2 increases telomere fragility in ALT-positive 
cells 
Fragile sites are specific chromosomal loci that exhibit gaps and breaks in 
response to treatment with aphidicolin, which causes DNA replication stress by 
inhibition of DNA polymerase α, δ and ε (Sheaff et al., 1991). Recently, telomeres 
have been identified as common fragile sites, as treatment of human and mouse 
cells with aphidicolin resulted in the appearance of multiple telomeric signals (Sfeir 
et al., 2009). Telomeric FISH analysis usually results in the visualisation of one 
signal per chromatid end, although ALT-positive cells exhibit a high level of 
telomere-free chromosome ends (approximately 10%, Figure 5.7). Upon replication 
stress, telomeres appear broken, as indicated by the presence of smaller, spatially 
separated telomeric signals (Figure 5.11A). This abnormal signal pattern has been 
referred to as telomere fragility and it is likely to result from the presence of regions 
of single-stranded DNA caused by incomplete replication (Sfeir et al., 2009). The 
repetitive nature of telomeric DNA constitutes an obstacle to the DNA replication 
machinery, most likely because of the formation of secondary structures like 
G4-quadruplexes (Section 1.4.3). In line with this hypothesis, the DNA helicases 
BLM and RTEL1, which are involved in the removal of G4 structures, repress the 
fragility phenotype at telomeres (Sfeir et al., 2009). Also, loss of TRF1, which is 
required for the recruitment of BLM and RTEL1 to telomeres, results in a dramatic 
increase in telomere fragility (Sfeir et al., 2009). 
 
Given the role of MUS81-EME2 in the repair of stalled RFs, we investigated 
whether depletion of EME2 in U2OS cells causes an increase in telomere fragility. 
FISH analysis performed on EME2-depleted U2OS cells revealed that loss of 
EME2 caused a two-fold increase in the frequency of multiple telomeric signals 
compared with that observed in cells treated with luciferase or EME1 siRNAs 
(Figure 5.10B). The increase in chromatids exhibiting telomere fragility was not 
statistically significant in cells depleted of MUS81. Additionally, we did not observe 
an increase in telomere fragility in ALT-negative cells (data not shown). Taken 
together, these results suggest that the activity of MUS81-EME2 might be required 
to ensure complete DNA replication of telomeres in ALT-positive cells. 
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Figure 5.11 Depletion of EME2 causes an increase in telomere fragility in 
ALT-positive cells 
A. Representative images of chromosomes from U2OS cells with multiple telomeric 
signals. B. Quantification of chromosome ends with multiple telomeric signals. 
Cells were transfected with the indicated siRNAs (Section 2.6.1). Data are 
presented as the mean of three different experiments (±SD). n = number of 
telomere ends analysed. P values were determined using Pearson’s chi-squared 
test.
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Figure 5.12 Depletion of EME2 or MUS81 causes a significant increase in 
mitotic aberrations in ALT-positive cells 
A. Representative images of DAPI-stained dividing cells undergoing normal mitosis 
or showing anaphase bridges and laggard chromosomes. B. Quantification of 
mitotic aberrations showed in A in ALT-positive (U2OS) and ALT-negative (HeLa 
Kyoto) cells transfected with the indicated siRNAs (Section 2.6.1). A total of 150 
cells per condition were counted. Data are presented as the mean of three different 
experiments (±SD). P values were determined using a two-tailed Fisher’s Exact 
test.
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Figure 5.13 Quantification of mitotic aberrations in ALT-positive and 
ALT-negative  
U2OS (ALT-positive) and HeLa Kyoto (telomerase-positive) cells were transfected 
with the indicated siRNAs (Section 2.6.1). A total of 150 cells per condition were 
counted. Data are presented as the mean of three different experiments (±SD). P 
values were determined using a two-tailed Fisher’s Exact test. 
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5.5 Depletion of MUS81-EME2 causes mitotic aberrations in 
ALT-positive cells 
Defects in DNA replication progression create regions of unreplicated DNA that 
represent an impediment for the proper segregation of chromatids during mitosis 
and result in mitotic aberrations like bulky DAPI-positive anaphase bridges and 
lagging chromosomes (Figure 5.12), which are indicators of genomic instability. To 
determine whether depletion of EME2 increased the frequency of mitotic 
aberrations, we counted the number of anaphase bridges and laggard 
chromosomes in ALT-positive (U2OS) and telomerase-positive (HeLa Kyoto) cells 
following treatment with control, EME1, EME2 and MUS81 siRNAs (Figure 5.13, 
Section 2.6.1). We observed that depletion of EME1 in both ALT-positive and ALT-
negative cells caused a two-fold increase in the number of cells exhibiting mitotic 
aberrations compared to control-treated cells. Loss of EME2 resulted in a 
significant increase in the rate of mitotic defects in U2OS cells but not in HeLa 
Kyoto cells. Also, the difference between the frequency of mitotic aberrations in 
MUS81-depleted and control U2OS cells was not statistically significant. Taken 
together, these results suggest that depletion of the MUS81-EME2 complex causes 
mitotic aberrations specifically in ALT-positive cells, whereas loss of MUS81-EME1 
contributes to the formation of bulky bridges and laggards in both ALT-positive and 
ALT-negative cells. 
 
5.6 Conclusions 
In summary, these studies indicate that MUS81-EME2, rather than MUS81-EME1, 
is implicated in telomere maintenance of ALT-positive cells. In support of this, 
ALT-cells depleted of the MUS81-EME2 complex exhibit an increased frequency in 
telomere-free chromosome ends and a decreased frequency in T-SCEs when 
compared to control cells or cells depleted of the MUS81-EME1 complex. We 
propose that the phenotype observed might be related to the function of 
MUS81-EME2 at stalled RFs that was described in Chapter 4. Indeed, depletion of 
EME2 in U2OS cells results in an increase in chromosome ends exhibiting multiple 
telomeric signals, which have been proposed to indicate defects in RF progression 
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(Sfeir et al., 2009). Furthermore, loss of EME2 in ALT-cells, but not in 
telomerase-positive cells, results in an increased rate of bulky DNA bridges and 
laggard chromosomes, which may derive from regions of unreplicated DNA and are 
indicators of genomic instability. 
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CHAPTER 6 
Discussion 
 
The role of MUS81 has been widely studied in both yeast and human cells. In yeast, 
Mus81 forms a heterodimeric complex with Eme1/Mms4 and functions in the 
resolution of HJs generated during meiotic and mitotic HR and in the repair of 
stalled RFs (Sections 1.3.1 and 1.3.2). Conversely, human MUS81 forms two 
heterodimeric complexes, one with EME1 and the other with EME2. However, 
studies conducted so far on human MUS81 have often disregarded the existence 
of MUS81-EME2, thereby relating all the phenotypes observed to the activity of 
MUS81-EME1. As a result, the biological role of MUS81-EME2 and its differences 
(if any) with MUS81-EME1 have not been investigated. In contrast to EME1, EME2 
is exclusively expressed in vertebrates, suggesting that higher eukaryotes require 
two MUS81 endonucleases to fulfil specific distinct functions. In this study, we 
performed a detailed comparison of the biochemical properties and cellular 
functions of the two human MUS81 complexes, providing evidence of distinct 
biological roles for MUS81-EME1 and MUS81-EME2. 
 
MUS81-EME1 and MUS81-EME2 have different biochemical properties 
In this study, we reported the identification of two isoforms of EME2, referred to as 
EME2A and EME2B (Figure 3.1). Both isoforms align mainly with the C-terminal 
region of EME1 and interact with endogenous MUS81 (Figure 3.2 and 3.3). Like 
XPF-ERCC1 and MUS81-EME1, MUS81-EME2A and MUS81-EME2B have a 
single subunit (MUS81) with an active ERCC4 nuclease domain because, as 
already reported for EME1, the ERKXXXD catalytic motif has evolutionarily 
diverged in both EME2A and EME2B (Figure 3.2) (Ciccia et al., 2003). In the case 
of XPF-ERCC1, the nuclease domain is contained in the XPF subunit, whereas the 
HhH domain of ERCC1 is required for DNA binding (Tripsianes et al., 2005). It is 
likely that the inactive subunits of the MUS81 complexes are also necessary for the 
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targeting of MUS81 to DNA and that the binding of MUS81 to EME1, EME2A or 
EME2B defines the structure specificity of the endonuclease. Therefore, we 
decided to characterise the endonucleolytic activities of purified MUS81-SFEME1, 
MUS81-SFEME2A and MUS81-SFEME2B complexes on a set of synthetic model 
DNA structures. Given that we observed no remarkable difference between the 
cleavage activities of MUS81-SFEME1 and MUS81-SFEME2B, we focused our 
attention on the comparison between MUS81-SFEME1 and MUS81-SFEME2A. We 
found that the interaction between MUS81 and EME2A results in a novel 3’-flap 
endonuclease, which differs from MUS81-EME1 in both efficiency and mechanisms 
of cleavage of model DNA substrates. Specifically, MUS81-SFEME2A was found to 
be approximately 10-fold more active than MUS81-SFEME1 on all the DNA 
substrates analysed and, in contrast to MUS81-SFEME1, it was able to process a 
5’-flap structure by cleaving the DNA strand complementary to that containing the 
flap (Figure 3.7 and 3.11).  
 
The mechanisms by which MUS81-SFEME1 and MUS81-SFEME2A cleave a 3’-flap 
substrate is similar: both complexes cleave the structure in the duplex DNA region 
3 to 7 nucleotides on the 5’-side of the branch point (Figure 3.10). This cleavage 
pattern is consistent with that observed with purified S. cerevisiae Mus81-Mms4, 
which binds to the 5’-end located downstream of the flap and cleaves the duplex 
DNA 3 to 7 nucleotides upstream of the branch point (Bastin-Shanower et al., 
2003). Hence, it is likely that the cleavage mechanism of 3’-flap structures is an 
evolutionarily conserved feature of the MUS81 endonuclease, which does not 
depend on the identity of the catalytically inactive subunit. Nevertheless, we 
observed that, unlike MUS81-SFEME1, MUS81-SFEME2A was able to process the 
3’-flap in a two-step reaction: in the first step, which is comparable to the cleavage 
by MUS81-SFEME1, MUS81-SFEME2A removes the flap, generating a nicked 
duplex molecule; in the second step, it cleaves the nicked DNA generating smaller 
duplex DNA products (Figure 3.7 and 3.10). MUS81-SFEME2A employs the same 
mechanism to process RFs but the biological relevance of the second reaction step 
is unknown. We favour the hypothesis that MUS81-EME2A performs only the first 
step of the cleavage reaction in vivo, as it is likely that the complex is displaced 
from the substrate once the first cleavage has occurred. 
 
CHAPTER 6 - Discussion 
 
 182 
MUS81-SFEME1 and MUS81-SFEME2A differ in the cleavage mechanism of HR 
intermediate structures such as HJs and D-loops. Although MUS81-SFEME1 does 
not cleave HJs efficiently, it exhibits a preference for mobile over immobile HJs 
(Figure 3.8). It has been suggested that this preference might be due to the ability 
of MUS81-EME1 to recognise and cleave transient flap structures that are formed 
when the mobile HJ undergoes spontaneous thermal denaturation at the junction 
point (Ciccia et al., 2003). Conversely, MUS81-SFEME2A exhibits a 3-fold 
preference for immobile over mobile HJs (Figure 3.8). This difference might be due 
to the fact that MUS81-SFEME1 and MUS81-SFEME2A recognise and bind HJs in 
different manners. Indeed, the cleavage mechanisms of MUS81-SFEME1 and 
MUS81-SFEME2A on immobile HJs are different, with the major cuts inserted by 
MUS81-SFEME1 being closer to the branch point compared to the cleavage sites by 
MUS81-SFEME2A (Figure 3.14).  
 
When D-loops were exposed to the activities of MUS81-SFEME1 and 
MUS81-SFEME2A, we found that, unlike MUS81-SFEME1, MUS81-SFEME2A was 
able to cleave the invading strand 2 and 4 nucleotides on the 5’-side of the invasion 
point, thereby disengaging the D-loop structure (Figure 3.15 and 3.16). This result 
indicates that MUS81-EME2A might function as an anti-recombinase in vivo. 
However, in contrast to the anti-recombinogenic reaction performed by helicases 
(Section 1.2.2), the cleavage of the D-loop by MUS81-SFEME2A would require 
further processing of the structure in order to remove either the invading or the 
displaced DNA strand and restore the duplex DNA. D-loops are intermediates of 
HR-mediated repair of DSBs but they also form at telomeres, where the invasion of 
duplex DNA by the G-rich single-stranded overhang causes the formation of a 
T-loop. The release of the single-stranded G-rich-invading overhang by 
MUS81-EME2A would result in the opening of the T-loop structure, which is 
required to ensure full telomere replication or to promote HR-mediated telomere 
elongation in ALT-positive cells. Recent studies show that mouse cells require the 
activity of the helicase RTEL-1 to dismantle T-loop structures (Vannier et al., 2012). 
Also, in the absence of RTEL-1, T-loops are released in the form of T-circles in a 
reaction catalysed by the SLX1-SLX4 endonuclease. Further investigation is 
required to understand whether the expression and/or the activity of RTEL-1 varies 
according to the cell type and whether cells defective in RTEL-1-mediated T-loop 
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disassembly require the endonucleolytic activity of MUS81-EME2A to dismantle the 
T-loop structure.  
 
Taken together, these results indicate that MUS81-EME1 and MUS81-EME2A are 
3’-flap endonucleases that differ in cleavage efficiency and substrate preference. 
Indeed, MUS81-SFEME2A is more active than MUS81-SFEME1 and it preferentially 
cleaves 3’-flaps and RFs, whereas the nicked HJ is the preferred substrate for 
MUS81-SFEME1. To further investigate the basis of these differences, future 
studies will be aimed at determining the structural properties of MUS81-EME1 and 
MUS81-EME2A. We believe that, depending on whether MUS81 interacts with 
EME1 or EME2A, the complex might adopt a different structural conformation, 
thereby conferring distinct biochemical properties.  
 
EME2A might be the only functional isoform  
To determine whether both EME2 isoforms are translated in human cells, we raised 
a rabbit polyclonal antibody and tested its specificity for western blotting using 
human WCEs. We observed that our antibody could only recognise a band 
corresponding to EME2A (42 kDa), whereas no band at the predicted size of 
EME2B (49 kDa) was detected (Figure 4.1A). Hence, given that we could not 
observe any remarkable difference between the cleavage activities of 
MUS81-SFEME2B and MUS81-SFEME1 (Figure 3.7), we favour the hypothesis that, 
despite the presence of two transcripts, human cells translate only one isoform of 
EME2, i.e. EME2A. We do not, however, exclude the possibility of tissue-specific 
expression.  
 
MUS81, EME1 and EME2 are interdependent 
To address the biological role of EME2 and determine the functional dissection of 
the two MUS81 complexes, we depleted MUS81, EME1 or EME2 (i.e. EME2A and 
EME2B) in human cells. Previous studies had shown that the depletion of MUS81 
or EME1 resulted in the destabilisation of the MUS81-EME1 complex (Forment et 
al., 2011). Similarly, we found that knockdown of MUS81 resulted in the depletion 
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of EME2, whereas the knockdown of EME2 caused approximately 30% decrease 
in the level of MUS81, which is likely to correspond to the fraction of the total 
cellular MUS81 that interacts with EME2 (Figure 4.1A). This data, together with the 
evidence that EME2 does not interact with EME1 (data not shown), indicates that 
MUS81 forms two mutually exclusive complexes with EME1 and EME2. 
  
MUS81-EME2, rather than MUS81-EME1, appears to process stalled RFs 
The biological functions of the MUS81 endonuclease have been widely studied in 
the past years. However, little attention has been paid to understanding whether 
the phenotype observed was related to MUS81-EME1 or MUS81-EME2. For 
example, after prolonged cisplatin or HU treatment, murine Mus81 cleaves stalled 
RFs in order to create one-sided DSBs that are required for the initiation of HR-
mediated DNA repair (Hanada et al., 2007). Without any supporting evidence, this 
activity was related to the Mus81-Eme1 complex. In my work, I determined whether 
the role of human MUS81 at stalled RFs depends on the activity of MUS81-EME1 
or MUS81-EME2. Treatment with increasing concentrations of HU or cisplatin 
induced DSBs in both luciferase-transfected cells and EME1-depleted cells, 
suggesting that EME1 was not required for DSB formation (Figure 4.3 and 4.4). 
Conversely, MUS81- and EME2-depleted cells displayed a significant decrease in 
DSBs, indicating that MUS81-EME2, rather than MUS81-EME1 is important for 
repair of stalled RFs.  
 
Although DSBs are harmful to cells, their formation is essential for the HR-
mediated repair of stalled RFs. If forks are left unrepaired, regions of unreplicated 
DNA accumulate and cause chromosomes to break when sister chromatids 
separate during mitosis. Given the function of Mus81 in the repair of stalled RFs, its 
depletion in HU-treated mouse ES cells results in an increase in chromosomal 
aberrations (Hanada et al., 2007). In human cells, collapse of stalled RFs appears 
to be dependent on the activity of the MUS81-EME2 endonuclease. Hence, it is not 
surprising that, 24 hr after treatment with HU, MUS81- and EME2-depleted cells 
accumulate more chromosomal aberrations than luciferase or EME1 siRNA-treated 
cells, indicating that MUS81-EME2 is required for the maintenance of genomic 
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stability after treatment with HU (Figure 4.6 and Table 4.1). In mouse ES cells, the 
activity of MUS81 is required for the restart of DNA replication (Hanada et al., 
2007). Whether MUS81 is important for RF restart in human cells is unclear. DNA 
fiber analysis of U2OS cells after 24 hr treatment with HU revealed that restart of 
DNA replication occurs by new origin firing and does not depend on MUS81-
mediated DSB formation (Petermann et al., 2010). However, a recent study 
showed that replication restart following HU treatment is impaired in MUS81-
depleted cells (Ying et al., 2013). The reason of this difference is unknown and 
needs further investigation.  
 
When we analysed metaphase spreads from untreated MUS81-, EME1- and 
EME2-depleted cells, we noticed that cells transfected with EME2 siRNA showed 
an elevated frequency of endoreduplication (Figure 4.7). At present, it is unclear 
what causes chromosomes to associate into these ‘butterfly-like’ structures, 
although it is likely that this phenotype results from repetitive failure of chromatid 
segregation during mitosis. Endoreduplication has been observed in human cells 
depleted of XRCC3 and MUS81, albeit at a much lower rate than that observed in 
EME2-depleted cells (Hiyama et al., 2006; Yoshihara et al., 2004). Interestingly, 
depletion of MUS81 dramatically reduced the frequency of diplochromosomes, 
indicating that the high rate of endoreduplication is exclusively due to depletion of 
the MUS81-EME2 complex, whereas loss of all cellular MUS81 alleviates the 
severity of the phenotype.  
 
Evidence for a role of MUS81 in HJ resolution came from studies on BS cells, 
which are defective in the HJ dissolution pathway and display an elevated rate of 
SCEs. Depletion of MUS81 in these cells caused a decrease in the frequency of 
SCEs, indicating that MUS81 contributes to SCE formation (Wechsler et al., 2011). 
To test whether the activity of MUS81 on HJs was dependent on MUS81-EME1 or 
MUS81-EME2, we analysed SCE formation in BS cells depleted of EME1, EME2 or 
MUS81 (Figure 4.9). In line with the role of MUS81-EME2 in the repair of stalled RF, 
we found that cells depleted of EME2 showed SCE frequencies comparable to that 
of control-treated cells, whereas both MUS81 and EME1 depletion caused a 
significant decrease in the frequency of SCEs. Given that SLX4 contributes to SCE 
formation in BS cells and it works in the same pathway of HJ resolution as MUS81, 
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our results further confirm a model in which SLX1-SLX4 and MUS81-EME1 
cooperate to efficiently process dHJs that escape BTR-mediated dissolution. 
 
Interactions between MUS81 and EME2 are cell-cycle dependent 
In further support of the role of MUS81-EME2 during DNA replication, we found 
that the interaction between MUS81 and EME2 is cell cycle-regulated and occurs 
predominantly during S-phase (Figure 4.5). However, given that the level of EME2 
is stable throughout the cell cycle, it is unclear how the formation of the 
MUS81-EME2 complex is prevented (or reduced) during G2 and M phase. 
Although we could not detect a slower-migrating form of EME2 that would indicate 
the presence of a cell cycle-dependent phosphorylation, further studies should be 
aimed at determining whether the cell cycle-specific interaction with MUS81 is 
modulated by post-translational modifications. In addition, it was surprising to 
discover that, like MUS81-EME1, MUS81-EME2 can interact with SLX1-SLX4 and 
XPF-ERCC1 (Figure 4.8). We believe that the low expression level of EME2 has 
been an impediment for its identification as an SLX4-interacting protein in previous 
studies. Also, given that MUS81 interacts with SLX4 predominantly during the 
G2/M phase of the cell cycle, when the level of the MUS81-EME2 complex is low, it 
is likely that SLX1-SLX4 interacts mainly with MUS81-EME1. However, a smaller 
fraction of SLX4 interacts with MUS81 during S-phase. Hence, it is likely that, while 
the majority of SLX1-SLX4 forms a complex with MUS81-EME1 during G2/M, a 
smaller fraction interacts with MUS81-EME2 during S-phase. Whether the 
interaction between SLX1-SLX4-XPF-ERCC1 and MUS81-EME2 is cell cycle 
stage-dependent will be investigated in future studies. 
 
In summary, our results highlight a difference between the biological roles of 
MUS81-EME1 and MUS81-EME2. It is likely that, while MUS81-EME1 cooperates 
with SLX1-SLX4 to process intact HJs by a nick and counter-nick mechanism, the 
activity of MUS81-EME2 is required for the repair of stalled RFs. After prolonged 
treatments with replication stalling agents (e.g. HU or cisplatin), MUS81-EME2 
cleaves stalled RFs to create a one-ended DSB that is required for HR-mediated 
repair (Figure 6.1). Remarkably, the functional difference observed between 
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MUS81-EME1 and MUS81-EME2 is consistent with our biochemical analysis, 
which shows that purified MUS81-EME2 preferentially cleaves 3’-flaps and RF 
substrates, whereas the nicked HJ is the preferred substrate of MUS81-EME1. 
 
MUS81-EME2, but not MUS81-EME1, appears to be required for telomere 
maintenance of ALT cells 
The activity of the MUS81 endonuclease is required for telomere maintenance of 
ALT-positive cells, which are characterised by telomere length heterogeneity and 
by an elevated frequency of T-SCEs (Bryan et al., 1995; Londono-Vallejo et al., 
2004). Loss of MUS81 in ALT-positive cells causes telomere loss and a significant 
decrease in T-SCEs and cell viability (Zeng et al., 2009). Conversely, in 
accordance with the evidence that MUS81 does not associate with telomeres of 
telomerase-positive cells, telomere loss was not observed after depletion of MUS81 
in HT1080, MCF-7 or mouse embryonic fibroblasts. Our findings reveal that the role 
of MUS81 in telomere maintenance of ALT-positive cells might be dependent on 
the activity of MUS81-EME2. In support of this, FISH analysis performed on 
metaphase spreads from MUS81-, EME1- or EME2-depleted ALT-positive cells 
showed that loss of EME2 or MUS81 causes an increase in the frequency of 
telomere-free ends and a significant decrease in the rate of T-SCEs (Figure 5.6, 
5.7, 5.9 and 5.10). Conversely, the fraction of EME1-depleted cells containing 
telomere-free ends and T-SCEs was comparable to that of control-treated cells. 
Also, in line with what was already observed for MUS81, loss of EME2 did not 
cause telomeric loss in ALT-negative cells (Figure 5.8), confirming that the function 
of MUS81-EME2 is specific to cells that use the ALT pathway. 
 
MUS81-EME2 might be required for the processing of stalled RFs at 
telomeres of ALT cells 
Cell cycle distribution analysis of MUS81-, EME1- or EME2-depleted ALT-positive 
and ALT-negative cells revealed that loss of EME2 causes ALT-positive cells to 
accumulate in the G2/M phase of the cell cycle (Figure 5.1 and 5.2). Interestingly, a 
similar phenotype has been observed in RPA-depleted U2OS and GM847 cells and 
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it correlated with the generation of large telomeric aggregates at the ends of 
metaphase chromosomes (Grudic et al., 2007). We observed that depletion of 
EME2 caused a significant increase in chromosome ends carrying multiple 
telomeric signals (Figure 5.11). This feature has been referred to as telomere 
fragility and reflects a defect in the replication of telomeric DNA (Sfeir et al., 2009). 
Telomeres are a difficult substrate for the DNA replication machinery because 
telomeric repeats promote the formation of G4 quadruplexes. Remarkably, in 
ALT-positive cells, many chromosome ends display telomere fragility 
(approximately 2.3%, Figure 5.11) and depletion of proteins involved in the repair of 
stalled RFs like FEN1, WRN, FANCD2 and MUS81 causes an elevated rate of 
telomere loss (Crabbe et al., 2004; Fan et al., 2009; Saharia and Stewart, 2009; 
Zeng et al., 2009). It is likely that ALT-positive cells are more sensitive to defects in 
the repair of stalled RFs and, given that telomere replication is unidirectional and 
starts from the sub-telomeric region, unrepaired stalled RFs can cause the loss of 
the distal telomeric sequences. Therefore, our finding that MUS81-EME2 functions 
in the repair of stalled RFs upon replication stress might explain the requirement for 
the MUS81-EME2 complex in telomere maintenance of ALT-positive cells.  
 
The efficient repair of stalled RFs is essential to avoid the accumulation of 
unreplicated DNA, which constitutes an impediment to the correct chromosome 
segregation during cell division. Defects in sister chromatid disjunction during 
anaphase cause genomic instability and induce mitotic aberrations such as lagging 
chromosomes and DAPI-positive bulky bridges (Figure 5.12). In line with a role of 
MUS81-EME2 in the repair of stalled RFs at telomeres of ALT-positive cells, we 
observed that depletion of EME2 in U2OS cells results in an elevated frequency of 
mitotic aberrations, whereas the number of EME2-depleted HeLa Kyoto cells 
displaying bridges and laggards was not significantly different from that of cells 
transfected with luciferase siRNA (Figure 5.13). Interestingly, loss of EME1 caused 
a significant increase in mitotic aberrations in both ALT-positive and ALT-negative 
cells, suggesting that the function of EME1 is required for the maintenance of 
genomic stability and for proper chromosome segregation.  
 
It has been proposed that elongation of telomeres in ALT-positive cells occurs at 
APBs (Draskovic et al., 2009). We found that both EME1 and EME2 localise to 
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APBs, indicating a role for MUS81-EME1 and MUS81-EME2 in telomere 
lengthening (Figure 5.4 and 5.5). We believe that the presence of EME1 at APBs 
might be related to the function of the MUS81-EME1 complex in the processing of 
recombination intermediates that are generated during ALT. Also, as described 
before, processing of stalled RFs by MUS81-EME2 creates a one-ended DSB that 
triggers HR and the formation of HJs, which are substrates of the SLX-MUS 
complex. 
 
MUS81-depleted cells exhibit a milder phenotype than EME2-depleted cells 
Finally, in all the experiments performed in this study, we observed that the 
phenotype displayed by EME2-depleted cells was more severe that that of 
MUS81-depleted cells. Remarkably, we reported that co-depletion of EME2 and 
MUS81 could rescue both the elevated frequency of endoreduplication in 
EME2-depleted RPE-1 hTERT cells (Figure 4.7) and the G2/M arrest caused by 
the loss of EME2 in ALT-positive cells (Figure 5.3). Although a clear explanation for 
this result is missing, we propose a scenario in which, given that loss of EME2 
causes the depletion of the fraction of MUS81 that interacts with EME2, the 
residual MUS81, in complex with EME1, functions as a dominant negative. Hence, 
only the complete depletion of MUS81 induces cells to employ other 
MUS81-independent DNA repair pathways. Furthermore, the observation that loss 
of EME1 does not trigger a cell cycle arrest may be due to the presence of two 
redundant mechanisms of HJ resolution in human cells, whereby HJs that have 
escaped resolution by the SLX-MUS complex are processed by the HJ resolvase 
GEN1 later in the cell cycle. In conclusion, on the basis of the observation that both 
MUS81-EME1 and MUS81-EME2 can interact with SLX1-SLX4 and XPF-ERCC1 
(Figure 4.8), we believe that future studies should focus on the biological relevance 
of these two multi-nuclease complexes and on the contribution of SLX1-SLX4 to 
the activity of MUS81-EME2. 
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Conclusions 
Previous studies conducted to determine the cellular role of the MUS81 
endonuclease have often disregarded the existence of two MUS81 complexes in 
higher eukaryotes: MUS81-EME1 and MUS81-EME2. In this study, we investigate 
the functional differences between the two human MUS81 heterodimers and we 
provide evidence for distinct biological roles of MUS81-EME1 and MUS81-EME2: 
while MUS81-EME1 co-operates with SLX1-SLX4 to resolve joint molecules that 
are formed during HR-mediated DSB repair, MUS81-EME2 cleaves stalled RFs 
and creates one-ended DSBs that are substrates for HR-mediated RF repair. 
Hence, we believe that future studies should be more regardful of the existence of 
two human MUS81 complexes and should discriminate between the activities of 
MUS81-EME1 and MUS81-EME2. 
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Figure 6.1 Model for MUS81-EME2 and MUS81-EME1 functions in the repair 
of stalled RFs 
MUS81-EME2 cleaves stalled RFs to create a one-ended DSB. RAD51-mediated 
strand invasion initiates HR and results in the formation of a D-loop structure. 
Resolution of the single HJ by SLX1-SLX4 and MUS81-EME1 restores the RF and 
allows DNA replication to restart. In a scenario in which DNA replication restarts by 
the firing of new origins, RAD51-mediated strand invasion is followed by second-
end capture and by the formation of a dHJ, which can be processed by BTR-
mediated dissolution or by SLX-MUS/GEN1-mediated resolution. 
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